Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


Articles published in J Alzheimers Dis

Retrieve available abstracts of 1823 articles:
HTML format



Single Articles


    March 2024

  1. Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer's Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-239016.
    PubMed    


  2. GOHEL D, Zhang P, Gupta AK, Li Y, et al
    Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-231391.
    PubMed     Abstract available


  3. YANG J, Liu X, Oveisgharan S, Zammit AR, et al
    Inferring Alzheimer's Disease Pathologic Traits from Clinical Measures in Living Adults.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-230639.
    PubMed     Abstract available


    February 2024
  4. WANG CS, Chen PS, Tsai TY, Hou NT, et al
    Cognitive Effect of Transcranial Direct Current Stimulation on Left Dorsolateral Prefrontal Cortex in Mild Alzheimer's Disease: A Randomized, Double-Blind, Cross-Over Small-Scale Exploratory Study.
    J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-240002.
    PubMed     Abstract available


  5. LI S, Lan X, Liu Y, Zhou J, et al
    Unlocking the Potential of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease: A Meta-Analysis of Randomized Clinical Trials to Optimize Intervention Strategies.
    J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-231031.
    PubMed     Abstract available


  6. LU TV, Grill JD, Gillen DL
    Study Partner Type and Adverse Event Reporting in Mild-to-Moderate Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231283.
    PubMed     Abstract available


  7. SIGURDSSON EM
    Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231238.
    PubMed     Abstract available


  8. GARCIA-ALBERCA JM, de Rojas I, Sanchez-Mejias E, Garrido-Martin D, et al
    An Insertion Within SIRPbeta1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231150.
    PubMed     Abstract available


  9. CHI HC, Ma LZ, Wang ZB, Sheng ZH, et al
    Associations of Frailty with Neuropsychiatric Symptoms of Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231111.
    PubMed     Abstract available


  10. ROSSI E, Marrosu F, Saba L
    Music Therapy as a Complementary Treatment in Patients with Dementia Associated to Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230852.
    PubMed     Abstract available


  11. NJOMBORO P, Lekhutlile T
    The Effect of Apathy and Depressive Syndromes on Functional Outcomes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230426.
    PubMed     Abstract available


  12. VERWAERDE P, Estrella C, Burlet S, Barrier M, et al
    First-In-Human Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of AZP2006, A Synthetic Compound for the Treatment of Alzheimer's Disease and Related Diseases.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-220883.
    PubMed     Abstract available


  13. KUMARI S, Kaur P, Singh AK, Ashar MS, et al
    Quantification of COX-2 Level in Alzheimer's Disease Patients to Develop Potential Blood-Based Biomarker for Early Diagnosis and Therapeutic Target.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-231445.
    PubMed     Abstract available


  14. KAVOOSI S, Shahraki A, Sheervalilou R
    Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230966.
    PubMed     Abstract available


  15. SABBIR MG
    Cholinergic Receptor Muscarinic 1 Co-Localized with Mitochondria in Cultured Dorsal Root Ganglion Neurons, and Its Deletion Disrupted Mitochondrial Ultrastructure in Peripheral Neurons: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230883.
    PubMed     Abstract available


  16. CULIBRK RA, Ebbert KA, Yeisley DJ, Chen R, et al
    Impact of Suramin on Key Pathological Features of Sporadic Alzheimer's Disease-Derived Forebrain Neurons.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230600.
    PubMed     Abstract available


  17. KAMEYAMA H, Tagai K, Takasaki E, Kashibayashi T, et al
    Examining Frontal Lobe Asymmetry and Its Potential Role in Aggressive Behaviors in Early Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-231306.
    PubMed     Abstract available


  18. VAISHNAV N, Gonzalez R, Karunungan K, Tyler A, et al
    Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-230067.
    PubMed     Abstract available


  19. ADAMS JA, Uryash A, Lopez JR
    Harnessing Passive Pulsatile Shear Stress for Alzheimer's Disease Prevention and Intervention.
    J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-231010.
    PubMed     Abstract available


  20. RAPOS PEREIRA F, George N, Dalla Barba G, Dubois B, et al
    The Memory Binding Test Detects Early Subtle Episodic Memory Decline in Preclinical Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-230921.
    PubMed     Abstract available


  21. COGRAM P, Garduno BM, Ren B, Xu X, et al
    First International Conference on Unconventional Animal Models of Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-249004.
    PubMed     Abstract available


  22. ACHARYA NK, Grossman HC, Clifford PM, Levin EC, et al
    A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.
    J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-231028.
    PubMed     Abstract available


  23. CZUCZWAR SAJ, Kocki J, Miziak B, Bogucki J, et al
    Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231333.
    PubMed     Abstract available


  24. RAJABLI F, Seixas AA, Akgun B, Adams LD, et al
    African Ancestry Individuals with Higher Educational Attainment are Resilient to Alzheimer's Disease Measured by pTau181.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231116.
    PubMed     Abstract available


  25. SUN H, Li P, Gao L, Yang J, et al
    Altered Motor Activity Patterns within 10-Minute Timescale Predict Incident Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230928.
    PubMed     Abstract available


  26. NELSON D, Thompson KJ, Wang L, Wang Z, et al
    Pericyte Control of Gene Expression in the Blood-Brain Barrier Endothelium: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230907.
    PubMed     Abstract available


  27. GILLS JL, Bubu OM
    Obstructive Sleep Apnea and Alzheimer's Disease Pathology: Is Sleep Architecture the Missing Key?
    J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-231385.
    PubMed     Abstract available


  28. KIM SA, Maeda M, Murata F, Fujii T, et al
    Impact of Concurrent Visual and Hearing Impairment on Incident Alzheimer's Disease: The LIFE Study.
    J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-230806.
    PubMed     Abstract available


  29. JU IG, Lee S, Kim SH, Im H, et al
    Trichosanthis Semen Exerts Neuroprotective Effects in Alzheimer's Disease Models by Inhibiting Amyloid-beta Accumulation and Regulating the Akt and ERK Signaling Pathways.
    J Alzheimers Dis. 2024 Feb 13. doi: 10.3233/JAD-231124.
    PubMed     Abstract available


  30. LI Z, Fan Z, Zhang Q
    The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024 Feb 7. doi: 10.3233/JAD-230799.
    PubMed     Abstract available


  31. GEPHINE L, Roux CM, Freret T, Boulouard M, et al
    Vulnerability of Spatial Pattern Separation in 5xFAD Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-231112.
    PubMed     Abstract available


  32. DE LA MONTE SM, Tong M
    Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230881.
    PubMed     Abstract available


  33. GIULIETTI MV, Fabbietti P, Spatuzzi R, Vespa A, et al
    Effects of Mindfulness Based Interventions in Adults and Older Adults Caregivers of Patients with Early Stage Alzheimer's Disease: A Randomized Pilot Study.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230284.
    PubMed     Abstract available


    January 2024
  34. MONE P, De Luca A, Kansakar U, Santulli G, et al
    Leukocytes and Endothelial Cells Participate in the Pathogenesis of Alzheimer's Disease: Identifying New Biomarkers Mirroring Metabolic Alterations.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231464.
    PubMed     Abstract available


  35. ZHANG X, Haeri M, Swerdlow RH, Wang N, et al
    Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231303.
    PubMed     Abstract available


  36. SIBLE IJ, Nation DA
    Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230930.
    PubMed     Abstract available


  37. NOORI A, Jayakumar R, Moturi V, Li Z, et al
    Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230884.
    PubMed     Abstract available


  38. WHEELER KV, Irimia A, Braskie MN
    Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230553.
    PubMed     Abstract available


  39. JIAO L, Jing Z, Zhang W, Su X, et al
    Codon Pattern and Context Analysis in Genes Triggering Alzheimer's Disease and Latent Tau Protein Aggregation Post-Anesthesia Exhibited Unique Molecular Patterns Associated with Functional Aspects.
    J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-231142.
    PubMed     Abstract available


  40. NG PY, Zhang C, Li H, Baker DJ, et al
    Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.
    J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-230465.
    PubMed     Abstract available


  41. CABAN-HOLT A, Cuccaro ML, Lloyd SL, Starks TD, et al
    Attitudes and Perceptions about Brain Donation Among African Americans: Implications for Recruitment into Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Jan 29. doi: 10.3233/JAD-230461.
    PubMed     Abstract available


  42. BELKHELFA M, Bekrar S, Rezaig L, Beder N, et al
    Neuroinflammatory Responses Occur in Brain Lesions During Alzheimer's Disease: Postmortem Case Report.
    J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230910.
    PubMed     Abstract available


  43. WEI G, Tian X, Yang H, Luo Y, et al
    Adjunct Methods for Alzheimer's Disease Detection: A Review of Auditory Evoked Potentials.
    J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230822.
    PubMed     Abstract available


  44. TAKASE H, Hamanaka G, Hoshino T, Ohtomo R, et al
    Transcriptomic Profiling Reveals Neuroinflammation in the Corpus Callosum of a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-231049.
    PubMed     Abstract available


  45. OKINAKA Y, Shinagawa Y, Claussen C, Gul S, et al
    RNA Analysis of Circulating Leukocytes in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230874.
    PubMed     Abstract available


  46. SAEED A, Alharazi T, Alshaghdali K, Rezgui R, et al
    Targeting GluR3 in Depression and Alzheimer's Disease: Novel Compounds and Therapeutic Prospects.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230821.
    PubMed     Abstract available


  47. VILLEMAGNE VL, Dore V, Chong L, Kassiou M, et al
    Brain 11beta-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem Assessed by PET in Alzheimer's Disease and Cognitively Normal Individuals.
    J Alzheimers Dis. 2024 Jan 19. doi: 10.3233/JAD-220542.
    PubMed     Abstract available


  48. ZHOU J, Zhao M, Yang Z, Chen L, et al
    Exploring the Value of MRI Measurement of Hippocampal Volume for Predicting the Occurrence and Progression of Alzheimer's Disease Based on Artificial Intelligence Deep Learning Technology and Evidence-Based Medicine Meta-Analysis.
    J Alzheimers Dis. 2024 Jan 18. doi: 10.3233/JAD-230733.
    PubMed     Abstract available


  49. GORHAM IK, Reid DM, Sun J, Zhou Z, et al
    Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.
    J Alzheimers Dis. 2024 Jan 16. doi: 10.3233/JAD-230880.
    PubMed     Abstract available


  50. KURANO M, Saito Y, Yatomi Y
    Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 13. doi: 10.3233/JAD-230942.
    PubMed     Abstract available


  51. CHEN M, Wang F, Lei H, Yang Z, et al
    In Silico Insights into Micro-Mechanism Understanding of Extracts of Taxus Chinensis Fruits Against Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-231066.
    PubMed     Abstract available


  52. FORT-AZNAR L, Molina-Porcel L, Ramos-Campoy O, Esteller D, et al
    Misfolded alpha-Synuclein in Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230919.
    PubMed     Abstract available


  53. SMITH HS, Robinson JO, Levchenko A, Pereira S, et al
    Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230609.
    PubMed     Abstract available


  54. HAN Y, Huang C, Pan Y, Gu X, et al
    Single Cell Sequencing Technology and Its Application in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230861.
    PubMed     Abstract available


  55. WU LY, Chong JR, Chong JPC, Hilal S, et al
    Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230811.
    PubMed     Abstract available


  56. ZHANG C, Lei X, Ma W, Long J, et al
    Diagnosis Framework for Probable Alzheimer's Disease and Mild Cognitive Impairment Based on Multi-Dimensional Emotion Features.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230703.
    PubMed     Abstract available


  57. STONE J, Mitrofanis J, Johnstone DM, Robinson SR, et al
    The Catastrophe of Intracerebral Hemorrhage Drives the Capillary-Hemorrhage Dementias, Including Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-231202.
    PubMed     Abstract available


  58. SAFIEH M, Liraz O, Ovadia M, Michaelson D, et al
    The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230514.
    PubMed     Abstract available


  59. FAN X, Cai Y, Zhao L, Liu W, et al
    Machine Learning-Derived MRI-Based Neurodegeneration Biomarker for Alzheimer's Disease: A Multi-Database Validation Study.
    J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230574.
    PubMed     Abstract available


  60. VALENTIN-ESCALERA J, Leclerc M, Calon F
    High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?
    J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230118.
    PubMed     Abstract available


  61. SELLES MC, Oliveira MM
    The Oxytocin Puzzle: Unlocking Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 3. doi: 10.3233/JAD-231127.
    PubMed     Abstract available


  62. LI J, Yang M, Wei R, Cao Y, et al
    The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer's Disease Continuum: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024 Jan 2. doi: 10.3233/JAD-231080.
    PubMed     Abstract available


  63. NADEAU PA, Jobin B, Boller B
    Erratum to: Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024;97:521.
    PubMed    



  64. The Journal of Alzheimer's Disease Is Happy to Announce the Appointment of Paula I. Moreira, PhD, as Co-Editor-in-Chief of the Journal.
    J Alzheimers Dis. 2024;97:1.
    PubMed    


  65. ANGELIDOU IA, Stocker H, Beyreuther K, Teichmann B, et al
    Validation of the "Perceptions Regarding pRE-Symptomatic Alzheimer's Disease Screening" (PRE-ADS) Questionnaire in the German Population: Attitudes, Motivations, and Barriers to Pre-Symptomatic Dementia Screening.
    J Alzheimers Dis. 2024;97:309-325.
    PubMed     Abstract available


  66. ZENG Y, Cao S, Pang K, Tang J, et al
    Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2024;97:229-237.
    PubMed     Abstract available


  67. DE SIMONE MS, Spalletta G, Vecchio D, Bassi A, et al
    The Role of the Anterior Thalamic Nuclei in the Genesis of Memory Disorders in Alzheimer's Disease: An Exploratory Study.
    J Alzheimers Dis. 2024;97:507-519.
    PubMed     Abstract available


  68. ALSHAHERI DURAZO A, Weigand AJ, Bangen KJ, Membreno R, et al
    Type 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans.
    J Alzheimers Dis. 2024;97:219-228.
    PubMed     Abstract available


  69. LOBUE C, Stopschinski BE, Saez Calveras N, Douglas PM, et al
    Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort.
    J Alzheimers Dis. 2024;97:345-358.
    PubMed     Abstract available


  70. GUO Y, Sun Y, Li M, Qi WY, et al
    Amyloid Pathology Modulates the Associations of Neuropsychiatric Symptoms with Cognitive Impairments and Neurodegeneration in Non-Demented Elderly.
    J Alzheimers Dis. 2024;97:471-484.
    PubMed     Abstract available


  71. LAPEYRE L, Piret J, Rheaume C, Pons V, et al
    Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-beta Pathology in APP/PS1 Mice.
    J Alzheimers Dis. 2024;97:171-178.
    PubMed     Abstract available


  72. MARTIN J, Reid N, Ward DD, King S, et al
    Investigating Sex Differences in Risk and Protective Factors in the Progression of Mild Cognitive Impairment to Dementia: A Systematic Review.
    J Alzheimers Dis. 2024;97:101-119.
    PubMed     Abstract available


  73. YANG M, Gan J, Liu S, Yang Y, et al
    Associations Between Plasma Orexin-A Level and Constipation in Cognitive Impairment.
    J Alzheimers Dis. 2024;97:409-419.
    PubMed     Abstract available


  74. KIM REY, Lee M, Kang DW, Wang SM, et al
    Increased Likelihood of Dementia with Coexisting Atrophy of Multiple Regions of Interest.
    J Alzheimers Dis. 2024;97:259-271.
    PubMed     Abstract available


  75. NA S, Lee C, Ho S, Hong YJ, et al
    A Longitudinal Study on Memory Enhancement in Subjective Cognitive Decline Patients: Clinical and Neuroimaging Perspectives.
    J Alzheimers Dis. 2024;97:193-204.
    PubMed     Abstract available


  76. POSSEMIS N, Ter Huurne D, Banning L, Gruters A, et al
    The Reliability and Clinical Validation of Automatically-Derived Verbal Memory Features of the Verbal Learning Test in Early Diagnostics of Cognitive Impairment.
    J Alzheimers Dis. 2024;97:179-191.
    PubMed     Abstract available


  77. BRUNO JL, Shaw JS, Hosseini SMH
    Toward Personalized Cognitive Training in Older Adults: A Pilot Investigation of the Effects of Baseline Performance and Age on Cognitive Training Outcomes.
    J Alzheimers Dis. 2024;97:327-343.
    PubMed     Abstract available


  78. DE LA PERRELLE L
    Health Care Is Not Enough to Prevent Dementia.
    J Alzheimers Dis. 2024;97:951-952.
    PubMed     Abstract available


  79. DIGMA LA, Winer JR, Greicius MD
    Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.
    J Alzheimers Dis. 2024;97:567-572.
    PubMed     Abstract available


  80. FRENTZ I, van Arendonk J, Leeuwis AE, Vernooij MW, et al
    Interaction Between Arteriosclerosis and Amyloid-beta on Cognitive Function.
    J Alzheimers Dis. 2024;97:953-961.
    PubMed     Abstract available


  81. MATERS J, van der Steen JT, de Vugt ME, Bakker C, et al
    Palliative Care in Nursing Home Residents with Young-Onset Dementia: Professional and Family Caregiver Perspectives.
    J Alzheimers Dis. 2024;97:573-586.
    PubMed     Abstract available


  82. SCHRODER VE, Skrozic A, Erz D, Kaysen A, et al
    Programme Dementia Prevention (pdp): A Nationwide Program for Personalized Prevention in Luxembourg.
    J Alzheimers Dis. 2024;97:791-804.
    PubMed     Abstract available


  83. DINGLE SE, Milte CM, Daly RM, Torres SJ, et al
    Attitudes and Considerations for Multidomain Lifestyle Approaches to Dementia Prevention: A Qualitative Study.
    J Alzheimers Dis. 2024;97:939-949.
    PubMed     Abstract available


  84. KOSEL F, Hartley MR, Franklin TB
    Aberrant Cortical Activity in 5xFAD Mice in Response to Social and Non-Social Olfactory Stimuli.
    J Alzheimers Dis. 2024;97:659-677.
    PubMed     Abstract available


  85. REHMAN H, Ang TFA, Tao Q, Espenilla AL, et al
    Comparison of Commonly Measured Plasma and Cerebrospinal Fluid Proteins and Their Significance for the Characterization of Cognitive Impairment Status.
    J Alzheimers Dis. 2024;97:621-633.
    PubMed     Abstract available


  86. REN J, Yu Y, Wang Y, Dong Y, et al
    Association Between Urinary Glyphosate Exposure and Cognitive Impairment in Older Adults from NHANES 2013-2014.
    J Alzheimers Dis. 2024;97:609-620.
    PubMed     Abstract available


  87. MAZZOLA P, Zanetti M, Ferraguzzi G, Villa ML, et al
    Shifting the Paradigm of Nursing Home Care for People with Dementia: The Italian Experience of Il Paese Ritrovato and the Impact of SARS-CoV-2.
    J Alzheimers Dis. 2024;97:741-752.
    PubMed     Abstract available


  88. BRITZ J, Ojo E, Haque N, Dhukhwa A, et al
    Sex-Dependent Effects of Chronic Circadian Disruption in AbetaPP/PS1 Mice.
    J Alzheimers Dis. 2024;97:855-870.
    PubMed     Abstract available


  89. GURJAR P, Khan AA, Alanazi AM, Vasil'ev VG, et al
    Molecular Dissection of Herpes Simplex Virus Type 1 to Elucidate Molecular Mechanisms Behind Latency and Comparison of Its Codon Usage Patterns with Genes Modulated During Alzheimer's Disease as a Part of Host-Pathogen Interaction.
    J Alzheimers Dis. 2024;97:1111-1123.
    PubMed     Abstract available


  90. SCHWINNE M, Alonso A, Roberts BR, Hickle S, et al
    The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa.
    J Alzheimers Dis. 2024;97:1353-1363.
    PubMed     Abstract available


  91. ASIAMAH EA, Feng B, Guo R, Yaxing X, et al
    The Contributions of the Endolysosomal Compartment and Autophagy to APOEvarepsilon4 Allele-Mediated Increase in Alzheimer's Disease Risk.
    J Alzheimers Dis. 2024;97:1007-1031.
    PubMed     Abstract available


  92. PLASSMAN BL, Ford CB, Smith VA, DePasquale N, et al
    Elevated Amyloid-beta PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.
    J Alzheimers Dis. 2024;97:1161-1171.
    PubMed     Abstract available


  93. ROBILLARD JM, Masellis M, Martin SE, Khachaturian AS, et al
    The Return of Biomarker Results in Research: Balancing Complexity, Precision, and Ethical Responsibility.
    J Alzheimers Dis. 2024;97:1083-1090.
    PubMed     Abstract available


  94. PANZAVOLTA A, Cerami C, Marcone A, Zamboni M, et al
    Diagnostic Performance of Socio-Emotional Informant-Based Questionnaires for the Clinical Detection of the Behavioral Variant of Frontotemporal Dementia.
    J Alzheimers Dis. 2024;97:1249-1260.
    PubMed     Abstract available


  95. OKAHASHI S, Noguchi T, Ishihara M, Osawa A, et al
    Dyadic Art Appreciation and Self-Expression Program (NCGG-ART) for People with Dementia or Mild Cognitive Impairment and Their Family Caregivers: A Feasibility Study.
    J Alzheimers Dis. 2024;97:1435-1448.
    PubMed     Abstract available


  96. DU P, Zhang X, Lian X, Holscher C, et al
    O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.
    J Alzheimers Dis. 2024;97:1051-1068.
    PubMed     Abstract available


  97. SHANG L, Dong L, Huang X, Chu S, et al
    Comorbidity of Dementia: A Cross-Sectional Study of PUMCH Dementia Cohort.
    J Alzheimers Dis. 2024;97:1313-1322.
    PubMed     Abstract available


  98. ALEGRET M, Garcia-Gutierrez F, Munoz N, Espinosa A, et al
    FACEmemory(R), an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.
    J Alzheimers Dis. 2024;97:1173-1187.
    PubMed     Abstract available


  99. MARIN-MARIN L, Renau-Lagranja J, Avila C, Costumero V, et al
    Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;97:1341-1351.
    PubMed     Abstract available


  100. TSENG YT, Chang YL, Chiu YS
    Assessment of Language Function in Older Mandarin-Speaking Adults with Mild Cognitive Impairment using Multifaceted Language Tests.
    J Alzheimers Dis. 2024;97:1189-1209.
    PubMed     Abstract available


  101. KARAYIANNIS CC, Srikanth V, Beare R, Mehta H, et al
    Type 2 Diabetes and Biomarkers of Brain Structure, Perfusion, Metabolism, and Function in Late Mid-Life: A Multimodal Discordant Twin Study.
    J Alzheimers Dis. 2024;97:1223-1233.
    PubMed     Abstract available


  102. ZAWISLAK-FORNAGIEL K, Ledwon D, Bugdol M, Grazynska A, et al
    Quantitative EEG Spectral and Connectivity Analysis for Cognitive Decline in Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;97:1235-1247.
    PubMed     Abstract available


  103. FERINI-STRAMBI L
    Which Are the Most Reliable Sleep Parameters that Predict Cognitive Decline and Alzheimer's Disease?
    J Alzheimers Dis. 2024;97:1641-1643.
    PubMed     Abstract available


  104. KANG J, Park M, Kim T
    Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024;97:1939-1950.
    PubMed     Abstract available


  105. GROECHEL RC, Liu AC, Koton S, Kucharska-Newton AM, et al
    Associations Between Mid-Life Psychosocial Measures and Estimated Late Life Amyloid Burden: The Atherosclerosis Risk in Communities (ARIC)-PET Study.
    J Alzheimers Dis. 2024;97:1901-1911.
    PubMed     Abstract available


  106. BACHAND AM, Dell LD
    Can Incorrect Analysis of Time-Dependent Exposure Explain Associations between PM2.5 Exposure and Risk of Dementia?
    J Alzheimers Dis. 2024;97:1931-1937.
    PubMed     Abstract available


  107. VERMEULEN RJ, Roudijk B, Govers TM, Rovers MM, et al
    Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life.
    J Alzheimers Dis. 2024;97:1829-1840.
    PubMed     Abstract available


  108. HARRIS JL, Wang X, Christian SK, Novikova L, et al
    Traumatic Brain Injury Alters the Trajectory of Age-Related Mitochondrial Change.
    J Alzheimers Dis. 2024;97:1793-1806.
    PubMed     Abstract available


  109. VALENCIA-OLVERA AC, Balu D, Moore A, Shah M, et al
    APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-beta42 Levels in Non-Hyperlipidemic Mice.
    J Alzheimers Dis. 2024;97:1629-1639.
    PubMed     Abstract available


  110. ZHANG S, Ai H, Wang J, Liu T, et al
    Reduced Prefrontal-Thalamic Theta Flow During Working Memory Retrieval in APP/PS1 Mice.
    J Alzheimers Dis. 2024;97:1737-1749.
    PubMed     Abstract available


  111. DAI Y, Hsu YC, Fernandes BS, Zhang K, et al
    Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach.
    J Alzheimers Dis. 2024;97:1807-1827.
    PubMed     Abstract available


  112. HEIKKINEN AL, Paajanen TI, Hanninen T, Tikkanen V, et al
    Neuropsychological Profiles, Etiologies, and Medical Comorbidities in Early-Onset Dementia and Cognitive Impairment: A Memory Outpatient Clinic Cohort Study.
    J Alzheimers Dis. 2024;97:1765-1776.
    PubMed     Abstract available


  113. VESTIN E, Bostrom G, Olsson J, Elgh F, et al
    Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study.
    J Alzheimers Dis. 2024;97:1841-1850.
    PubMed     Abstract available


  114. ARMSTRONG MJ, Barnes LL
    Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors.
    J Alzheimers Dis. 2024;97:1571-1580.
    PubMed     Abstract available


  115. CUI X, Wang J, Wu B, Zhao Q, et al
    Interventions for Persons with Young-Onset Dementia and Their Families: A Scoping Review.
    J Alzheimers Dis. 2024;97:1519-1531.
    PubMed     Abstract available


  116. FINCH CE, Burstein SM
    Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.
    J Alzheimers Dis. 2024;97:1581-1588.
    PubMed     Abstract available


    December 2023
  117. AHMED T, Zhang P, Kumar K
    Equilibrium of Dietary Patterns Between Alzheimer's Disease Patients and Healthy People: A Comprehensive Analysis Using Multiple Factor Analysis and Classification Modeling.
    J Alzheimers Dis. 2023 Dec 30. doi: 10.3233/JAD-230634.
    PubMed     Abstract available


  118. RICCI F, Martorana A, Bonomi CG, Serafini C, et al
    Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer's Disease Continuum: A Retrospective Observational Study.
    J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230792.
    PubMed     Abstract available


  119. ALMKVIST O, Larsson M, Graff C
    Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230618.
    PubMed     Abstract available


  120. ZHANG E, Dai F
    Diagnostic Model for Alzheimer's Disease Based on PANoptosis-Related Genes.
    J Alzheimers Dis. 2023 Dec 28. doi: 10.3233/JAD-231103.
    PubMed     Abstract available


  121. WEINBERG MS, He Y, Kivisakk P, Arnold SE, et al
    Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230899.
    PubMed     Abstract available


  122. FAN X, Li H, Liu L, Zhang K, et al
    Early Diagnosing and Transformation Prediction of Alzheimer's Disease Using Multi-Scaled Self-Attention Network on Structural MRI Images with Occlusion Sensitivity Analysis.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230705.
    PubMed     Abstract available


  123. MIYANO T, Ayukawa Y, Anada T, Takahashi I, et al
    Association Between Reduced Posterior Occlusal Contact and Alzheimer's Disease Onset in Older Japanese Adults: Results from the LIFE Study.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230449.
    PubMed     Abstract available


  124. MORIN P, Aguilar BJ, Li X, Chen J, et al
    Alzheimer's Disease Stage Transitions Among United States Veterans.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230850.
    PubMed     Abstract available


  125. MAHZARNIA A, Lutz MW, Badea A
    A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230934.
    PubMed     Abstract available


  126. GE Y, AlObaidi AS, Kuchel GA, Bartley JM, et al
    Dysfunctional Bladder Morphology and Functional Impairments Are Identified in the Alzheimer's Disease APPNL-G-F/NL-G-F Murine Model.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230547.
    PubMed     Abstract available


  127. ROBINSON CG, Coleman T, Buciuc M, Singh NA, et al
    Behavioral and Neuropsychiatric Differences Across Two Atypical Alzheimer's Disease Variants: Logopenic Progressive Aphasia and Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-230652.
    PubMed     Abstract available


  128. EL HAFFAF LM, Ronat L, Cannizzaro A, Hanganu A, et al
    Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-220857.
    PubMed     Abstract available


  129. LI KY, Lin BT, Hsu ST, Chien CF, et al
    Quetiapine Oral Solution in Alzheimer's Disease: Efficacy and Dosage Insights from a Real-World Retrospective Study.
    J Alzheimers Dis. 2023 Dec 20. doi: 10.3233/JAD-231007.
    PubMed     Abstract available


  130. LOJO-RAMIREZ JA, Guerra-Gomez M, Marin-Cabanas AM, Fernandez-Rodriguez P, et al
    Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 19. doi: 10.3233/JAD-230744.
    PubMed     Abstract available


  131. KEIZER HG, Brands R, Oosting RS, Seinen W, et al
    The Carnitine Palmitoyl-Transferase 2 Cascade Hypothesis for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230991.
    PubMed     Abstract available


  132. PARK YS, Joo HJ, Jang YS, Jeon H, et al
    Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.
    J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230715.
    PubMed     Abstract available


  133. BAPAT R, Ma D, Duong TQ
    Predicting Four-Year's Alzheimer's Disease Onset Using Longitudinal Neurocognitive Tests and MRI Data Using Explainable Deep Convolutional Neural Networks.
    J Alzheimers Dis. 2023 Dec 16. doi: 10.3233/JAD-230893.
    PubMed     Abstract available


  134. JANG YJ, Choi MG, Yoo BJ, Lee KJ, et al
    Interaction Between a High-Fat Diet and Tau Pathology in Mice: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230927.
    PubMed     Abstract available


  135. MALOTAUX V, Colmant L, Quenon L, Huyghe L, et al
    Suspecting Non-Alzheimer's Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230696.
    PubMed     Abstract available


  136. UKRAINTSEVA S, Duan H, Holmes R, Bagley O, et al
    Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-220998.
    PubMed     Abstract available


  137. ANSCHUETZ A, Schwab K, Harrington CR, Wischik CM, et al
    A Meta-Analysis on Presynaptic Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-231034.
    PubMed     Abstract available


  138. DA X, Hempel E, Ou Y, Rowe OE, et al
    Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-230506.
    PubMed     Abstract available


  139. NGUYEN SA, Oughli HA, Lavretsky H
    Use of Complementary and Integrative Medicine for Alzheimer's Disease and Cognitive Decline.
    J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-230710.
    PubMed     Abstract available


  140. SCHMUED L, Maloney B, Schmued C, Lahiri DK, et al
    Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-221285.
    PubMed     Abstract available


    November 2023
  141. HAO N, Bai X, Hu A, Zhao G, et al
    Assessing the Global, Regional, and National Impact of High Body Mass Index on Alzheimer's Disease and Other Dementias Between 1990 and 2019.
    J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230827.
    PubMed     Abstract available


  142. LI Y, Chen X, Zhou M, Feng S, et al
    Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230273.
    PubMed     Abstract available


  143. CARPI M, Fernandes M, Mercuri NB, Liguori C, et al
    Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.
    J Alzheimers Dis. 2023 Nov 29. doi: 10.3233/JAD-230933.
    PubMed     Abstract available


  144. WANG Y, Jiang R, Li M, Wang Z, et al
    Characteristics of T Cells in Single-Cell Datasets of Peripheral Blood and Cerebrospinal Fluid in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2023 Nov 27. doi: 10.3233/JAD-230784.
    PubMed     Abstract available


  145. ZHANG X, Wu P, Zhao Y
    COVID-19 in Relation to Alzheimer's Disease: Mendelian Randomization Analyses Add to Multiple Lines of Evidence.
    J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-231151.
    PubMed     Abstract available


  146. CHU C, Low YLC, Ma L, Wang Y, et al
    How Can We Use Mathematical Modeling of Amyloid-beta in Alzheimer's Disease Research and Clinical Practices?
    J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-230938.
    PubMed     Abstract available


  147. KAWARABAYASHI T, Nakamura T, Miyashita K, Segawa T, et al
    Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases.
    J Alzheimers Dis. 2023 Nov 23. doi: 10.3233/JAD-230419.
    PubMed     Abstract available


  148. MELENDEZ JC, Satorres E, Pitarque A, Escudero J, et al
    Transcranial Direct Current Stimulation Intervention in Alzheimer's Disease and Its Follow-Up.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230826.
    PubMed     Abstract available


  149. WANG X, Huang R, Huang B, Li X, et al
    S1PR2 Regulates Autophagy Through the AKT/mTOR Pathway to Promote Pathological Damage in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230533.
    PubMed     Abstract available


  150. JOHNSON CE, Duncan MJ, Murphy MP
    Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230527.
    PubMed     Abstract available


  151. SPAMPINATO MV, Ulber JL, Fayyaz H, Sullivan A, et al
    Neuropsychiatric Symptoms and In Vivo Alzheimer's Biomarkers in Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-220835.
    PubMed     Abstract available


  152. WHITE JP, Schembri A, Prenn-Gologranc C, Ondrus M, et al
    Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 21. doi: 10.3233/JAD-230352.
    PubMed     Abstract available


  153. LEWIS JE, McDaniel HR, Woolger JM, Khan SA, et al
    The Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer's Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230659.
    PubMed     Abstract available


  154. MONLLOR P, Kumar P, Lloret MA, Ftara A, et al
    Multifactorial Causation of Alzheimer's Disease Due to COVID-19.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230396.
    PubMed     Abstract available


  155. EL KADIRI W, Perrignon-Sommet M, Delpont B, Graber M, et al
    Changes in Taste Perception in Patients with Minor and Major Cognitive Impairment Linked to Alzheimer's Disease Recorded by Gustatory Evoked Potentials.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230270.
    PubMed     Abstract available


  156. TETZLOFF KA, Duffy JR, Clark HM, Pham NTT, et al
    Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230912.
    PubMed     Abstract available


  157. ZHANG F, Petersen M, Johnson L, Hall J, et al
    Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer's Disease in the HABS-HD Study.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230755.
    PubMed     Abstract available


  158. DING P, Gurney M, Perry G, Xu R, et al
    Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230632.
    PubMed     Abstract available


  159. GIUNTI E, Collu R, Daley S, Querfurth H, et al
    Reduction of Phosphorylated Tau in Alzheimer's Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230551.
    PubMed     Abstract available


  160. LIU YB, Wang XJ, Tan L, Tan CC, et al
    PICALM Variation Moderates the Relationships of APOE varepsilon4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230516.
    PubMed     Abstract available


  161. LAI D, Zhang M, Li R, Zhang C, et al
    Identifying Genes Associated with Alzheimer's Disease Using Gene-Based Polygenic Risk Score.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230510.
    PubMed     Abstract available


  162. BOZKURT AS, Yilmaz SG
    Ferroptotic Potency of ISM1 Expression in the Drug-Induced Alzheimer's Disease-Like Phenotype Under the Influence of Betulin.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230940.
    PubMed     Abstract available


  163. LI JQ, Zhong XL, Song JH, Chi S, et al
    Associations Between TREML2 Gene Variants and Alzheimer's Disease: Biomarkers, Neuroimage, and Cognition.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230936.
    PubMed     Abstract available


  164. LOPES BOSCHETTI JC, Soares KL, Carvalho GR, Filho ACV, et al
    CGAs-Rich Conilon Coffee Consumption Improves Cognition and Reduces Oxidative Stress in Elderly with Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230843.
    PubMed     Abstract available


  165. YANG Z, Banks SJ, Ritter AR, Cummings JL, et al
    Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230631.
    PubMed     Abstract available


  166. WU W, Shen A, Lee I, Miranda-Morales EG, et al
    Changes of tRNA-Derived Fragments by Alzheimer's Disease in Cerebrospinal Fluid and Blood Serum.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230412.
    PubMed     Abstract available


  167. ZENG XX, Zeng JB
    Systems Medicine as a Strategy to Deal with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230739.
    PubMed     Abstract available


  168. TAO S, Fan W, Liu J, Wang T, et al
    NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230567.
    PubMed     Abstract available


  169. CERNOTOVA D, Hruzova K, Levcik D, Svoboda J, et al
    Linking Social Cognition, Parvalbumin Interneurons, and Oxytocin in Alzheimer's Disease: An Update.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230333.
    PubMed     Abstract available


  170. SNYTNIKOVA O, Telegina D, Savina E, Tsentalovich Y, et al
    Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.
    J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230706.
    PubMed     Abstract available


  171. FERNANDO MG, Silva R, Fernando WMADB, de Silva HA, et al
    Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial.
    J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230670.
    PubMed     Abstract available


  172. MATSUMOTO H, Tagai K, Endo H, Matsuoka K, et al
    Association of Tooth Loss with Alzheimer's Disease Tau Pathologies Assessed by Positron Emission Tomography.
    J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230581.
    PubMed     Abstract available


  173. FREDERIKSEN KS, Lanctot KL, Weidner W, Hahn-Pedersen JH, et al
    A Literature Review on the Burden of Alzheimer's Disease on Care Partners.
    J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230487.
    PubMed     Abstract available


  174. SHINAGAWA H, Ohuchi K, Goto Y, Hashimoto K, et al
    Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230686.
    PubMed     Abstract available


  175. AZAMI H, Daftarifard E, Humeau-Heurtier A, Fernandez A, et al
    Assessment and Comparison of Nonlinear Measures in Resting-State Magnetoencephalograms in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230544.
    PubMed     Abstract available


  176. LY M, Yu GZ, Chwa WJ, Raji CA, et al
    Paving the Way for Alzheimer's Disease Prevention: A Systematic Review of Global Open-Access Neuroimaging Datasets in Healthy Individuals.
    J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230738.
    PubMed     Abstract available


  177. LI K, Rashid T, Li J, Honnorat N, et al
    Postmortem Brain Imaging in Alzheimer's Disease and Related Dementias: The South Texas Alzheimer's Disease Research Center Repository.
    J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230389.
    PubMed     Abstract available


  178. MANI S, Dubey R, Lai IC, Babu MA, et al
    Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 2. doi: 10.3233/JAD-220700.
    PubMed     Abstract available


  179. PERRON J, Scramstad C, Hyun Ko J
    Analysis of Costs for Imaging-Assisted Pharmaceutical Intervention in Alzheimer's Disease with Lecanemab: Snapshot of the First 3 Years.
    J Alzheimers Dis. 2023 Nov 1. doi: 10.3233/JAD-230633.
    PubMed     Abstract available


    October 2023
  180. FUJISAWA C, Umegaki H, Sugimoto T, Nakashima H, et al
    Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer's Disease Stage.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230786.
    PubMed     Abstract available


  181. YANG J, Shi X, Wang Y, Ma M, et al
    Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230593.
    PubMed     Abstract available


  182. SALHI L, Al Taep Y, Salmon E, Van Hede D, et al
    How Periodontitis or Periodontal Bacteria Can Influence Alzheimer's Disease Features? A Systematic Review of Pre-Clinical Studies.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230478.
    PubMed     Abstract available


  183. GRANT WB, Blake SM
    Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding.
    J Alzheimers Dis. 2023 Oct 28. doi: 10.3233/JAD-230418.
    PubMed     Abstract available


  184. DONG Y, Hou T, Li Y, Liu R, et al
    Plasma Amyloid-beta, Total Tau, and Neurofilament Light Chain Across the Alzheimer's Disease Clinical Spectrum: A Population-Based Study.
    J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230932.
    PubMed     Abstract available


  185. ALROUJI M, Majrashi TA, Alhumaydhi FA, Zari A, et al
    Unveiling Phytoconstituents with Inhibitory Potential Against Tyrosine-Protein Kinase Fyn: A Comprehensive Virtual Screening Approach Targeting Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230828.
    PubMed     Abstract available


  186. INGANNATO A, Bessi V, Chiari A, Salvatori D, et al
    GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports.
    J Alzheimers Dis. 2023 Oct 21. doi: 10.3233/JAD-230689.
    PubMed     Abstract available


  187. BEN KHEDHER MR, Haddad M, Fulop T, Laurin D, et al
    Implication of Circulating Extracellular Vesicles-Bound Amyloid-beta42 Oligomers in the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230823.
    PubMed     Abstract available


  188. HOANG MT, Kareholt I, Schon P, von Koch L, et al
    The Impact of Educational Attainment and Income on Long-Term Care for Persons with Alzheimer's Disease and Other Dementias: A Swedish Nationwide Study.
    J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230388.
    PubMed     Abstract available


  189. TZENG IS
    Examination of Matching Methods, Sparse Effects, and Limitations in a Nationwide Database Study on Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230701.
    PubMed     Abstract available


  190. LEE A, Shan D, Castle D, Rajji TK, et al
    Landscape of Phase II Trials in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230660.
    PubMed     Abstract available


  191. BUCHMAN AS, Leurgans SE, Kim N, Agrawal S, et al
    Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230223.
    PubMed     Abstract available


  192. JIANG J, Hong Y, Li W, Wang A, et al
    Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E varepsilon4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230577.
    PubMed     Abstract available


  193. XUE W, He W, Yan M, Zhao H, et al
    Exploring Shared Biomarkers of Myocardial Infarction and Alzheimer's Disease via Single-Cell/Nucleus Sequencing and Bioinformatics Analysis.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230559.
    PubMed     Abstract available


  194. XIA S, Chen H, Tang T
    Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230554.
    PubMed     Abstract available


  195. LI A, Du J, Cai Y, Chen X, et al
    Body Mass Index Decrease Has a Distinct Association with Alzheimer's Disease Pathophysiology in APOE varepsilon4 Carriers and Non-Carriers.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230446.
    PubMed     Abstract available


  196. BIAN Z, Hu X, Liu X, Yu H, et al
    Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer's Disease Combined with Cerebral Hypoperfusion.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230413.
    PubMed     Abstract available


  197. ROACH JC, Rapozo MK, Hara J, Glusman G, et al
    A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230403.
    PubMed     Abstract available


  198. KIM M, Yi D, Byun MS, Ahn H, et al
    Development of a Cognitive Composite for Preclinical Alzheimer's Disease in Korean Older Adults.
    J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-230263.
    PubMed     Abstract available


  199. AKUSHEVICH I, Yashkin A, Ukraintseva S, Yashin AI, et al
    The Construction of a Multidomain Risk Model of Alzheimer's Disease and Related Dementias.
    J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-221292.
    PubMed     Abstract available


  200. KETCHUM FB, Erickson CM, Basche KE, Chin NA, et al
    Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230732.
    PubMed     Abstract available


  201. BREDESEN DE, Toups K, Hathaway A, Gordon D, et al
    Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230467.
    PubMed     Abstract available


  202. UKRAINTSEVA S, Duan M, Simanek AM, Holmes R, et al
    Vaccination Against Pneumonia May Provide Genotype-Specific Protection Against Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230088.
    PubMed     Abstract available


  203. LIU CC, Wang QH, Xin JY, Liu YH, et al
    Association of Adipokines with Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-220860.
    PubMed     Abstract available


    September 2023
  204. BARBA L, Otto M, Abu-Rumeileh S
    The Underestimated Relevance of Alzheimer's Disease Copathology in Amyotrophic Lateral Sclerosis.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230900.
    PubMed     Abstract available


  205. GONZALEZ-MADRID A, Calfio C, Gonzalez A, Luttges V, et al
    Toward Prevention and Reduction of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230454.
    PubMed     Abstract available


  206. LIU Y, Shen Y
    Applications of Nanoparticles in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230098.
    PubMed     Abstract available


  207. HUANG Y, Driedonks TAP, Cheng L, Turchinovich A, et al
    Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230872.
    PubMed     Abstract available


  208. GUILLIOT S, Gauthier S, Touchon J, Soto ME, et al
    Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future Perspectives.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230568.
    PubMed     Abstract available


  209. POLIN C, Gelle T, Auditeau E, Adou C, et al
    Repetitive Behaviors in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230380.
    PubMed     Abstract available


  210. DALY T
    Improving Clinical Trials of Antioxidants in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230308.
    PubMed     Abstract available


  211. IKANGA J, Hickle S, Schwinne M, Epenge E, et al
    Association Between Hippocampal Volume and African Neuropsychology Memory Tests in Adult Individuals with Probable Alzheimer's Disease in Democratic Republic of Congo.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230206.
    PubMed     Abstract available


  212. ROGERS JT, Cahill CM
    Iron Responsiveness to Lysosomal Disruption: A Novel Pathway to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 25. doi: 10.3233/JAD-230953.
    PubMed     Abstract available


  213. BRAMEN JE, Siddarth P, Popa ES, Kress GT, et al
    Impact of Eating a Carbohydrate-Restricted Diet on Cortical Atrophy in a Cross-Section of Amyloid Positive Patients with Alzheimer's Disease: A Small Sample Study.
    J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230458.
    PubMed     Abstract available


  214. CHOW TE, Veziris CR, Mundada N, Martinez-Arroyo AI, et al
    Medial Temporal Lobe Tau Aggregation Relates to Divergent Cognitive and Emotional Empathy Abilities in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230367.
    PubMed     Abstract available


  215. QEADAN F, McCunn A, Tingey B, Price R, et al
    Exploring the Association Between Opioid Use Disorder and Alzheimer's Disease and Dementia Among a National Sample of the U.S. Population.
    J Alzheimers Dis. 2023 Sep 21. doi: 10.3233/JAD-230714.
    PubMed     Abstract available


  216. DINNERSTEIN E
    Erratum to: The Time for Combination Therapy Research in Alzheimer's Disease is Now.
    J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-239010.
    PubMed    


  217. SUN Y, Moghekar A, Soldan A, Pettigrew C, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarker Patterns of Change Prior to the Onset of Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-230807.
    PubMed     Abstract available


  218. ALKON DL, Sun MK, Tuchman AJ, Thompson RE, et al
    Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.
    J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230868.
    PubMed     Abstract available


  219. LEIBY AC, Scambray KA, Nguyen HL, Basith F, et al
    Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.
    J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230238.
    PubMed     Abstract available


  220. LARDELLI M, Baer L, Hin N, Allen A, et al
    The Use of Zebrafish in Transcriptome Analysis of the Early Effects of Mutations Causing Early Onset Familial Alzheimer's Disease and Other Inherited Neurodegenerative Conditions.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230522.
    PubMed     Abstract available


  221. ZHANG Y, Xue Y, Wang L, Han Z, et al
    rs56405341 Variant Associates with Expression of C4orf33 and C4orf33 Was Downregulated in Alzheimer's Disease and Progressive Supranuclear Palsy.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230327.
    PubMed     Abstract available


  222. MERLO S, Costa L, Chiechio S, Busceti CL, et al
    Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230148.
    PubMed     Abstract available


  223. BLUSZTAJN JK, Aytan N, Rajendiran T, Mellott TJ, et al
    Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230543.
    PubMed     Abstract available


  224. PARRENO TORRES A, Roncero-Parra C, Borja AL, Mateo-Sotos J, et al
    Inter-Hospital Advanced and Mild Alzheimer's Disease Classification Based on Electroencephalogram Measurements via Classical Machine Learning Algorithms.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230525.
    PubMed     Abstract available


  225. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
    Asymmetric Cerebral Peduncle Atrophy: A Simple Diagnostic Clue for Distinguishing Frontotemporal Lobar Degeneration from Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230441.
    PubMed     Abstract available


  226. NIK AKHTAR S, Lu Q
    RhoA-LIMK Signaling Axis Reveals Rostral-Caudal Plane and Spatial Dysregulation in the Brain of Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230408.
    PubMed     Abstract available


  227. O'BRYANT SE, Zhang F, Johnson LA, Hall J, et al
    Precision Medicine for Preventing Alzheimer's Disease: Analysis of the ADAPT Study.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230317.
    PubMed     Abstract available


  228. YANG Y, Li M, Leng B, Yao R, et al
    Alzheimer's Disease Biomarkers and Complement Proteins Mediate the Impact of Sleep Fragmentation on Cognitive Impairment in Obstructive Sleep Apnea Patients Without Dementia.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-221288.
    PubMed     Abstract available


  229. TANG H, Sun Y, Fachim HA, Cheung TKD, et al
    Elevated Expression of Two Pore Potassium Channel THIK-1 in Alzheimer's Disease: An Inflammatory Mechanism.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230616.
    PubMed     Abstract available


  230. WITUCKI L, Borowczyk K, Suszynska-Zajczyk J, Warzych E, et al
    Deletion of the Homocysteine Thiolactone Detoxifying Enzyme Bleomycin Hydrolase, in Mice, Causes Memory and Neurological Deficits and Worsens Alzheimer's Disease-Related Behavioral and Biochemical Traits in the 5xFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230578.
    PubMed     Abstract available


  231. GUIEYSSE T, Lamothe R, Houot M, Razafimahatratra S, et al
    Detecting Anosognosia from the Prodromal Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230552.
    PubMed     Abstract available


  232. FERNANDES C, Montalvo G, Caligiuri M, Pertsinakis M, et al
    Handwriting Changes in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230438.
    PubMed     Abstract available


  233. XU X, Wang H, Zhang QY, Meng XY, et al
    Dissecting Mitochondrial Mechanisms of Alzheimer's Disease Using Gene Dependency Network and Its Implications for Discovering Nutrients Combatting the Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230366.
    PubMed     Abstract available


  234. LARDELLI M
    An Alternative View of Familial Alzheimer's Disease Genetics.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230313.
    PubMed     Abstract available


  235. DE LA MONTE SM
    Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).
    J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230555.
    PubMed     Abstract available


  236. FORTEL I, Zhan L, Ajilore O, Wu Y, et al
    Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230035.
    PubMed     Abstract available


  237. DAVIDSON S, Allenback G, Decourt B, Sabbagh MN, et al
    Type 2 Diabetes Comorbidity and Cognitive Decline in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230489.
    PubMed     Abstract available


  238. FUKUDA H, Kanzaki H, Murata F, Maeda M, et al
    Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer's Disease Identified from Japanese Claims Data: Evidence from the LIFE Study.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230471.
    PubMed     Abstract available


  239. ZIYAD SR, Altulyan M, Alharbi M
    SHMAD: A Smart Health Care System to Monitor Alzheimer's Disease Patients.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230402.
    PubMed     Abstract available


  240. NAKAMURA Y, Narita K, Kim R, Nishiyama K, et al
    Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230386.
    PubMed     Abstract available


  241. VERDE F, Aiello EN, Adobbati L, Poletti B, et al
    Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.
    J Alzheimers Dis. 2023 Sep 7. doi: 10.3233/JAD-230562.
    PubMed     Abstract available


  242. DU Y, Chen X, Zhang B, Jin X, et al
    Identification of Copper Metabolism Related Biomarkers, Polygenic Prediction Model, and Potential Therapeutic Agents in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230565.
    PubMed     Abstract available


  243. LEHMANN DJ, Elshorbagy A, Hurley MJ
    Many Paths to Alzheimer's Disease: A Unifying Hypothesis Integrating Biological, Chemical, and Physical Risk Factors.
    J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230295.
    PubMed     Abstract available


  244. KOPPELMANS V, Ruitenberg MFL, Schaefer SY, King JB, et al
    Delayed and More Variable Unimanual and Bimanual Finger Tapping in Alzheimer's Disease: Associations with Biomarkers and Applications for Classification.
    J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221297.
    PubMed     Abstract available


  245. ADEWALE BA, Coker MM, Ogunniyi A, Kalaria RN, et al
    Biomarkers and Risk Assessment of Alzheimer's Disease in Low- and Middle-Income Countries.
    J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221030.
    PubMed     Abstract available


  246. MAKRI M, Gkioka M, Moraitou D, Fidani L, et al
    Attitudes, Motivations, and Barriers to Pre-Symptomatic Alzheimer's Disease Screening: Development and Validation of the 'Perceptions regarding pRE-symptomatic Alzheimer's Disease Screening' (PRE-ADS) Questionnaire.
    J Alzheimers Dis. 2023 Sep 1. doi: 10.3233/JAD-220954.
    PubMed     Abstract available


    August 2023
  247. LI Z, Wu H, Ji Y, Shi Z, et al
    Toward Reagent-Free Discrimination of Alzheimer's Disease Using Blood Plasma Spectral Digital Biomarkers and Machine Learning.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230248.
    PubMed     Abstract available


  248. GEZEN-AK D, Dursun E
    Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer's Type Neurodegeneration.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230214.
    PubMed     Abstract available


  249. ZHANG J, Liu Q, Zhang H, Dai M, et al
    Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230027.
    PubMed     Abstract available


  250. FAZLOLLAHI A, Lee S, Coleman F, McCann E, et al
    Increased Resolution of Structural MRI at 3T Improves Estimation of Regional Cortical Degeneration in Individual Dementia Patients Using Surface Thickness Maps.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230030.
    PubMed     Abstract available


  251. UCHIDA Y, Onda K, Hou Z, Troncoso JC, et al
    Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230452.
    PubMed     Abstract available


  252. WU Y, Eisel ULM
    Microglia-Astrocyte Communication in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230199.
    PubMed     Abstract available


  253. SCHORK NJ, Elman JA
    Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer's Disease-Related Biomarkers.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230548.
    PubMed     Abstract available


  254. BEI J, Miranda-Morales EG, Gan Q, Qiu Y, et al
    Circulating Exosomes from Alzheimer's Disease Suppress Vascular Endothelial-Cadherin Expression and Induce Barrier Dysfunction in Recipient Brain Microvascular Endothelial Cell.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230347.
    PubMed     Abstract available


  255. SATTAROV R, Toresson H, Orbjorn C, Mattsson-Carlgren N, et al
    Direct Conversion of Fibroblast into Neurons for Alzheimer's Disease Research: A Systematic Review.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230119.
    PubMed     Abstract available


  256. HEIDARZADEH N, Ratte S
    'Eye-Tracking' with Words for Alzheimer's Disease Detection: Time Alignment of Words Enunciation with Image Regions During Image Description Tasks.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-220711.
    PubMed     Abstract available


  257. LI J, Mountz EJ, Mizuno A, Shah AM, et al
    Functional Asymmetry During Working Memory and Its Association with Markers of Alzheimer's Disease in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-230379.
    PubMed     Abstract available


  258. RAMOS C, Madrigal C, Aguirre-Acevedo DC, Giraldo-Chica M, et al
    Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia.
    J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-220941.
    PubMed     Abstract available


  259. JIANG J, Wang A, Liu Y, Yao Z, et al
    Spatiotemporal Characteristics of Regional Brain Perfusion Associated with Neuropsychiatric Symptoms in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230499.
    PubMed     Abstract available


  260. KIM DY, Kim JS, Seo YS, Park WY, et al
    Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer's Disease: A Protocol for Multicenter Phase II Clinical Trial.
    J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230241.
    PubMed     Abstract available


  261. ABYADEH M, Yadav VK, Kaya A
    Common Molecular Signatures Between Coronavirus Infection and Alzheimer's Disease Reveal Targets for Drug Development.
    J Alzheimers Dis. 2023 Aug 22. doi: 10.3233/JAD-230684.
    PubMed     Abstract available


  262. JANN K, Boudreau J, Albrecht D, Cen SY, et al
    FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 18. doi: 10.3233/JAD-220851.
    PubMed     Abstract available


  263. MAMELAK M
    The Alzheimer's Disease Brain, Its Microvasculature, and NADPH Oxidase.
    J Alzheimers Dis. 2023 Aug 14. doi: 10.3233/JAD-230415.
    PubMed     Abstract available


  264. KATISKO K, Kruger J, Soppela H, Hartikainen P, et al
    Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 12. doi: 10.3233/JAD-230494.
    PubMed     Abstract available


  265. KOBRO-FLATMOEN A, Hormann TM, Gouras G
    Intracellular Amyloid-beta in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 10. doi: 10.3233/JAD-230349.
    PubMed     Abstract available


  266. YANG H, Wang W, Jia L, Qin W, et al
    Erratum to: The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L).
    J Alzheimers Dis. 2023 Aug 8. doi: 10.3233/JAD-239007.
    PubMed    


  267. WANG X, Sundermann EE, Buckley RF, Reas ET, et al
    Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230466.
    PubMed     Abstract available


  268. KENKPEN AK, Storey JJ, Olson ER, Guden TE, et al
    Developing Connections Between LINC00298 RNA and Alzheimer's Disease Through Mapping Its Interactome and Through Biochemical Characterization.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230057.
    PubMed     Abstract available


  269. HARRIS K, Ling Y, Bukhbinder AS, Chen L, et al
    The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-221231.
    PubMed     Abstract available


  270. CONTI E, Grana D, Angiulli F, Karantzoulis A, et al
    TSPO Modulates Oligomeric Amyloid-beta-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 5. doi: 10.3233/JAD-230239.
    PubMed     Abstract available


  271. CAI HY, Yang D, Qiao J, Yang JT, et al
    Erratum to: A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 2. doi: 10.3233/JAD-239006.
    PubMed    


  272. QAISER H, Uzair M, Al-Regaiey K, Rafiq S, et al
    Role of Thioredoxin System in Regulating Cellular Redox Status in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230394.
    PubMed     Abstract available


  273. MENDEZ MF
    Can Speaking More Than One Language Help Prevent Alzheimer's Disease?
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230285.
    PubMed     Abstract available


  274. SONG S, Asken B, Armstrong MJ, Yang Y, et al
    Predicting Progression to Clinical Alzheimer's Disease Dementia Using the Random Survival Forest.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230208.
    PubMed     Abstract available


  275. BACHMAN SL, Blankenship JM, Busa M, Serviente C, et al
    Capturing Measures That Matter: The Potential Value of Digital Measures of Physical Behavior for Alzheimer's Disease Drug Development.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230152.
    PubMed     Abstract available


  276. BAUMARD J
    Is Shadowing Behavior Caused by Body Representation Disorders and Apraxia?
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230731.
    PubMed     Abstract available


    July 2023
  277. LA BARBERA L, D'Amelio M
    Alzheimer's Disease and Sex-Dependent Alterations in the Striatum: A Lesson from a Mouse Model.
    J Alzheimers Dis. 2023 Jul 28. doi: 10.3233/JAD-230681.
    PubMed     Abstract available


  278. LIN Y, Hu T, Cheng L, Chen Y, et al
    Causal Effects of Plasma Haptoglobin Levels on Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Jul 26. doi: 10.3233/JAD-230159.
    PubMed     Abstract available


  279. LEITAO ADG, Spencer B, Sarsoza F, Ngolab J, et al
    Hippocampal Reduction of alpha-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230232.
    PubMed     Abstract available


  280. VICENTE MC, Paneghini JL, Stabile AM, Amorim M, et al
    Inhibition of Pro-Inflammatory Microglia with Minocycline Improves Cognitive and Sleep-Wake Dysfunction Under Respiratory Stress in a Sporadic Model for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230151.
    PubMed     Abstract available


  281. NADEAU PA, Jobin B, Boller B
    Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-220991.
    PubMed     Abstract available


  282. VOSSEL K
    Putting the Brakes on Accelerated Cognitive Decline in Alzheimer's Disease with Epileptic Activity.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230613.
    PubMed     Abstract available


  283. WHITE LR, Corrada MM, Kawas CH, Cholerton BA, et al
    Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230331.
    PubMed     Abstract available


  284. NOWRANGI MA, Outen JD, Kim J, Avramopoulos D, et al
    Neuropsychiatric Symptoms of Alzheimer's Disease: An Anatomic-Genetic Framework for Treatment Development.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-221247.
    PubMed     Abstract available



  285. Henning Tiemeier, MD, PhD, and Rosanne Freak-Poli, PhD, are the recipients of the 2023 Alzheimer Award.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-239005.
    PubMed    


  286. LI J, Zeng Q, Luo X, Li K, et al
    Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer's Continuum.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230503.
    PubMed     Abstract available


  287. LOPEZ-MARTOS D, Brugulat-Serrat A, Canas-Martinez A, Canals-Gispert L, et al
    Reference Data for Attentional, Executive, Linguistic, and Visual Processing Tests Obtained from Cognitively Healthy Individuals with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230290.
    PubMed     Abstract available


  288. KILPATRICK LA, Siddarth P, Krause-Sorio B, Milillo MM, et al
    Impact of Yoga Versus Memory Enhancement Training on Hippocampal Connectivity in Older Women at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-221159.
    PubMed     Abstract available


  289. STALLARD E, Kociolek A, Jin Z, Ryu H, et al
    Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.
    J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-220811.
    PubMed     Abstract available


  290. YU Y, Xia X, Meng X, Li D, et al
    Plasma Phosphorylated Tau181 and Amyloid-beta42 in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.
    J Alzheimers Dis. 2023 Jul 18. doi: 10.3233/JAD-230085.
    PubMed     Abstract available


  291. HARTLEY SL, Fleming V, Schworer EK, Peven J, et al
    Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.
    J Alzheimers Dis. 2023 Jul 17. doi: 10.3233/JAD-230200.
    PubMed     Abstract available


  292. PUENTES-DIAZ N, Chaparro D, Reyes-Marquez V, Morales-Morales D, et al
    Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-230542.
    PubMed     Abstract available


  293. OLMOS-VILLASENOR R, Sepulveda-Silva C, Julio-Ramos T, Fuentes-Lopez E, et al
    Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-221272.
    PubMed     Abstract available


  294. CHENG C, Yang C, Jia C, Wang Q, et al
    The Role of Cerebellum in Alzheimer's Disease: A Forgotten Research Corner.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230381.
    PubMed     Abstract available


  295. CHUM PP, Bishara MA, Solis SR, Behringer EJ, et al
    Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230300.
    PubMed     Abstract available


  296. CHEN R, Morris BJ, Donlon TA, Ross GW, et al
    Incidence of Alzheimer's Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230350.
    PubMed     Abstract available


  297. XU Y, Vasiljevic E, Deming YK, Jonaitis EM, et al
    Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230097.
    PubMed     Abstract available


  298. TIO ES, Hohman TJ, Milic M, Bennett DA, et al
    Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230434.
    PubMed     Abstract available


  299. KUDO S, Funayama M, Kurose S, Shimizu Y, et al
    Shadowing Behavior May Be Associated with an Inability to Recognize the External World: A Case Report of Shadowing in a Patient with Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230257.
    PubMed     Abstract available


  300. MIGUEL L, Gervais J, Nicolas G, Lecourtois M, et al
    SorLA Protective Function Is Restored by Improving SorLA Protein Maturation in a Subset of Alzheimer's Disease-Associated SORL1 Missense Variants.
    J Alzheimers Dis. 2023 Jul 8. doi: 10.3233/JAD-230211.
    PubMed     Abstract available


  301. YANG Y, Lv J, Bai H, Ren L, et al
    Periodontal Status and Saliva Metabolic Signature in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 7. doi: 10.3233/JAD-230291.
    PubMed     Abstract available


  302. XIA ZD, Ma RX, Wen JF, Zhai YF, et al
    Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230326.
    PubMed     Abstract available


  303. MAO M, Wang C, Hou T, Han X, et al
    Ventricular Electrocardiographic Signatures Associated with Dementia and Plasma Alzheimer's Disease Biomarkers in Older Adults: A Population-Based Study.
    J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230056.
    PubMed     Abstract available


  304. ZHANG HQ, Chau ACM, Shea YF, Chiu PK, et al
    Disrupted Structural White Matter Network in Alzheimer's Disease Continuum, Vascular Dementia, and Mixed Dementia: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2023 Jul 3. doi: 10.3233/JAD-230341.
    PubMed     Abstract available


    June 2023
  305. CAI HY, Hou SJ, Wen R, Feng QF, et al
    Causal Association Between mTOR-Dependent Protein Levels and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230128.
    PubMed     Abstract available


  306. AKADA K, Koyama N, Miura Y, Takahashi K, et al
    Nationwide Database Analysis of Risk Factors Associated with Decreased Activities of Daily Living in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230106.
    PubMed     Abstract available


  307. HANSEN SB
    Cholesterol's Function and Origin in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-230538.
    PubMed     Abstract available


  308. MOBASHERI K, Zaefizadeh M, Ghobeh M, Eidi A, et al
    Synthesis of Novel Magnetic Quercetin-Neuropeptide Nanocomposite as a Smart Nano-Drug Shuttle System: Investigation of Its Effect on Behavior, Histopathological Characteristics, and Expression of MAPT and APP Genes in Alzheimer's Disease Rats.
    J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-221095.
    PubMed     Abstract available


  309. MERTEN N, Pinto AA, Paulsen AJ, Chen Y, et al
    Associations of Midlife Lifestyle and Health Factors with Long-Term Changes in Blood-Based Biomarkers of Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2023 Jun 28. doi: 10.3233/JAD-221287.
    PubMed     Abstract available


  310. SCHAFER HACKENHAAR F, Josefsson M, Nordin Adolfsson A, Landfors M, et al
    Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-230039.
    PubMed     Abstract available


  311. CHHIMPA N, Singh N, Puri N, Kayath HP, et al
    The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-220514.
    PubMed     Abstract available


  312. KANG JM, Shin JH, Kim WR, Seo S, et al
    Effects of the APOEvarepsilon4 Allele on the Relationship Between Tau and Amyloid-beta in Early- and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230339.
    PubMed     Abstract available


  313. SORRENTINO F, Fenoglio C, Sacchi L, Serpente M, et al
    Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230322.
    PubMed     Abstract available


  314. ALVES SS, de Oliveira JAC, Lazarini-Lopes W, Servilha-Menezes G, et al
    Audiogenic Seizures in the Streptozotocin-Induced Rat Alzheimer's Disease Model.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230153.
    PubMed     Abstract available


  315. ZHANG J, Gao S, Liu W
    Bioinformatics-Based Analysis of Circadian Rhythm Regulation Mechanisms in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230177.
    PubMed     Abstract available


  316. AUDRONYTE E, Pakulaite-Kazliene G, Sutnikiene V, Kaubrys G, et al
    Odor Discrimination as a Marker of Early Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230077.
    PubMed     Abstract available


  317. KULMINSKI AM, Feng F, Loiko E, Nazarian A, et al
    Prevailing Antagonistic Risks in Pleiotropic Associations with Alzheimer's Disease and Diabetes.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230397.
    PubMed     Abstract available


  318. JEONG SH, Cha J, Jung JH, Yun M, et al
    Occipital Amyloid Deposition Is Associated with Rapid Cognitive Decline in the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230187.
    PubMed     Abstract available


  319. HAUTECLOQUE-RAYSZ G, Sellal F, Bousiges O, Phillipi N, et al
    Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-221197.
    PubMed     Abstract available


  320. BELAN AFR, Pais MV, Camargo MVZA, Sant'Ana LCFG, et al
    Diagnostic Performance of an Eye-Tracking Assisted Visual Inference Language Test in the Assessment of Cognitive Decline due to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230250.
    PubMed     Abstract available


  321. CHEN W, Lin C, Su F, Fang Y, et al
    Early Diagnosis of Mild Cognitive Impairment due to Alzheimer's Disease Using a Composite of MemTrax and Blood Biomarkers.
    J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230182.
    PubMed     Abstract available


  322. FU XX, Wei B, Cao HM, Duan R, et al
    Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.
    J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-230133.
    PubMed     Abstract available


  323. ORTI-CASAN N, Wajant H, Kuiperij HB, Hooijsma A, et al
    Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-beta Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.
    J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-221230.
    PubMed     Abstract available


  324. BOLLINGER RM, Gabel M, Coble DW, Chen SW, et al
    Retention of Study Partners in Longitudinal Studies of Alzheimer Disease.
    J Alzheimers Dis. 2023 Jun 18. doi: 10.3233/JAD-230079.
    PubMed     Abstract available


  325. NAKAMURA Y, Omori T, Kim R, Nishiyama K, et al
    Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study.
    J Alzheimers Dis. 2023 Jun 14. doi: 10.3233/JAD-230387.
    PubMed     Abstract available


  326. YAN R, Wang W, Yang W, Huang M, et al
    Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230314.
    PubMed     Abstract available


  327. JIANG WR, Wu W, Yang LJ, Yang W, et al
    Alteration of Cognitive Function in Aging and Alzheimer's Disease Mice Is Related to Dysfunction of the Neuroimmune System.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230292.
    PubMed     Abstract available


  328. MANSOR NI, Ling KH, Rosli R, Hassan Z, et al
    Centella asiatica (L.) Urban. Attenuates Cell Damage in Hydrogen Peroxide-Induced Oxidative Stress in Transgenic Murine Embryonic Stem Cell Line-Derived Neural-Like Cells: A Preliminary Study for Potential Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-221233.
    PubMed     Abstract available


  329. XU GY, Liu YH, Zeng XQ, Chen DW, et al
    The Diagnostic Potential of Circulating Autoantibodies to Amyloid-beta in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230252.
    PubMed     Abstract available


  330. QAISAR R, Karim A, Iqbal MS, Alkahtani SA, et al
    ACE Inhibitors Improve Skeletal Muscle by Preserving Neuromuscular Junctions in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230201.
    PubMed     Abstract available


  331. PATEL S, Wei J, Shi Z, Rifkin AS, et al
    Refining Risk for Alzheimer's Disease Among Heterozygous APOEvarepsilon4 Carriers.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230156.
    PubMed     Abstract available


  332. PEAVY GM
    Can't Have One Without the Other: Study Partner Retention in Alzheimer's Disease Research.
    J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230455.
    PubMed     Abstract available


  333. VANNINEN A, Lukkarinen H, Kokkola T, Koivisto AM, et al
    Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230144.
    PubMed     Abstract available


  334. MILANO C, Hoxhaj D, Del Chicca M, Pascazio A, et al
    Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers.
    J Alzheimers Dis. 2023 Jun 9. doi: 10.3233/JAD-230170.
    PubMed     Abstract available


  335. HU D, Dong X, Wang Q, Liu M, et al
    PCP4 Promotes Alzheimer's Disease Pathogenesis by Affecting Amyloid-beta Protein Precursor Processing.
    J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230192.
    PubMed     Abstract available


  336. ZHANG X, Liu Y, Huang M, Gunewardena S, et al
    Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer's Disease and Non-Demented Individuals.
    J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230316.
    PubMed     Abstract available


  337. RUDGE JD
    The Lipid Invasion Model: Growing Evidence for This New Explanation of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 3. doi: 10.3233/JAD-221175.
    PubMed     Abstract available


    May 2023
  338. SUN L, Ye KX, Wong HLK, Wang L, et al
    The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230406.
    PubMed     Abstract available


  339. HAZAN J, Liu K, Fox N, Howard R, et al
    Advancing Diagnostic Certainty in Alzheimer's Disease: A Synthesis of the Diagnostic Process.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230186.
    PubMed     Abstract available


  340. FINDLEY CA, McFadden SA, Cox MF, Sime LN, et al
    Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and Spatial Cognition in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221245.
    PubMed     Abstract available


  341. LI D, Yu YY, Hu N, Zhang M, et al
    Composite Indices of the Color-Picture Version of Boston Naming Test Have Better Discriminatory Power: Reliability and Validity in a Chinese Sample with Diverse Neurodegenerative Diseases.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221227.
    PubMed     Abstract available


  342. GONZALEZ A, Calfio C, Luttges V, Gonzalez-Madrid A, et al
    The Multifactorial Etiopathogenesis of Alzheimer's Disease: Neuroinflammation as the Major Contributor.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230150.
    PubMed     Abstract available


  343. LIU M, Li M, He J, He Y, et al
    Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230142.
    PubMed     Abstract available


  344. JARHOLM JA, Bjornerud A, Dalaker TO, Akhavi MS, et al
    Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221274.
    PubMed     Abstract available


  345. LIU J, Xie Y, Lu Y, Zhao Z, et al
    APP/PS1 Gene-Environmental Cadmium Interaction Aggravates the Progression of Alzheimer's Disease in Mice via the Blood-Brain Barrier, Amyloid-beta, and Inflammation.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221205.
    PubMed     Abstract available


  346. KARIMA S, Aghamollaii V, Mahmoodi Baram S, Balenci L, et al
    Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221026.
    PubMed     Abstract available


  347. MI Z, Abrahamson EE, Ryu AY, Malek-Ahmadi M, et al
    Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 19. doi: 10.3233/JAD-221063.
    PubMed     Abstract available


  348. PUOYAN-MAJD S, Parnow A, Rashno M, Heidarimoghadam R, et al
    The Protective Effects of High-Intensity Interval Training Combined with Q10 Supplementation on Learning and Memory Impairments in Male Rats with Amyloid-beta-Induced Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230096.
    PubMed     Abstract available


  349. MORI H, Yoshino Y, Iga JI, Ochi S, et al
    Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230078.
    PubMed     Abstract available


  350. HUI HYH, Ran AR, Dai JJ, Cheung CY, et al
    Deep Reinforcement Learning-Based Retinal Imaging in Alzheimer's Disease: Potential and Perspectives.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230055.
    PubMed     Abstract available


  351. ELZAYAT EM, Shahien SA, El-Sherif AA, Hosney M, et al
    miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221298.
    PubMed     Abstract available


  352. QUERRY M, Blanc F, Bousiges O, Philippi N, et al
    Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221243.
    PubMed     Abstract available


  353. GONZALEZ C, Mimmack KJ, Amariglio RE, Becker JA, et al
    Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-220885.
    PubMed     Abstract available


  354. VOLLOCH V, Rits-Volloch S
    Effect of Lecanemab in Early Alzheimer's Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective.
    J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-230164.
    PubMed     Abstract available


  355. ORTNER M, Lanz K, Goldhardt O, Muller-Sarnowski F, et al
    Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer's Disease Regardless of Concomitant Small Vessel Disease.
    J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-221187.
    PubMed     Abstract available


  356. WHEELERA CJ
    Evolutionary Selection of APOEvarepsilon4 Encourages Increased Focus on Immunity in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230390.
    PubMed     Abstract available


  357. DINNERSETIN E
    The Time for Combination Therapy Research in Alzheimer's Disease is Now.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230254.
    PubMed    


  358. HIROTA Y, Sakakibara Y, Takei K, Nishijima R, et al
    Alzheimer's Disease-Related Phospho-Tau181 Signals Are Localized to Demyelinated Axons of Parvalbumin-Positive GABAergic Interneurons in an App Knock-In Mouse Model of Amyloid-beta Pathology.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230121.
    PubMed     Abstract available


  359. WHITE LR
    If Midlife Brain Injury Is a Risk Factor for Alzheimer's Disease and Related Dementias, What Is the Neuropathologic Mechanism?
    J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230332.
    PubMed     Abstract available


  360. TOPPING M, Kim J, Fletcher J
    Area-Level Infant Mortality Exposure in Early Life and Alzheimer's Disease Mortality: Examining Variation Based on Age, Sex, and Place of Birth.
    J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230086.
    PubMed     Abstract available


  361. BALIETTI M, Casoli T, Giorgetti B, Colangeli R, et al
    Generation and Characterization of the First Murine Model of Alzheimer's Disease with Mutated AbetaPP Inserted in a BALB/c Background (C.B6/J-APPswe).
    J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-230195.
    PubMed     Abstract available


  362. CARLOS AF, Machulda MM, Rutledge MH, Nguyen AT, et al
    Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer's Disease Neuropathologic Spectrum.
    J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-221094.
    PubMed     Abstract available


  363. EIKELBOOM WS, van den Berg E, Coesmans M, Goudzwaard JA, et al
    Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer's Disease at the Memory Clinic: The BEAT-IT Study.
    J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-230116.
    PubMed     Abstract available


  364. LIN H, Pan T, Wang M, Ge J, et al
    Metabolic Asymmetry Relates to Clinical Characteristics and Brain Network Abnormalities in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-221258.
    PubMed     Abstract available


  365. YAN Y, Wu Y, Xiao G, Wang L, et al
    White Matter Changes as an Independent Predictor of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 9. doi: 10.3233/JAD-221037.
    PubMed     Abstract available


  366. CHENG J, Zheng H, Liu C, Jin J, et al
    Age-Associated UBE2O Reduction Promotes Neuronal Death in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 6. doi: 10.3233/JAD-221143.
    PubMed     Abstract available


  367. LI Y, Chang J, Chen X, Liu J, et al
    Advances in the Study of APOE and Innate Immunity in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230179.
    PubMed     Abstract available


  368. VIG V, Garg I, Tuz-Zahra F, Xu J, et al
    Vitreous Humor Biomarkers Reflect Pathological Changes in the Brain for Alzheimer's Disease and Chronic Traumatic Encephalopathy.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230167.
    PubMed     Abstract available


  369. SACCHI L, Contarino VE, Siggillino S, Carandini T, et al
    Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230095.
    PubMed     Abstract available


  370. BLUSZTAJN JK, Slack BE
    Accelerated Breakdown of Phosphatidylcholine and Phosphatidylethanolamine Is a Predominant Brain Metabolic Defect in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230061.
    PubMed     Abstract available


  371. ABBATE C
    The Adult Neurogenesis Theory of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221279.
    PubMed     Abstract available


  372. HUGGINS LKL, Min SH, Kaplan S, Wei J, et al
    Meta-Analysis of Variations in Association between APOE varepsilon4 and Alzheimer's Disease and Related Dementias Across Hispanic Regions of Origin.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221167.
    PubMed     Abstract available


  373. MOYAERT P, Beun S, Achten E, Clement P, et al
    Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221125.
    PubMed     Abstract available


  374. BEADELL AV, Zhang Z, Capuano AW, Bennett DA, et al
    Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221113.
    PubMed     Abstract available


    April 2023
  375. HSIAO WW, Angela S, Le TN, Ku CC, et al
    Evolution of Detecting Early Onset of Alzheimer's Disease: From Neuroimaging to Optical Immunoassays.
    J Alzheimers Dis. 2023 Apr 28. doi: 10.3233/JAD-221202.
    PubMed     Abstract available


  376. PRESS DZ, Musaeus CS, Zhao L, Breton J, et al
    Levetiracetam Increases Hippocampal Blood Flow in Alzheimer's Disease as Measured by Arterial Spin Labelling MRI.
    J Alzheimers Dis. 2023 Apr 26. doi: 10.3233/JAD-220614.
    PubMed     Abstract available


  377. ZHANG K, Du X, Gao Y, Liu S, et al
    Mesenchymal Stem Cells for Treating Alzheimer's Disease: Cell Therapy and Chemical Reagent Pretreatment.
    J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221253.
    PubMed     Abstract available


  378. LIU R, Zhang L, You H
    Insulin Resistance and Impaired Branched-Chain Amino Acid Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221147.
    PubMed     Abstract available


  379. LIEW Y, Retinasamy T, Arulsamy A, Ali I, et al
    Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-230059.
    PubMed     Abstract available


  380. LIANG J, LeFleur B, Hussainy S, Perry G, et al
    Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer's Disease-Related Genes.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-221241.
    PubMed     Abstract available


  381. OTOKI Y, Yu D, Shen Q, Sahlas DJ, et al
    Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer's Disease and Subcortical Cerebrovascular Disease.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-220795.
    PubMed     Abstract available


  382. SINGH M, Jindal D, Kumar R, Pancham P, et al
    Molecular Docking and Network Pharmacology Interaction Analysis of Gingko Biloba (EGB761) Extract with Dual Target Inhibitory Mechanism in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221222.
    PubMed     Abstract available


  383. WILLIAMS E, Mutlu-Smith M, Alex A, Chin XW, et al
    Mid-Adulthood Cognitive Training Improves Performance in a Spatial Task but Does Not Ameliorate Hippocampal Pathology in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221185.
    PubMed     Abstract available


  384. STARK J, Hiersche KJ, Yu JC, Hasselbach AN, et al
    Partial Least Squares Regression Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognitive Change in Older Adults with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221084.
    PubMed     Abstract available


  385. HENDRIE HC
    Screening and Assessment for Alzheimer's Disease in the Days of Biological Biomarkers.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230215.
    PubMed     Abstract available


  386. TIAN J, Stucky C, Wang T, Muma NA, et al
    Mitochondrial Dysfunction Links to Impaired Hippocampal Serotonin Release in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230072.
    PubMed     Abstract available


  387. ZHAO Z, Wang J, Wang Y, Liu X, et al
    18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-221251.
    PubMed     Abstract available


  388. EITHZ N, Sorensen J, Sopina L
    Healthcare Costs in the Year Before and After Alzheimer's Disease Diagnosis: A Danish Register-Based Matched Cohort Study.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-220821.
    PubMed     Abstract available


  389. JIA J, Zhang Y, Shi Y, Yina X, et al
    Erratum to: A 19-Year-Old Adolescent with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 5. doi: 10.3233/JAD-239001.
    PubMed    


  390. MAO C, You H, Hou B, Chu S, et al
    Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
    J Alzheimers Dis. 2023 Apr 4. doi: 10.3233/JAD-221023.
    PubMed     Abstract available


  391. SULHEIM E, WiderOe M, Back M, Nilsson KPR, et al
    Contrast Enhanced Magnetic Resonance Imaging of Amyloid-beta Plaques in a Murine Alzheimer's Disease Model.
    J Alzheimers Dis. 2023 Apr 3. doi: 10.3233/JAD-220198.
    PubMed     Abstract available


  392. QIAN L, Bian W, Wang D, Ming Z, et al
    Adeno-Associated Virus-Mediated Immunotherapy Based on Bispecific Tandem scFv for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-221088.
    PubMed     Abstract available


  393. NAGARAJA N, Wang WE, Duara R, DeKosky ST, et al
    Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-220624.
    PubMed     Abstract available


    March 2023
  394. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
    Voxel-Based and Surface-Based Morphometry Analysis in Patients with Pathologically Confirmed Argyrophilic Grain Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-230068.
    PubMed     Abstract available


  395. RAHMANI F, Ghezzi L, Tosti V, Liu J, et al
    Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-221007.
    PubMed     Abstract available


  396. ZIYAD SR, Alharbi M, Altulyan M
    Artificial Intelligence Model for Alzheimer's Disease Detection with Convolution Neural Network for Magnetic Resonance Images.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221250.
    PubMed     Abstract available


  397. SUN Y, Hu HY, Hu H, Huang LY, et al
    Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221207.
    PubMed     Abstract available


  398. FORTEA J, Garcia-Arcelay E, Terrancle A, Galvez B, et al
    Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221160.
    PubMed     Abstract available


  399. WIDJAYA MA, Cheng YJ, Kuo YM, Liu CH, et al
    Transcriptomic Analyses of Exercise Training in Alzheimer's Disease Cerebral Cortex.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221139.
    PubMed     Abstract available


  400. NAKAMURA T, Kawarabayashi T, Ueda T, Shimomura S, et al
    Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Abeta 40/42 Ratio as a Biomarker of Amyloid-beta Amyloidosis in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-220996.
    PubMed     Abstract available


  401. HOOK G, Kindy M, Hook V
    Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-beta in hAbetaPP Mouse Models Representing the Major Sporadic Alzheimer's Disease Condition.
    J Alzheimers Dis. 2023 Mar 21. doi: 10.3233/JAD-221005.
    PubMed     Abstract available


  402. FILLENBAUM GG, Mohs R
    CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-230026.
    PubMed     Abstract available


  403. BAYAT S, Roe CM, Schindler S, Murphy SA, et al
    Everyday Driving and Plasma Biomarkers in Alzheimer's Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221268.
    PubMed     Abstract available


  404. DOLCET-NEGRE MM, Imaz Aguayo L, de Eulate RG, Marti-Andres G, et al
    Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221002.
    PubMed     Abstract available


  405. MOON SW, Byun MS, Yi D, Kim MJ, et al
    Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-220911.
    PubMed     Abstract available


  406. MAN S, Chen B, Zhang Y, Xu H, et al
    The Associations Between Cataracts and Alzheimer's Disease: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221137.
    PubMed     Abstract available


  407. GOLAS AC, Salwierz P, Rajji TK, Bowie CR, et al
    Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221097.
    PubMed     Abstract available


  408. HE Y, Li J, Yi L, Li X, et al
    Octadecaneuropeptide Ameliorates Cognitive Impairments Through Inhibiting Oxidative Stress in Alzheimer's Disease Models.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221115.
    PubMed     Abstract available


  409. HOLLENBENDERS Y, Pobiruchin M, Reichenbach A
    Two Routes to Alzheimer's Disease Based on Differential Structural Changes in Key Brain Regions.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221061.
    PubMed     Abstract available


  410. BONOMI CG, Assogna M, Di Donna MG, Bernocchi F, et al
    Cerebrospinal Fluid sTREM-2, GFAP, and beta-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221010.
    PubMed     Abstract available


  411. XU S, Xie L, Zhang Y, Wu X, et al
    Inferior Frontal Sulcal Hyperintensity on FLAIR Is Associated with Small Vessel Disease but not Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-220843.
    PubMed     Abstract available


  412. XU Y, Zheng F, Zhong Q, Zhu Y, et al
    Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications.
    J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-230002.
    PubMed     Abstract available


  413. GARCIA-ESCOBAR G, Puig-Pijoan A, Puente-Periz V, Fernandez-Lebrero A, et al
    NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-beta and Tau Levels in the Continuum of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-220930.
    PubMed     Abstract available


  414. SHAH J, Rahman Siddiquee MM, Krell-Roesch J, Syrjanen JA, et al
    Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer's Disease: A Literature Review from a Machine Learning Perspective.
    J Alzheimers Dis. 2023 Mar 3. doi: 10.3233/JAD-221261.
    PubMed     Abstract available


  415. LIU H, Reynolds GP, Wei X
    The Influence of Agricultural Work and Plasma Uric Acid on Hospital Admission for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 2. doi: 10.3233/JAD-221226.
    PubMed     Abstract available


    February 2023
  416. LOUGHMAN A, Adler C, Macpherson H
    Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?
    J Alzheimers Dis. 2023 Feb 27. doi: 10.3233/JAD-220760.
    PubMed     Abstract available


  417. SOTO-MERCADO V, Mendivil-Perez M, Velez-Pardo C, Jimenez-Del-Rio M, et al
    Neuroprotective Effect of Combined Treatment with Epigallocatechin 3-Gallate and Melatonin on Familial Alzheimer's Disease PSEN1 E280A Cerebral Spheroids Derived from Menstrual Mesenchymal Stromal Cells.
    J Alzheimers Dis. 2023 Feb 24. doi: 10.3233/JAD-220903.
    PubMed     Abstract available


  418. ATWOOD CS, Perry G
    Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema and Stroke?
    J Alzheimers Dis. 2023 Feb 22. doi: 10.3233/JAD-230040.
    PubMed     Abstract available


  419. WALKER JM, Gonzales MM, Goette W, Farrell K, et al
    Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.
    J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-230022.
    PubMed     Abstract available


  420. DEMARSHALL CA, Viviano J, Emrani S, Thayasivam U, et al
    Early Detection of Alzheimer's Disease-Related Pathology Using a Multi-Disease Diagnostic Platform Employing Autoantibodies as Blood-Based Biomarkers.
    J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-221091.
    PubMed     Abstract available


  421. ACOSTA-BAENA N, Lopera-Gomez CM, Jaramillo-Elorza MC, Velilla-Jimenez L, et al
    Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221294.
    PubMed     Abstract available


  422. YIN W, Wan K, Zhu W, Zhou X, et al
    Bilateral Hippocampal Volume Mediated the Relationship Between Plasma BACE1 Concentration and Memory Function in the Early Stage of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221174.
    PubMed     Abstract available


  423. DING P, Gorenflo MP, Zhu X, Xu R, et al
    Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-220787.
    PubMed     Abstract available


  424. WANG Z, Tan L, Zong Y, Ma YH, et al
    sTREM2 and GFAP Mediated the Association of IGF-1 Signaling Biomarkers with Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2023 Feb 16. doi: 10.3233/JAD-220725.
    PubMed     Abstract available


  425. STITES SD, Coe NB
    Let's Not Repeat History's Mistakes: Two Cautions to Scientists on the Use of Race in Alzheimer's Disease and Alzheimer's Disease Related Dementias Research.
    J Alzheimers Dis. 2023 Feb 16. doi: 10.3233/JAD-220507.
    PubMed     Abstract available


  426. ERSOEZLUE E, Perneczky R, Tato M, Utecht J, et al
    A Residual Marker of Cognitive Reserve Is Associated with Resting-State Intrinsic Functional Connectivity Along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Feb 15. doi: 10.3233/JAD-220464.
    PubMed     Abstract available


  427. HAO SW, Li TR, Han C, Han Y, et al
    Associations Between Levels of Peripheral NCAPH2 Promoter Methylation and Different Stages of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2023 Feb 14. doi: 10.3233/JAD-221211.
    PubMed     Abstract available


  428. MARCISZ A, Polanska J
    Can T1-Weighted Magnetic Resonance Imaging Significantly Improve Mini-Mental State Examination-Based Distinguishing Between Mild Cognitive Impairment and Early-Stage Alzheimer's Disease?
    J Alzheimers Dis. 2023 Feb 14. doi: 10.3233/JAD-220806.
    PubMed     Abstract available


  429. SHIR D, Mielke MM, Hofrenning EI, Lesnick TG, et al
    Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology.
    J Alzheimers Dis. 2023 Feb 13. doi: 10.3233/JAD-221015.
    PubMed     Abstract available


  430. SWERDLOW RH
    The Alzheimer's Disease Mitochondrial Cascade Hypothesis: A Current Overview.
    J Alzheimers Dis. 2023 Feb 11. doi: 10.3233/JAD-221286.
    PubMed     Abstract available


  431. AGGER MP, Danielsen ER, Carstensen MS, Nguyen NM, et al
    Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study.
    J Alzheimers Dis. 2023 Feb 9. doi: 10.3233/JAD-221238.
    PubMed     Abstract available


  432. WANG Z, Zeng S, Jing Y, Mao W, et al
    Sarm1 Regulates Circadian Rhythm Disorder in Alzheimer's Disease in Mice.
    J Alzheimers Dis. 2023 Feb 9. doi: 10.3233/JAD-221027.
    PubMed     Abstract available


  433. CHATTERJEE P, Dore V, Pedrini S, Krishnadas N, et al
    Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 9. doi: 10.3233/JAD-220908.
    PubMed     Abstract available


  434. PETTI U, Baker S, Korhonen A, Robin J, et al
    The Generalizability of Longitudinal Changes in Speech Before Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2023 Feb 9. doi: 10.3233/JAD-220847.
    PubMed     Abstract available


  435. REN JR, Wang Z, Cheng Y, He CY, et al
    Associations Between Plasma Klotho with Renal Function and Cerebrospinal Fluid Amyloid-beta Levels in Alzheimer's Disease: The Chongqing Ageing & Dementia Study.
    J Alzheimers Dis. 2023 Feb 7. doi: 10.3233/JAD-221107.
    PubMed     Abstract available


  436. KHEZRI MR, Ghasemnejad-Berenji M, Moloodsouri D
    The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-221157.
    PubMed     Abstract available


  437. ZHAO YL, Ou YN, Ma YH, Tan L, et al
    Characteristics of Subjective Cognitive Decline Associated with Alzheimer's Disease Amyloid Pathology: Findings from The CABLE Study.
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-221154.
    PubMed     Abstract available


  438. ZHU CW, Gu Y, Kociolek AJ, Fernandez KK, et al
    Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-221021.
    PubMed     Abstract available


  439. VAN DEN BERG E, Nilsson J, Kersten I, Brinkmalm G, et al
    Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-220977.
    PubMed     Abstract available


  440. STOCKS J, Heywood A, Popuri K, Beg MF, et al
    Longitudinal Spatial Relationships Between Atrophy and Hypometabolism Across the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-220975.
    PubMed     Abstract available


  441. TANDON R, Levey AI, Lah JJ, Seyfried NT, et al
    Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 6. doi: 10.3233/JAD-220683.
    PubMed     Abstract available


  442. ZHOU M, Jiao Q, Wu Z, Li W, et al
    Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer's Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks.
    J Alzheimers Dis. 2023 Feb 2. doi: 10.3233/JAD-220727.
    PubMed     Abstract available


  443. PANYARD DJ, Deming YK, Darst BF, Van Hulle CA, et al
    Liver-Specific Polygenic Risk Score Is Associated with Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2023 Feb 2. doi: 10.3233/JAD-220599.
    PubMed     Abstract available


  444. HIGHET B, Wiseman JA, Mein H, Parker R, et al
    PSA-NCAM Regulatory Gene Expression Changes in the Alzheimer's Disease Entorhinal Cortex Revealed with Multiplexed in situ Hybridization.
    J Alzheimers Dis. 2023 Feb 1. doi: 10.3233/JAD-220986.
    PubMed     Abstract available


    January 2023
  445. LILEK J, Ajroud K, Feldman AZ, Krishnamachari S, et al
    Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 30. doi: 10.3233/JAD-220848.
    PubMed    


  446. NEWTON P, Tchounguen J, Pettigrew C, Lim C, et al
    Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Jan 28. doi: 10.3233/JAD-220846.
    PubMed     Abstract available


  447. VOSS T, Kost J, Mercer SP, Furtek C, et al
    Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.
    J Alzheimers Dis. 2023 Jan 28. doi: 10.3233/JAD-220836.
    PubMed     Abstract available


  448. WU C, Ma YH, Hu H, Zhao B, et al
    Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study.
    J Alzheimers Dis. 2023 Jan 28. doi: 10.3233/JAD-220731.
    PubMed     Abstract available


  449. WAN K, Yin W, Tang Y, Zhu W, et al
    Brain Gray Matter Volume Mediated the Correlation Between Plasma P-Tau and Cognitive Function of Early Alzheimer's Disease in China: A Cross-Sectional Observational Study.
    J Alzheimers Dis. 2023 Jan 25. doi: 10.3233/JAD-221100.
    PubMed     Abstract available


  450. TAO X, Zhang R, Wang L, Li X, et al
    Luteolin and Exercise Combination Therapy Ameliorates Amyloid-beta1-42 Oligomers-Induced Cognitive Impairment in Alzheimer's Disease Mice by Mediating Neuroinflammation and Autophagy.
    J Alzheimers Dis. 2023 Jan 25. doi: 10.3233/JAD-220904.
    PubMed     Abstract available


  451. DENG L, Wang Y
    Fully Connected Multi-Kernel Convolutional Neural Network Based on Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2023 Jan 25. doi: 10.3233/JAD-220519.
    PubMed     Abstract available


  452. SALEM H, Suchting R, Gonzales MM, Seshadri S, et al
    Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.
    J Alzheimers Dis. 2023 Jan 24. doi: 10.3233/JAD-220826.
    PubMed     Abstract available



  453. Erratum to: Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.
    J Alzheimers Dis. 2023 Jan 23. doi: 10.3233/JAD-229019.
    PubMed    


  454. PERRY G
    Alzheimer's Disease: Not Just for the Aged?
    J Alzheimers Dis. 2023 Jan 23. doi: 10.3233/JAD-230016.
    PubMed    


  455. WINSTON CN, Langford O, Levin N, Raman R, et al
    Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 23. doi: 10.3233/JAD-221118.
    PubMed     Abstract available


  456. SAMUDRA N, Ranasinghe K, Kirsch H, Rankin K, et al
    Etiology and Clinical Significance of Network Hyperexcitability in Alzheimer's Disease: Unanswered Questions and Next Steps.
    J Alzheimers Dis. 2023 Jan 23. doi: 10.3233/JAD-220983.
    PubMed     Abstract available


  457. SAGARO GG, Traini E, Amenta F
    Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Jan 20. doi: 10.3233/JAD-221189.
    PubMed     Abstract available


  458. BASHA SC, Ramaiah MJ, Kosagisharaf JR
    Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfunction: A Hypothesis on a Novel Pathway in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 20. doi: 10.3233/JAD-221070.
    PubMed     Abstract available


  459. HUANG W, Xia Q, Zheng F, Zhao X, et al
    Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 18. doi: 10.3233/JAD-221064.
    PubMed     Abstract available


  460. ISHABIYI FO, Ogidi J, Olukade BA, Amorha CC, et al
    Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 18. doi: 10.3233/JAD-221020.
    PubMed     Abstract available


  461. GUO X, Zhang G, Peng Q, Huang L, et al
    Emerging Roles of Meningeal Lymphatic Vessels in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 18. doi: 10.3233/JAD-221016.
    PubMed     Abstract available


  462. DALY T, Henry V, Bourdenx M
    From Association to Intervention: The Alzheimer's Disease-Associated Processes and Targets (ADAPT) Ontology.
    J Alzheimers Dis. 2023 Jan 18. doi: 10.3233/JAD-221004.
    PubMed     Abstract available


  463. CORRIGAN RR, Labrador L, Grizzanti J, Mey M, et al
    Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 13. doi: 10.3233/JAD-221057.
    PubMed     Abstract available


  464. AZAMI H, Moguilner S, Penagos H, Sarkis RA, et al
    EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 12. doi: 10.3233/JAD-221152.
    PubMed     Abstract available


  465. WANG X, Zhou X, Lee J, Furdui CM, et al
    In-Depth Proteomic Analysis of De Novo Proteome in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 11. doi: 10.3233/JAD-221044.
    PubMed     Abstract available


  466. GARCIA-ALBERCA JM, Gris E, de la Guia P, Mendoza S, et al
    Efficacy of Souvenaid(R) Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 11. doi: 10.3233/JAD-221003.
    PubMed     Abstract available


  467. FISCHER MHF, Zibrandtsen IC, Hogh P, Musaeus CS, et al
    Systematic Review of EEG Coherence in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 9. doi: 10.3233/JAD-220508.
    PubMed     Abstract available



  468. Erratum to: Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.
    J Alzheimers Dis. 2023 Jan 7. doi: 10.3233/JAD-229020.
    PubMed    


  469. NICOLAZZO J, Cavuoto M, Rowsthorn E, Cribb L, et al
    Insomnia Symptoms and Biomarkers of Alzheimer's Disease in the Community.
    J Alzheimers Dis. 2023 Jan 7. doi: 10.3233/JAD-220924.
    PubMed     Abstract available


  470. RAHKONEN A, Taipale H, Koponen M, Hartikainen S, et al
    The Cumulative Use of Muscle Relaxants and the Risk of Alzheimer's Disease: A Nationwide Case-Control Study.
    J Alzheimers Dis. 2023 Jan 7. doi: 10.3233/JAD-220409.
    PubMed     Abstract available


  471. ZHU M, Tang M, Du Y
    Identification of TAC1 Associated with Alzheimer's Disease Using a Robust Rank Aggregation Approach.
    J Alzheimers Dis. 2023 Jan 6. doi: 10.3233/JAD-220950.
    PubMed     Abstract available


  472. EISER AR, Fulop T
    Alzheimer's Disease is a Multi-Organ Disorder: It May Already Be Preventable.
    J Alzheimers Dis. 2023 Jan 3. doi: 10.3233/JAD-221078.
    PubMed     Abstract available


  473. LIMA M, Tabuas-Pereira M, Duraes J, Vieira D, et al
    Neuropsychological Assessment in the Distinction Between Biomarker Defined Frontal-Variant of Alzheimer's Disease and Behavioral-Variant of Frontotemporal Dementia.
    J Alzheimers Dis. 2023 Jan 3. doi: 10.3233/JAD-220897.
    PubMed     Abstract available


  474. SHARMA N, Banerjee R, Davis RL
    Early Mitochondrial Defects in the 5xFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jan 3. doi: 10.3233/JAD-220884.
    PubMed     Abstract available


  475. HUIE EZ, Escudero A, Saito N, Harvey D, et al
    TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.
    J Alzheimers Dis. 2023 Jan 3. doi: 10.3233/JAD-220558.
    PubMed     Abstract available


  476. RADESTIG MA, Skoog J, Zetterberg H, Skillback T, et al
    Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.
    J Alzheimers Dis. 2023;91:291-303.
    PubMed     Abstract available


  477. HU LT, Xie XY, Zhou GF, Wen QX, et al
    HMGCS2-Induced Autophagic Degradation of Tau Involves Ketone Body and ANKRD24.
    J Alzheimers Dis. 2023;91:407-426.
    PubMed     Abstract available


  478. KATABATHULA S, Davis PB, Xu R
    Sex-Specific Heterogeneity of Mild Cognitive Impairment Identified Based on Multi-Modal Data Analysis.
    J Alzheimers Dis. 2023;91:233-243.
    PubMed     Abstract available


  479. NOGUCHI-SHINOHARA M, Hamaguchi T, Sakai K, Komatsu J, et al
    Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial.
    J Alzheimers Dis. 2023;91:805-814.
    PubMed     Abstract available


  480. LIU Y, Zeng Z, Huang S, Shang P, et al
    Brain Activation During Working Memory Task in Amnestic Mild Cognitive Impairment Patients and Its Association with Memory and Attention.
    J Alzheimers Dis. 2023;91:863-875.
    PubMed     Abstract available


  481. CHANDLER J, Kubisiak J
    Clinical and Economic Assessment in Early-Stage Dementia by Severity and Amyloid-beta Status: A 5-Year Retrospective Claims Study of GERAS-US Patients.
    J Alzheimers Dis. 2023;91:753-765.
    PubMed     Abstract available


  482. FENECH RK, Hamstra SI, Finch MS, Ryan CR, et al
    Low-Dose Lithium Supplementation Influences GSK3beta Activity in a Brain Region Specific Manner in C57BL6 Male Mice.
    J Alzheimers Dis. 2023;91:615-626.
    PubMed     Abstract available


  483. WU J, Su Y, Zhu W, Jalili Mallak N, et al
    Improved Prediction of Amyloid-beta and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding.
    J Alzheimers Dis. 2023;91:637-651.
    PubMed     Abstract available


  484. SAKAI K, Noguchi-Shinohara M, Tanaka H, Ikeda T, et al
    Cerebrospinal Fluid Biomarkers and Amyloid-beta Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation.
    J Alzheimers Dis. 2023;91:1173-1183.
    PubMed     Abstract available


  485. SCHAFER S, Mallick E, Schwed L, Konig A, et al
    Screening for Mild Cognitive Impairment Using a Machine Learning Classifier and the Remote Speech Biomarker for Cognition: Evidence from Two Clinically Relevant Cohorts.
    J Alzheimers Dis. 2023;91:1165-1171.
    PubMed     Abstract available


  486. MEYSAMI S, Raji CA, Glatt RM, Popa ES, et al
    Handgrip Strength Is Related to Hippocampal and Lobar Brain Volumes in a Cohort of Cognitively Impaired Older Adults with Confirmed Amyloid Burden.
    J Alzheimers Dis. 2023;91:999-1006.
    PubMed     Abstract available


  487. CASELLI RJ, Chen Y, Chen K, Bauer RJ, et al
    Cognition Before and After COVID-19 Disease in Older Adults: An Exploratory Study.
    J Alzheimers Dis. 2023;91:1049-1058.
    PubMed     Abstract available


  488. MASCARENHAS FONSECA L, Sage Chaytor N, Olufadi Y, Buchwald D, et al
    Intraindividual Cognitive Variability and Magnetic Resonance Imaging in Aging American Indians: Data from the Strong Heart Study.
    J Alzheimers Dis. 2023;91:1395-1407.
    PubMed     Abstract available


  489. SACRIPANTE R, Girtler N, Doglione E, Nobili F, et al
    Forgetting Rates of Prose Memory in Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;91:1385-1394.
    PubMed     Abstract available


  490. HAYS WEEKS CC, Zlatar ZZ, Meloy MJ, Shin DD, et al
    APOE Genotype Modifies the Association of Fusiform Gyrus Cerebral Metabolic Rate of Oxygen Consumption and Object Naming Performance.
    J Alzheimers Dis. 2023;91:1371-1383.
    PubMed     Abstract available


  491. JANSE A, van de Rest O, de Groot LCPGM, Witkamp RF, et al
    The Association of Vitamin D Status with Mild Cognitive Impairment and Dementia Subtypes: A Cross-Sectional Analysis in Dutch Geriatric Outpatients.
    J Alzheimers Dis. 2023;91:1359-1369.
    PubMed     Abstract available


  492. MARIN-MARIN L, Miro-Padilla A, Costumero V
    Structural But Not Functional Connectivity Differences within Default Mode Network Indicate Conversion to Dementia.
    J Alzheimers Dis. 2023;91:1483-1494.
    PubMed     Abstract available


  493. LIU C, Lee SH, Loewenstein DA, Galvin JE, et al
    Early Amnestic Mild Cognitive Impairment Is Associated with Reduced Total Cerebral Blood Flow with no Brain Tissue Loss.
    J Alzheimers Dis. 2023;91:1313-1322.
    PubMed     Abstract available


  494. HUQUE H, Eramudugolla R, Chidiac B, Ee N, et al
    Could Country-Level Factors Explain Sex Differences in Dementia Incidence and Prevalence? A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;91:1231-1241.
    PubMed     Abstract available


  495. BOUGES S, Fischer BL, Norton DL, Wyman MF, et al
    Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.
    J Alzheimers Dis. 2023;92:285-294.
    PubMed     Abstract available


  496. YOSHIDA M, Uemura T, Mizoi M, Waragai M, et al
    Urinary Amino Acid-Conjugated Acrolein and Taurine as New Biomarkers for Detection of Dementia.
    J Alzheimers Dis. 2023;92:361-369.
    PubMed     Abstract available


  497. BAEZ S, Trujillo-Llano C, de Souza LC, Lillo P, et al
    Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.
    J Alzheimers Dis. 2023;92:153-169.
    PubMed     Abstract available


  498. HUANG Z
    A Function of Amyloid-beta in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology.
    J Alzheimers Dis. 2023;92:29-57.
    PubMed     Abstract available


  499. GRASSET L, Power MC, Crivello F, Tzourio C, et al
    How Traumatic Brain Injury History Relates to Brain Health MRI Markers and Dementia Risk: Findings from the 3C Dijon Cohort.
    J Alzheimers Dis. 2023;92:183-193.
    PubMed     Abstract available


  500. CORRERO II AN, Gauthreaux K, Perales-Puchalt J, Chen YC, et al
    Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples.
    J Alzheimers Dis. 2023;92:109-128.
    PubMed     Abstract available


  501. MOEBIUS HJ, Church KJ
    The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators.
    J Alzheimers Dis. 2023;92:1-12.
    PubMed     Abstract available


  502. YANG M, Qi R, Liu Y, Shen X, et al
    Casein Kinase 1delta Phosphorylates TDP-43 and Suppresses Its Function in Tau mRNA Processing.
    J Alzheimers Dis. 2023;91:1527-1539.
    PubMed     Abstract available


  503. ONO R, Sakurai T, Sugimoto T, Uchida K, et al
    Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES.
    J Alzheimers Dis. 2023;92:487-498.
    PubMed     Abstract available


  504. GABRIELLI AP, Weidling I, Ranjan A, Wang X, et al
    Mitochondria Profoundly Influence Apolipoprotein E Biology.
    J Alzheimers Dis. 2023;92:591-604.
    PubMed     Abstract available


  505. TAN YJ, Siow I, Saffari SE, Ting SKS, et al
    Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.
    J Alzheimers Dis. 2023;92:573-580.
    PubMed     Abstract available


  506. ROYALL DR, Palmer RF
    Multiple Adipokines Predict Dementia Severity as Measured by delta: Replication Across Biofluids and Cohorts.
    J Alzheimers Dis. 2023;92:639-652.
    PubMed     Abstract available


  507. MANN FD, Clouston SAP, Cuevas A, Waszczuk MA, et al
    Genetic Liability, Exposure Severity, and Post-Traumatic Stress Disorder Predict Cognitive Impairment in World Trade Center Responders.
    J Alzheimers Dis. 2023;92:701-712.
    PubMed     Abstract available


  508. TANG M, Su N, Zhang D, Dai Y, et al
    The Differential Effects of APOEvarepsilon4 on Cerebral Volumetric Structures in Different Lifespan in Community-Dwelling Populations.
    J Alzheimers Dis. 2023;92:691-700.
    PubMed     Abstract available


  509. GYLLENHAMMAR M, Rennie A, Padilla DF, Wallert J, et al
    The Association Between Temporal Atrophy and Episodic Memory Is Moderated by Education in a Multi-Center Memory Clinic Sample.
    J Alzheimers Dis. 2023;92:605-614.
    PubMed     Abstract available


  510. JOHNSON CN, McCoin CS, Kueck PJ, Hawley AG, et al
    Relationship of Muscle Apolipoprotein E Expression with Markers of Cellular Stress, Metabolism, and Blood Biomarkers in Cognitively Healthy and Impaired Older Adults.
    J Alzheimers Dis. 2023;92:1027-1035.
    PubMed     Abstract available


  511. TARAWNEH HY, Jayakody DMP, Verma S, Dore V, et al
    Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints.
    J Alzheimers Dis. 2023;92:1093-1109.
    PubMed     Abstract available


  512. KANIA B, Sotelo A, Ty D, Wisco JJ, et al
    The Prevention of Inflammation and the Maintenance of Iron and Hepcidin Homeostasis in the Gut, Liver, and Brain Pathologies.
    J Alzheimers Dis. 2023;92:769-789.
    PubMed     Abstract available


  513. LI QY, Li XM, Hu HY, Ma YH, et al
    Associations of Lung Function Decline with Risks of Cognitive Impairment and Dementia: A Meta-Analysis and Systematic Review.
    J Alzheimers Dis. 2023;92:853-873.
    PubMed     Abstract available


  514. WELBERRY HJ, Chau T, Heffernan M, San Jose JC, et al
    Factors Associated with Participation in a Multidomain Web-Based Dementia Prevention Trial: Evidence from Maintain Your Brain (MYB).
    J Alzheimers Dis. 2023;92:959-974.
    PubMed     Abstract available


  515. KIM BS, Jun S, Kim H
    Cognitive Trajectories and Associated Biomarkers in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;92:803-814.
    PubMed     Abstract available


  516. ZHANG F, Niu L, Zhong R, Li S, et al
    Chronic Sleep Disturbances Alters Sleep Structure and Tau Phosphorylation in AbetaPP/PS1 AD Mice and Their Wild-Type Littermates.
    J Alzheimers Dis. 2023;92:1341-1355.
    PubMed     Abstract available


  517. BUKHBINDER AS, Hinojosa M, Harris K, Li X, et al
    Population-Based Mini-Mental State Examination Norms in Adults of Mexican Heritage in the Cameron County Hispanic Cohort.
    J Alzheimers Dis. 2023;92:1323-1339.
    PubMed     Abstract available


  518. KAWAKATSU S, Kobayashi R
    Towards Improved Clinical Diagnosis of Argyrophilic Grain Disease Using Brain Imaging.
    J Alzheimers Dis. 2023;93:389-392.
    PubMed     Abstract available


  519. PARKA A, Volbracht C, Hall B, Bastlund JF, et al
    Visual Evoked Potentials as an Early-Stage Biomarker in the rTg4510 Tauopathy Mouse Model.
    J Alzheimers Dis. 2023;93:247-262.
    PubMed     Abstract available


  520. GAO Y, Liu Y, Zhang Y, Wang Y, et al
    Olfactory Threshold Test as a Quick Screening Tool for Cognitive Impairment: Analysis of Two Independent Cohorts.
    J Alzheimers Dis. 2023;93:169-178.
    PubMed     Abstract available


  521. TETLOW AM, Jackman BM, Alhadidy MM, Perumal V, et al
    Influence of Host Age on Intracranial AAV9 TauP301L Induced Tauopathy.
    J Alzheimers Dis. 2023;93:365-378.
    PubMed     Abstract available


  522. RODRIGUES MARTINS D, Vandermeeren M, Van Kolen K, Brepoels E, et al
    Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid.
    J Alzheimers Dis. 2023;93:151-167.
    PubMed     Abstract available


  523. LV X, Chu M, Liu Y, Jing D, et al
    Neurofunctional Correlates of Activities of Daily Living in Patients with Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023;93:295-305.
    PubMed     Abstract available


  524. JANG S, Chorna N, Rodriguez-Graciani KM, Inyushin M, et al
    The Effects of Amyloid-beta on Metabolomic Profiles of Cardiomyocytes and Coronary Endothelial Cells.
    J Alzheimers Dis. 2023;93:307-319.
    PubMed     Abstract available


  525. LANOOIJ SD, Eisel ULM, van der Zee EA, Kas MJH, et al
    Variation in Group Composition Alters an Early-Stage Social Phenotype in hAPP-Transgenic J20 Mice.
    J Alzheimers Dis. 2023;93:211-224.
    PubMed     Abstract available


  526. UMFLEET LG, Bilder RM, Loring DW, Thames A, et al
    The Future of Cognitive Screening in Neurodegenerative Diseases.
    J Alzheimers Dis. 2023;93:47-59.
    PubMed     Abstract available


  527. KREBS C, Brill E, Minkova L, Federspiel A, et al
    Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline.
    J Alzheimers Dis. 2023;93:107-124.
    PubMed     Abstract available


  528. WEIDUNG B, Lovheim H, Littbrand H, Wahlin J, et al
    Temporal Dementia and Cognitive Impairment Trends in the Very Old in the 21st Century.
    J Alzheimers Dis. 2023;93:61-74.
    PubMed     Abstract available


  529. GRISANTI SG, Massa F, Chincarini A, Pretta S, et al
    Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;93:75-86.
    PubMed     Abstract available


  530. FLETCHER E
    Multifactorial Modeling of Cognitive Trajectories Using an Advanced Regression Technique: Improving Our Understanding of Biomarkers and Modifiable Variables that Support Cognition.
    J Alzheimers Dis. 2023;93:815-819.
    PubMed     Abstract available


  531. CASTELLANI RJ, Shanes ED, McCord M, Reish NJ, et al
    Neuropathology of Anti-Amyloid-beta Immunotherapy: A Case Report.
    J Alzheimers Dis. 2023;93:803-813.
    PubMed     Abstract available


  532. XIAO Y, Liao L, Huang K, Yao S, et al
    Coupling Between Hippocampal Parenchymal Fraction and Cortical Grey Matter Atrophy at Different Stages of Cognitive Decline.
    J Alzheimers Dis. 2023;93:791-801.
    PubMed     Abstract available


  533. HICKEY M, Hueg TK, Priskorn L, Uldbjerg CS, et al
    Depression in Mid- and Later-Life and Risk of Dementia in Women: A Prospective Study within the Danish Nurses Cohort.
    J Alzheimers Dis. 2023;93:779-789.
    PubMed     Abstract available


  534. CHEN CD, Ponisio MR, Lang JA, Flores S, et al
    Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment.
    J Alzheimers Dis. 2023;93:765-777.
    PubMed     Abstract available


  535. HATTORI Y, Saito S, Nakaoku Y, Ogata S, et al
    Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia.
    J Alzheimers Dis. 2023;93:743-754.
    PubMed     Abstract available


  536. ZHANG LY, Wang DZ, Wang J, Guo L, et al
    Associations of Serum Antimicrobial Peptide LL-37 with Longitudinal Cognitive Decline and Neurodegeneration Among Older Adults with Memory Complaints.
    J Alzheimers Dis. 2023;93:595-603.
    PubMed     Abstract available


  537. AGUILAR-BARBERA M, Soler-Girabau P, Tabuenca-Martin AI, Prieto-Del Val L, et al
    Fortasyn Connect Improves Neuropsychiatric Symptoms in Patients with Mild Cognitive Impairment and Dementia: Results from a Retrospective Real-World Study.
    J Alzheimers Dis. 2023;93:621-631.
    PubMed     Abstract available


  538. SIBLE IJ, Nation DA
    Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein varepsilon4 Carriers versus Apolipoprotein varepsilon3 Homozygotes.
    J Alzheimers Dis. 2023;93:533-543.
    PubMed     Abstract available


  539. BISWAS R, Kawas C, Montine TJ, Bukhari SA, et al
    Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study.
    J Alzheimers Dis. 2023;93:561-575.
    PubMed     Abstract available


  540. BROOK ES, D'Alonzo ZJ, Lam V, Chan DC, et al
    Plasma Amyloid-beta Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity.
    J Alzheimers Dis. 2023;93:653-664.
    PubMed     Abstract available


  541. RHYU JM, Park J, Shin BS, Kim YE, et al
    A Novel c.800G>C Variant of the ITM2B Gene in Familial Korean Dementia.
    J Alzheimers Dis. 2023;93:403-409.
    PubMed     Abstract available


  542. DUFF K, Wan L, Embree L, Hoffman JM, et al
    Change in the Quick Dementia Rating System Across Time in Older Adults with and without Cognitive Impairment.
    J Alzheimers Dis. 2023;93:449-457.
    PubMed     Abstract available


  543. ZHANG J, Zhang T, Wang Y, Yao L, et al
    Galpha13-Mediated Signaling Cascade Is Related to the Tau Pathology Caused by Anesthesia and Surgery in 5XFAD Transgenic Mice.
    J Alzheimers Dis. 2023;93:545-560.
    PubMed     Abstract available


  544. IMAI A, Matsuoka T, Narumoto J
    Emotional Dysregulation in Mild Behavioral Impairment Is Associated with Reduced Cortical Thickness in the Right Supramarginal Gyrus.
    J Alzheimers Dis. 2023;93:521-532.
    PubMed     Abstract available


  545. ZHENG YB, Sun J, Shi L, Su SZ, et al
    Association of Caffeine Consumption and Brain Amyloid Positivity in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2023;93:483-493.
    PubMed     Abstract available


  546. NOBLE JM, Papapanou PN
    With Teeth, Broken, or Fixed: The Challenges of Linking Periodontitis, Neuroepidemiology, and Biomarkers of Disease.
    J Alzheimers Dis. 2023;93:991-994.
    PubMed     Abstract available


  547. GOLLOP C, Zingel R, Jacob L, Smith L, et al
    Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study.
    J Alzheimers Dis. 2023;93:1033-1040.
    PubMed     Abstract available


  548. FAN J, Zhu Z, Chen Y, Yang C, et al
    SORL1 rs1699102 Moderates the Effect of Sex on Language Network.
    J Alzheimers Dis. 2023;93:1051-1063.
    PubMed     Abstract available


  549. WU J, Su Y, Chen Y, Zhu W, et al
    A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry.
    J Alzheimers Dis. 2023;93:1153-1168.
    PubMed     Abstract available


  550. JIANG C, Wang Y, Dong Y, Liu R, et al
    Associations of Microvascular Dysfunction with Mild Cognitive Impairment and Cognitive Function Among Rural-Dwelling Older Adults in China.
    J Alzheimers Dis. 2023;93:1111-1124.
    PubMed     Abstract available


  551. MARSHALL AJ, Gaubert A, Kapoor A, Tan A, et al
    Blood-Derived Progenitor Cells Are Depleted in Older Adults with Cognitive Impairment: A Role for Vascular Resilience?
    J Alzheimers Dis. 2023;93:1041-1050.
    PubMed     Abstract available


  552. NIJSKENS C, Henstra M, Rhodius-Meester H, Yasar S, et al
    Cardiovascular Risk Management in Persons with Dementia.
    J Alzheimers Dis. 2023;93:879-889.
    PubMed     Abstract available


  553. GIBBONS LE, Power MC, Walker RL, Kumar RG, et al
    Association of Traumatic Brain Injury with Late Life Neuropathological Outcomes in a Community-Based Cohort.
    J Alzheimers Dis. 2023;93:949-961.
    PubMed     Abstract available


  554. SMITH CJ, Ashford JW
    Apolipoprotein varepsilon4-Associated Protection Against Pediatric Enteric Infections Is a Survival Advantage in Pre-Industrial Populations.
    J Alzheimers Dis. 2023;93:907-918.
    PubMed     Abstract available


  555. BAUERNSCHMIDT D, Hirt J, Langer G, Meyer G, et al
    Technology-Based Counselling for People with Dementia and Their Informal Carers: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;93:891-906.
    PubMed     Abstract available


  556. PILONIETA G, Pisu M, Martin RC, Shan L, et al
    Specialist Availability and Drug Adherence in Older Adults with Dementia Across Regions of the United States.
    J Alzheimers Dis. 2023;93:927-937.
    PubMed     Abstract available


  557. XIANG Q, Andersen SL, Sweigart B, Gunn S, et al
    Signatures of Neuropsychological Test Results in the Long Life Family Study: A Cluster Analysis.
    J Alzheimers Dis. 2023;93:1457-1469.
    PubMed     Abstract available


  558. BEST MN, Lim Y, Ferenc NN, Kim N, et al
    Extracellular Tau Oligomers Damage the Axon Initial Segment.
    J Alzheimers Dis. 2023;93:1425-1441.
    PubMed     Abstract available


  559. XU S, Ren Y, Liu R, Li Y, et al
    Prevalence and Progression of Subjective Cognitive Decline Among Rural Chinese Older Adults: A Population-Based Study.
    J Alzheimers Dis. 2023;93:1355-1368.
    PubMed     Abstract available


  560. YANG F, Yang L, Fang X, Deng Y, et al
    Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
    J Alzheimers Dis. 2023;93:1341-1354.
    PubMed     Abstract available


  561. NALLAPU BT, Petersen KK, Lipton RB, Grober E, et al
    Association of Alcohol Consumption with Cognition in Older Population: The A4 Study.
    J Alzheimers Dis. 2023;93:1381-1393.
    PubMed     Abstract available


  562. ANDERSSON MJ, Stone J
    Best Medicine for Dementia: The Life-Long Defense of the Brain.
    J Alzheimers Dis. 2023;94:51-66.
    PubMed     Abstract available


  563. DI J, Nelson RS, Jicha GA, Moga DC, et al
    Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes.
    J Alzheimers Dis. 2023;94:333-346.
    PubMed     Abstract available


  564. MEDURI G, Guillemeau K, Daguinot C, Dounane O, et al
    Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
    J Alzheimers Dis. 2023;94:313-331.
    PubMed     Abstract available


  565. SINHA N, Fausto BA, Mander B, Gluck MA, et al
    High-Quality Sleep Mitigates ABCA7-Related Generalization Deficits in Healthy Older African Americans.
    J Alzheimers Dis. 2023;94:281-290.
    PubMed     Abstract available


  566. BUAWANGPONG N, Pinyopornpanish K, Phinyo P, Jiraporncharoen W, et al
    Effect of Comorbidities on Ten-Year Survival in Patients with Dementia.
    J Alzheimers Dis. 2023;94:163-175.
    PubMed     Abstract available


  567. DE ANDA-DURAN I, Kolachalama VB, Carmichael OT, Hwang PH, et al
    Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.
    J Alzheimers Dis. 2023;94:101-113.
    PubMed     Abstract available


  568. LOUGHREY DG, Leroi I
    Understanding the Association Between Sensory Impairment and Dementia: Toward Informing Future Research and Health Policy.
    J Alzheimers Dis. 2023;94:597-599.
    PubMed     Abstract available


  569. OLIVEIRA FF
    Looking Behind the Curtain: Patient Stratification According to Genetic or Demographic Factors May Yield Unexpected Results in Studies of Neurodegenerative Diseases.
    J Alzheimers Dis. 2023;94:777-780.
    PubMed     Abstract available


  570. CURTIS ME, Smith T, Nenov M, Blass BE, et al
    Retromer Stabilization Improves Cognitive Function and Synaptic Plasticity in a Mouse Model of Down Syndrome.
    J Alzheimers Dis. 2023;94:513-518.
    PubMed     Abstract available


  571. LI B, Shi K, Ren C, Kong M, et al
    Detection of Tau-PET Positivity in Clinically Diagnosed Mild Cognitive Impairment with Multidimensional Features.
    J Alzheimers Dis. 2023;94:627-640.
    PubMed     Abstract available


  572. TOCCACELI BLASI M, Valletta M, Trebbastoni A, D'Antonio F, et al
    Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates.
    J Alzheimers Dis. 2023;94:601-610.
    PubMed     Abstract available


  573. WANG J, Wang M, Ren S, Huang L, et al
    The Effect of Gender and APOE varepsilon4 Status on Brain Amyloid-beta Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study.
    J Alzheimers Dis. 2023;94:763-775.
    PubMed     Abstract available


  574. FARINA FR, Booi L, Occhipinti JA, Quoidbach V, et al
    Young Adult Brain Capital: A New Opportunity for Dementia Prevention.
    J Alzheimers Dis. 2023;94:415-423.
    PubMed     Abstract available


  575. MAURER A, Himmel G, Lange C, Mathies F, et al
    Individualized Summary Assessment of Detailed Neuropsychological Testing for the Etiological Diagnosis of Newly Detected Cognitive Impairment in Hospitalized Geriatric Patients.
    J Alzheimers Dis. 2023;94:559-584.
    PubMed     Abstract available


  576. EDWARDS L, Thomas KR, Weigand AJ, Edmonds EC, et al
    White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia.
    J Alzheimers Dis. 2023;94:695-707.
    PubMed     Abstract available


  577. CHOU OHI, Zhou J, Li L, Chan JSK, et al
    The Association Between Neutrophil-Lymphocyte Ratio and Variability with New-Onset Dementia: A Population-Based Cohort Study.
    J Alzheimers Dis. 2023;94:547-557.
    PubMed     Abstract available


  578. LI T, Pappas C, Klinedinst B, Pollpeter A, et al
    Associations Between Insulin-Like Growth Factor-1 and Resting-State Functional Connectivity in Cognitively Unimpaired Midlife Adults.
    J Alzheimers Dis. 2023;94.
    PubMed     Abstract available


  579. KOSTEV K
    Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk.
    J Alzheimers Dis. 2023;94:961-962.
    PubMed     Abstract available


  580. CASTELBLANCO-TORO SM, Jurado-Delgado J, Meneses-Bernal JF, Santacruz-Escudero JM, et al
    Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population.
    J Alzheimers Dis. 2023;94:1197-1207.
    PubMed     Abstract available


  581. CUBERO-PLAZAS L, Sancho-Cantus D, de la Rubia Orti JE, Prieto-Contreras L, et al
    Impact of Family Function on the Quality of Life and Health Perception of Non-Institutionalized Dementia Patients.
    J Alzheimers Dis. 2023;94:963-975.
    PubMed     Abstract available


  582. PANZA F, Solfrizzi V, Sardone R, Dibello V, et al
    Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders.
    J Alzheimers Dis. 2023;94:879-898.
    PubMed     Abstract available


  583. BAYRAM E, Holden SK, Fullard M, Armstrong MJ, et al
    Race and Ethnicity in Lewy Body Dementia: A Narrative Review.
    J Alzheimers Dis. 2023;94:861-878.
    PubMed     Abstract available


  584. WANG G, Li DY, Vance DE, Li W, et al
    Alcohol Use Disorder as a Risk Factor for Cognitive Impairment.
    J Alzheimers Dis. 2023;94:899-907.
    PubMed     Abstract available


  585. CAILLAUD M, Maltezos S, Hudon C, Mellah S, et al
    Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.
    J Alzheimers Dis. 2023;94:1047-1056.
    PubMed     Abstract available


  586. CHWA WJ, Lopez OL, Longstreth WT, Dai W, et al
    Longitudinal Patterns of Brain Changes in a Community Sample in Relation to Aging and Cognitive Status.
    J Alzheimers Dis. 2023;94:1035-1045.
    PubMed     Abstract available


  587. SANDISON H, Callan NGL, Rao RV, Phipps J, et al
    Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline.
    J Alzheimers Dis. 2023;94:993-1004.
    PubMed     Abstract available


  588. LI D, Yang H, Lyu M, Wang J, et al
    Acupuncture Therapy on Dementia: Explained with an Integrated Analysis on Therapeutic Targets and Associated Mechanisms.
    J Alzheimers Dis. 2023;94.
    PubMed     Abstract available


  589. GOTTSCHALK WK, Mahon S, Hodgson D, Barrera J, et al
    The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression.
    J Alzheimers Dis. 2023;94:1563-1576.
    PubMed     Abstract available


  590. SUSAC J, Vukojevic J, Debogovic S, Bajic Z, et al
    Share of and Absolute Costs of Informal Care in Five Subpopulations of Outpatients with Dementia in Croatia: A Latent Profile Analysis.
    J Alzheimers Dis. 2023;94:1417-1430.
    PubMed     Abstract available


  591. BAYER TA, Jiang L, Erqou S, Kunicki ZJ, et al
    Incidence of New Dementia Diagnosis in Veterans Admitted to Nursing Homes After Heart Failure Hospitalization.
    J Alzheimers Dis. 2023;94:1397-1404.
    PubMed     Abstract available


  592. LANSDELL TA, Xu H, Galligan JJ, Dorrance AM, et al
    Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice.
    J Alzheimers Dis. 2023;94:1361-1375.
    PubMed     Abstract available


  593. YABUUCHI K, Kimura N, Masuda T, Matsubara E, et al
    Comparison of Brain Amyloid Deposition and Cortical Glucose Metabolism Between Clinic- and Community-Based Cohort.
    J Alzheimers Dis. 2023;95:299-306.
    PubMed     Abstract available


  594. HUANG L, Li Y, Wu J, Chen N, et al
    Shanghai Cognitive Screening: A Mobile Cognitive Assessment Tool Using Voice Recognition to Detect Mild Cognitive Impairment and Dementia in the Community.
    J Alzheimers Dis. 2023;95:227-236.
    PubMed     Abstract available


  595. CASTILLO C, Bravo-Arrepol G, Wendt A, Saez-Orellana F, et al
    Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-beta Peptide Toxicity.
    J Alzheimers Dis. 2023;94.
    PubMed     Abstract available


  596. NORRIS CM
    Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia?
    J Alzheimers Dis. 2023;95:599-602.
    PubMed     Abstract available


  597. PANIKKAR D, Vivek S, Crimmins E, Faul J, et al
    Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology.
    J Alzheimers Dis. 2023;95:735-748.
    PubMed     Abstract available


  598. PASSMORE SR, Longhurst C, Gerbitz A, Green-Harris G, et al
    "I Want to Know Everything ... ": The Return of Research Results and the Importance of Transparency in the Acceptability of Lumbar Punctures for African American Older Adults.
    J Alzheimers Dis. 2023;95:663-675.
    PubMed     Abstract available


  599. ROSALES-LAGARDE A, Cubero-Rego L, Menendez-Conde F, Rodriguez-Torres EE, et al
    Dissociation of Arousal Index Between REM and NREM Sleep in Elderly Adults with Cognitive Impairment, No Dementia: A Pilot Study.
    J Alzheimers Dis. 2023;95:477-491.
    PubMed     Abstract available


  600. VOLGMAN AS, Engelstein E, Aggarwal NT
    Vascular Cognitive Impairment: A Little Bit of Good News for Women or Bad News for Men?
    J Alzheimers Dis. 2023;95:407-409.
    PubMed     Abstract available


  601. MIYAWAKI CE, McClellan A, Bouldin ED, Brohard C, et al
    Feasibility and Efficacy of Life Review Delivered by Virtually-Trained Family Caregivers.
    J Alzheimers Dis. 2023;95:573-583.
    PubMed     Abstract available


  602. MACYCZKO JR, Wang N, Lu W, Jeevaratnam S, et al
    Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology.
    J Alzheimers Dis. 2023;95:399-405.
    PubMed     Abstract available


  603. BOGDAN A, Fabre R, Desmidt T, Golebiowski J, et al
    Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.
    J Alzheimers Dis. 2023;95:415-426.
    PubMed     Abstract available


  604. GUEVARA JE, Kurniadi NE, Duff K
    Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas.
    J Alzheimers Dis. 2023;95:509-521.
    PubMed     Abstract available


  605. NG PY, Zhang C, Li H, Baker DJ, et al
    Senescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice.
    J Alzheimers Dis. 2023;95:493-507.
    PubMed     Abstract available


  606. LOPES DAS NEVES P, Duraes J, Silva-Spinola A, Lima M, et al
    Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center.
    J Alzheimers Dis. 2023;95:391-397.
    PubMed     Abstract available


  607. DALY T
    JAD: A Forum for Philosophy in Science.
    J Alzheimers Dis. 2023;95:411-413.
    PubMed     Abstract available


  608. HUA S, Peters BA, Lee S, Fitzgerald K, et al
    Gut Microbiota and Cognitive Function Among Women Living with HIV.
    J Alzheimers Dis. 2023;95:1147-1161.
    PubMed     Abstract available


  609. COSTA T, Premi E, Liloia D, Cauda F, et al
    Unleashing the Power of Bayesian Re-Analysis: Enhancing Insights into Lecanemab (Clarity AD) Phase III Trial Through Informed t-Test.
    J Alzheimers Dis. 2023;95:1059-1065.
    PubMed     Abstract available


  610. POZZI FE, Appollonio I, Ferrarese C, Tremolizzo L, et al
    Can Traditional Board Games Prevent or Slow Down Cognitive Impairment? A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;95:829-845.
    PubMed     Abstract available


  611. AL-LAHHAM R, Mendez N
    Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance.
    J Alzheimers Dis. 2023;95:1041-1058.
    PubMed     Abstract available


  612. VASSILAKI M, Fu S, Christenson LR, Garg M, et al
    Characterizing Performance Gaps of a Code-Based Dementia Algorithm in a Population-Based Cohort of Cognitive Aging.
    J Alzheimers Dis. 2023;95:931-940.
    PubMed     Abstract available


  613. DI GIOIA C, Santonico M, Zompanti A, Sabatini A, et al
    Detecting Dementia by Saliva Analysis: A Fingerprinting Unobtrusive Method Based on a Fast and Cheap Sensor System.
    J Alzheimers Dis. 2023;95:1067-1075.
    PubMed     Abstract available


  614. FLEISCHMAN DA, Arfanakis K, Zhang S, Leurgans SE, et al
    Acculturation in Context and Brain Health in Older Latino Adults: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2023;95:1585-1595.
    PubMed     Abstract available


  615. WANG S, Liu S, Ke S, Zhou W, et al
    APOEvarepsilon4 Status and Plasma p-tau181 Levels May Influence Memory and Executive Function Decline in Older Adults Without Dementia.
    J Alzheimers Dis. 2023;95:1509-1518.
    PubMed     Abstract available


  616. WATTS A, Haneline S, Welsh-Bohmer KA, Wu J, et al
    TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEvarepsilon3 Homozygotes.
    J Alzheimers Dis. 2023;95:1697-1707.
    PubMed     Abstract available


  617. AMOFA-HO PA, Stickel AM, Chen R, Kobayashi LC, et al
    The Mediating Roles of Neurobiomarkers in the Relationship Between Education and Late-Life Cognition.
    J Alzheimers Dis. 2023;95:1405-1416.
    PubMed     Abstract available


  618. MARCOLINI S, Rojczyk P, Seitz-Holland J, Koerte IK, et al
    Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans.
    J Alzheimers Dis. 2023;95:1427-1448.
    PubMed     Abstract available


  619. WANG R, Kuang C, Guo C, Chen Y, et al
    Automatic Detection of Putative Mild Cognitive Impairment from Speech Acoustic Features in Mandarin-Speaking Elders.
    J Alzheimers Dis. 2023;95:901-914.
    PubMed     Abstract available


  620. DAAMEN M, Scheef L, Li S, Grothe MJ, et al
    Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive Decline.
    J Alzheimers Dis. 2023;95:1013-1028.
    PubMed     Abstract available


  621. CODY SL, Miller GH, Fazeli PL, Wang G, et al
    Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research.
    J Alzheimers Dis. 2023;95:753-768.
    PubMed     Abstract available


  622. KEPP KP, Sensi SL, Johnsen KB, Barrio JR, et al
    The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
    J Alzheimers Dis. 2023;94:497-507.
    PubMed     Abstract available


  623. SAJI N, Ishihara Y, Murotani K, Uchiyama A, et al
    Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.
    J Alzheimers Dis. 2023;96:369-380.
    PubMed     Abstract available


  624. DATLOW LY, King J, Leventhal M, Wallace TC, et al
    Association of Pork Intake with Cognitive Performance in Older Adults Enrolled in the National Health and Nutrition Examination Survey (NHANES), 2011-2014 Data Cycles.
    J Alzheimers Dis. 2023;96:351-358.
    PubMed     Abstract available


  625. PACHECO PACHADO M, Casas AI, Elbatreek MH, Nogales C, et al
    Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.
    J Alzheimers Dis. 2023;96:47-56.
    PubMed     Abstract available


  626. CHEN S, Huang W, He T, Zhang M, et al
    Exploring the Causality Between Plasma Brain-Derived Neurotrophic Factor and Neurological Diseases: A Mendelian Randomization Study.
    J Alzheimers Dis. 2023;96:135-148.
    PubMed     Abstract available


  627. UTZ J, Olm P, Jablonowski J, Siegmann EM, et al
    Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score.
    J Alzheimers Dis. 2023;96:265-275.
    PubMed     Abstract available


  628. HAMMERS DB, Lin JH, Polsinelli AJ, Logan PE, et al
    Criterion Validation of Tau PET Staging Schemes in Relation to Cognitive Outcomes.
    J Alzheimers Dis. 2023;96:197-214.
    PubMed     Abstract available


  629. DING H, Mandapati A, Hamel AP, Karjadi C, et al
    Multimodal Machine Learning for 10-Year Dementia Risk Prediction: The Framingham Heart Study.
    J Alzheimers Dis. 2023;96:277-286.
    PubMed     Abstract available


  630. LINDH-RENGIFO M, Jonasson SB, Ullen S, Palmqvist S, et al
    Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;96:161-171.
    PubMed     Abstract available


  631. CAVUOTO MG, Robinson SR, O'Donoghue FJ, Barnes M, et al
    Associations Between Amyloid Burden, Hypoxemia, Sleep Architecture, and Cognition in Obstructive Sleep Apnea.
    J Alzheimers Dis. 2023;96:149-159.
    PubMed     Abstract available


  632. SMITH GS, Kuwabara H, Yan H, Nassery N, et al
    Serotonin Degeneration and Amyloid-beta Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.
    J Alzheimers Dis. 2023;96:215-227.
    PubMed     Abstract available



  633. Erratum to: Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    J Alzheimers Dis. 2023;96:859-860.
    PubMed    


  634. BAHRANI AA, Abner EL, DeCarli CS, Barber JM, et al
    Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.
    J Alzheimers Dis. 2023;96:683-693.
    PubMed     Abstract available


  635. KARJADI C, Xue C, Cordella C, Kiran S, et al
    Fusion of Low-Level Descriptors of Digital Voice Recordings for Dementia Assessment.
    J Alzheimers Dis. 2023;96:507-514.
    PubMed     Abstract available


  636. LI J, Weiss J, Rajadhyaksha A, Acosta D, et al
    Dementia Attributable Healthcare Utilizations in the Caribbean versus United States.
    J Alzheimers Dis. 2023;96:801-811.
    PubMed     Abstract available


  637. MICHOPOULOU S, Prosser A, Dickson J, Guy M, et al
    Perfusion Imaging and Inflammation Biomarkers Provide Complementary Information in Alzheimer's Disease.
    J Alzheimers Dis. 2023;96:1317-1327.
    PubMed     Abstract available


  638. ZHOU J, Wang ZB, Sun Y, Fu Y, et al
    Cerebrospinal Fluid Complement 4 Levels Were Associated with Alzheimer's Disease Pathology and Cognition in Non-Demented Elderly.
    J Alzheimers Dis. 2023;96:1071-1081.
    PubMed     Abstract available


  639. CHWA WJ, Raji CA, Toups K, Hathaway A, et al
    Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.
    J Alzheimers Dis. 2023;96:1051-1058.
    PubMed     Abstract available


  640. TU MC, Chung HW, Hsu YH, Yang JJ, et al
    Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia.
    J Alzheimers Dis. 2023;96:1329-1338.
    PubMed     Abstract available


  641. BROSENS N, Samouil D, Stolker S, Katsika EV, et al
    Early Life Stress Enhances Cognitive Decline and Alters Synapse Function and Interneuron Numbers in Young Male APP/PS1 Mice.
    J Alzheimers Dis. 2023;96:1097-1113.
    PubMed     Abstract available


  642. ZHU Y, Olchanski N, Cohen JT, Freund KM, et al
    Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life.
    J Alzheimers Dis. 2023;96:1183-1193.
    PubMed     Abstract available


  643. BERNARDES C, Lima M, Duro D, Silva-Spinola A, et al
    Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.
    J Alzheimers Dis. 2023;96:1173-1182.
    PubMed     Abstract available


  644. NAISMITH SL, Michaelian JC, Santos C, Mehrani I, et al
    Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans.
    J Alzheimers Dis. 2023;96:913-925.
    PubMed     Abstract available


  645. KOULOUSAKIS P, Willems E, Schepers M, Rombaut B, et al
    Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice.
    J Alzheimers Dis. 2023;96:1207-1219.
    PubMed     Abstract available


  646. HEALY E
    Impact of the MIND Diet on Cognition in Individuals with Dementia.
    J Alzheimers Dis. 2023;96:967-977.
    PubMed     Abstract available


  647. ZHAO B, Ou YN, Zhang XY, Fu Y, et al
    Differential Associations of APOEvarepsilon2 and APOEvarepsilon4 Genotypes with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Individuals Without Dementia.
    J Alzheimers Dis. 2023;96:1813-1825.
    PubMed     Abstract available


  648. ROBINSON MJ, Newbury S, Singh K, Leonenko Z, et al
    The Interplay Between Cholesterol and Amyloid-beta on HT22 Cell Viability, Morphology, and Receptor Tyrosine Kinase Signaling.
    J Alzheimers Dis. 2023;96:1663-1683.
    PubMed     Abstract available


  649. TIAN J, Du E, Jia K, Wang T, et al
    Elevated Ghrelin Promotes Hippocampal Ghrelin Receptor Defects in Humanized Amyloid-beta Knockin Mice During Aging.
    J Alzheimers Dis. 2023;96:1579-1592.
    PubMed     Abstract available


  650. SLUGGETT JK, Air T, Cations M, Caughey GE, et al
    Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services.
    J Alzheimers Dis. 2023;96:1747-1758.
    PubMed     Abstract available


  651. GAO Y, Duan X, Li W, Zhang X, et al
    Elevated Homocysteine Levels and Hypertension Relate to Cognitive Impairment via Increased White Matter Hyperintensity Volume.
    J Alzheimers Dis. 2023;96:1739-1746.
    PubMed     Abstract available


  652. YOON J, Sasaki K, Tateoka K, Arai T, et al
    Evaluation of Cognitive and Physical Function Among Older Adults by Their Physical Activity: A Cross-Sectional Kasama Study, Japan.
    J Alzheimers Dis. 2023;96:1801-1812.
    PubMed     Abstract available


  653. SOLIS-URRA P, Rodriguez-Ayllon M, Alvarez-Ortega M, Molina-Hidalgo C, et al
    Physical Performance and Amyloid-beta in Humans: A Systematic Review and Meta-Analysis of Observational Studies.
    J Alzheimers Dis. 2023;96:1427-1439.
    PubMed     Abstract available


  654. GARCIA-ALBERCA JM, de la Rosa MD, Solo de Zaldivar P, Ledesma M, et al
    Effect of Nordic Sensi(R) Chair on Behavioral and Psychological Symptoms of Dementia in Nursing Homes Residents: A Randomized Controlled Trial.
    J Alzheimers Dis. 2023;96:1609-1622.
    PubMed     Abstract available


  655. SHORT MI, Fohner AE, Skjellegrind HK, Beiser A, et al
    Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.
    J Alzheimers Dis. 2023;96:1767-1780.
    PubMed     Abstract available


  656. BRICENO EM, Dhakal U, Sharma U, Adhikari N, et al
    Neuropsychological Assessment of Older Adults in Nepal for Population-Based Dementia Ascertainment: Needs, Challenges, and Opportunities.
    J Alzheimers Dis. 2023;96:1339-1352.
    PubMed     Abstract available


  657. AXELSSON ANDREN E, Kettunen P, Bjerke M, Rolstad S, et al
    Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-beta Protein Precursor beta in the Subcortical Small Vessel Type of Dementia.
    J Alzheimers Dis. 2023;96:1515-1528.
    PubMed     Abstract available


  658. AGARWAL P, Ford CN, Leurgans SE, Beck T, et al
    Dietary Sugar Intake Associated with a Higher Risk of Dementia in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2023;95:1417-1425.
    PubMed     Abstract available


    December 2022
  659. ITZHAKI RF
    COVID-19 and Alzheimer's Disease: What Is the Connection?
    J Alzheimers Dis. 2022 Dec 26. doi: 10.3233/JAD-220955.
    PubMed     Abstract available


  660. BIAN Z, Yu H, Hu X, Bian Y, et al
    Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-beta-Induced NOX2 Activation in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 Dec 22. doi: 10.3233/JAD-220761.
    PubMed     Abstract available


  661. CHEN Y, Zhang Y, Chen Q, Liu Y, et al
    Inhibition of mGluR5/PI3K-AKT Pathway Alleviates Alzheimer's Disease-Like Pathology Through the Activation of Autophagy in 5XFAD Mice.
    J Alzheimers Dis. 2022 Dec 20. doi: 10.3233/JAD-221058.
    PubMed     Abstract available


  662. ERUYSAL E, Ravdin L, Zhang C, Kamel H, et al
    Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer's Pathology in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 20. doi: 10.3233/JAD-220686.
    PubMed     Abstract available


  663. JIA J, Zhang Y, Shi Y, Yin X, et al
    A 19-Year-Old Adolescent with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-221065.
    PubMed     Abstract available


  664. PARKER DC, Kraus WE, Whitson HE, Kraus VB, et al
    Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer's Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan St
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-220906.
    PubMed     Abstract available


  665. FLEMING V, Helsel BC, Ptomey LT, Rosas HD, et al
    Weight Loss and Alzheimer's Disease in Down Syndrome.
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-220865.
    PubMed     Abstract available


  666. CHAI YL, Liang NHP, Chong JR, Venketasubramanian N, et al
    Serum Cathepsin D Is a Potential Biomarker for Alzheimer's Disease Dementia and Cognitive Decline.
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-220852.
    PubMed     Abstract available


  667. MORYS F, Potvin O, Zeighami Y, Vogel J, et al
    Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study.
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-220535.
    PubMed     Abstract available


  668. CANARIO NS, Jorge LP, Santana IJ, Castelo-Branco MS, et al
    Hemispheric Patterns of Recruitment of Object Processing Regions in Early Alzheimer's Disease: A Study Along the Entire Ventral Stream.
    J Alzheimers Dis. 2022 Dec 19. doi: 10.3233/JAD-220055.
    PubMed     Abstract available


  669. DAI WZ, Liu L, Zhu MZ, Lu J, et al
    Morphological and Structural Network Analysis of Sporadic Alzheimer's Disease Brains Based on the APOE4 Gene.
    J Alzheimers Dis. 2022 Dec 14. doi: 10.3233/JAD-220877.
    PubMed     Abstract available


  670. CAO K, Bay AA, Hajjar I, Wharton W, et al
    Rationale and Design of the PARTNER Trial: Partnered Rhythmic Rehabilitation for Enhanced Motor-Cognition in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 14. doi: 10.3233/JAD-220783.
    PubMed     Abstract available


  671. CHEN Q, Abrigo J, Deng M, Shi L, et al
    Diffusion Changes in Hippocampal Cingulum in Early Biologically Defined Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 14. doi: 10.3233/JAD-220671.
    PubMed     Abstract available


  672. LI H, Liu H, Lutz MW, Luo S, et al
    Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 13. doi: 10.3233/JAD-220680.
    PubMed     Abstract available


  673. MATHEW S, WuDunn D, Mackay DD, Vosmeier A, et al
    Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 8. doi: 10.3233/JAD-210533.
    PubMed     Abstract available


  674. IBAN-ARIAS R, Trageser KJ, Yang EJ, Griggs E, et al
    Exposure to World Trade Center Dust Exacerbates Cognitive Impairment and Evokes a Central and Peripheral Pro-Inflammatory Transcriptional Profile in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 7. doi: 10.3233/JAD-221046.
    PubMed     Abstract available


  675. KLEIMAN MJ, Ariko T, Galvin JE
    Hierarchical Two-Stage Cost-Sensitive Clinical Decision Support System for Screening Prodromal Alzheimer's Disease and Related Dementias.
    J Alzheimers Dis. 2022 Dec 7. doi: 10.3233/JAD-220891.
    PubMed     Abstract available


  676. CHENG ZZ, Gao F, Lv XY, Wang Q, et al
    Features of Cerebral Small Vessel Disease Contributes to the Differential Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 7. doi: 10.3233/JAD-220872.
    PubMed     Abstract available


  677. XU LZ, Li BQ, Li FY, Li Y, et al
    NMDA Receptor GluN2B Subunit Is Involved in Excitotoxicity Mediated by Death-Associated Protein Kinase 1 in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 7. doi: 10.3233/JAD-220747.
    PubMed     Abstract available


  678. DELGADO-ALVAREZ A, Diez-Cirarda M, Delgado-Alonso C, Hernandez-Lorenzo L, et al
    Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis.
    J Alzheimers Dis. 2022 Dec 5. doi: 10.3233/JAD-220907.
    PubMed     Abstract available


  679. GORENFLO MP, Davis PB, Kendall EK, Olaker VR, et al
    Association of Aspirin Use with Reduced Risk of Developing Alzheimer's Disease in Elderly Ischemic Stroke Patients: A Retrospective Cohort Study.
    J Alzheimers Dis. 2022 Dec 5. doi: 10.3233/JAD-220901.
    PubMed     Abstract available


  680. HENEGHAN A, Deng F, Wells K, Ritchie K, et al
    Modifiable Lifestyle Activities Affect Cognition in Cognitively Healthy Middle-Aged Individuals at Risk for Late-Life Alzheimer's Disease.
    J Alzheimers Dis. 2022 Dec 5. doi: 10.3233/JAD-220267.
    PubMed     Abstract available


  681. RAJAH KUMARAN K, Yunusa S, Perimal E, Wahab H, et al
    Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective.
    J Alzheimers Dis. 2022 Dec 3. doi: 10.3233/JAD-220666.
    PubMed     Abstract available


    November 2022
  682. GREEN ZD, Vidoni ED, Swerdlow RH, Burns JM, et al
    Increased Functional Connectivity of the Precuneus in Individuals with a Family History of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 29. doi: 10.3233/JAD-210326.
    PubMed     Abstract available


  683. ZHANG R, Song Y, Su X
    Necroptosis and Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Opportunities.
    J Alzheimers Dis. 2022 Nov 28. doi: 10.3233/JAD-220809.
    PubMed     Abstract available


  684. SURYA K, Manickam N, Jayachandran KS, Kandasamy M, et al
    Resveratrol Mediated Regulation of Hippocampal Neuroregenerative Plasticity via SIRT1 Pathway in Synergy with Wnt Signaling: Neurotherapeutic Implications to Mitigate Memory Loss in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 28. doi: 10.3233/JAD-220559.
    PubMed     Abstract available


  685. FULLGRABE C
    Auditory Biases in Cognitive Assessment: Insights from a Hearing-Loss Simulation for the Screening of Dementia due to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 28. doi: 10.3233/JAD-215695.
    PubMed     Abstract available


  686. YEAP YJ, Kandiah N, Nizetic D, Lim KL, et al
    BACE2: A Promising Neuroprotective Candidate for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 26. doi: 10.3233/JAD-220867.
    PubMed     Abstract available


  687. ZHOU Y, Dong J, Song J, Lvy C, et al
    Efficacy of Glucose Metabolism-Related Indexes on the Risk and Severity of Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2022 Nov 26. doi: 10.3233/JAD-220751.
    PubMed     Abstract available


  688. PETRELLA JR, Michael AM, Qian M, Nwosu A, et al
    Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial.
    J Alzheimers Dis. 2022 Nov 25. doi: 10.3233/JAD-220946.
    PubMed     Abstract available


  689. COSTA T, Manuello J, Cauda F, Liloia D, et al
    Retrospective Bayesian Evidence of Null Effect in Two Decades of Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2022 Nov 25. doi: 10.3233/JAD-220942.
    PubMed     Abstract available


  690. DANIEL EV, Kleiman MJ, Galvin JE
    Exploring Reasons for Differential Vulnerability and Alzheimer's Disease Risk in Racial and Ethnic Minorities.
    J Alzheimers Dis. 2022 Nov 24. doi: 10.3233/JAD-220959.
    PubMed     Abstract available


  691. QUINTANA-HERNANDEZ DJ, Rojas-Hernandez J, Santana-Del Pino A, Cespedes Suarez C, et al
    Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial.
    J Alzheimers Dis. 2022 Nov 24. doi: 10.3233/JAD-220889.
    PubMed     Abstract available


  692. LI JG, Blass BE, Pratico D
    Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer's Disease Phenotype.
    J Alzheimers Dis. 2022 Nov 24. doi: 10.3233/JAD-220869.
    PubMed     Abstract available


  693. WISEMAN AL, Briggs CA, Peritt A, Kapecki N, et al
    Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2022 Nov 23. doi: 10.3233/JAD-220758.
    PubMed     Abstract available


  694. PREMA A, Justin Thenmozhi A, Manivasagam T, Mohamed Essa M, et al
    Erratum to: Fenugreek Seed Powder Attenuated Aluminum Chloride-Induced Tau Pathology, Oxidative Stress, and Inflammation in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 21. doi: 10.3233/JAD-229017.
    PubMed    


  695. ABBATE C, Trimarchi PD, Fumagalli GG, Gallucci A, et al
    Diencephalic versus Hippocampal Amnesia in Alzheimer's Disease: The Possible Confabulation-Misidentification Phenotype.
    J Alzheimers Dis. 2022 Nov 21. doi: 10.3233/JAD-220919.
    PubMed     Abstract available


  696. KHEZRI MR, Ghasemnejad-Berenji M
    The Role of Caspases in Alzheimer's Disease: Pathophysiology Implications and Pharmacologic Modulation.
    J Alzheimers Dis. 2022 Nov 21. doi: 10.3233/JAD-220873.
    PubMed     Abstract available


  697. WU BS, Zhang YR, Yang L, Zhang W, et al
    Polygenic Liability to Alzheimer's Disease Is Associated with a Wide Range of Chronic Diseases: A Cohort Study of 312,305 Participants.
    J Alzheimers Dis. 2022 Nov 21. doi: 10.3233/JAD-220740.
    PubMed     Abstract available


  698. GROBLER C, van Tongeren M, Gettemans J, Kell DB, et al
    Alzheimer's Disease: A Systems View Provides a Unifying Explanation of Its Development.
    J Alzheimers Dis. 2022 Nov 21. doi: 10.3233/JAD-220720.
    PubMed     Abstract available


  699. GARCIA MJ, Leadley R, Lang S, Ross J, et al
    Real-World Use of Symptomatic Treatments in Early Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 18. doi: 10.3233/JAD-220471.
    PubMed     Abstract available


  700. SWERDLOW NR, Joshi YB, Sprock J, Talledo J, et al
    Preliminary Evidence that Memantine Enhances Prepulse Effects on Startle Magnitude and Latency in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 17. doi: 10.3233/JAD-220769.
    PubMed     Abstract available


  701. WHITEHOUSE PJ, George DR
    Dignity for All: How the Challenges of Alzheimer's Disease Need Rethinking and Revaluing.
    J Alzheimers Dis. 2022 Nov 15. doi: 10.3233/JAD-221066.
    PubMed    


  702. KIM J, Jang H, Park YH, Youn J, et al
    Motor Symptoms in Early- versus Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 15. doi: 10.3233/JAD-220745.
    PubMed     Abstract available


  703. LUKKARINEN H, Vanninen A, Tesseur I, Pemberton D, et al
    Concordance of Alzheimer's Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2022 Nov 15. doi: 10.3233/JAD-220652.
    PubMed     Abstract available


  704. LIU S, Dashper SG, Zhao R
    Association Between Oral Bacteria and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Nov 14. doi: 10.3233/JAD-220627.
    PubMed     Abstract available


  705. CHEN L, Xue J, Zhao Q, Liang X, et al
    A Pilot Study of Near-Infrared Light Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 11. pii: JAD220866. doi: 10.3233/JAD-220866.
    PubMed     Abstract available


  706. LIU Z, Zhang H, Liu S, Hou Y, et al
    The Dual Role of Astrocyte-Derived Exosomes and Their Contents in the Process of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 11. pii: JAD220698. doi: 10.3233/JAD-220698.
    PubMed     Abstract available


  707. DOVER M, Moseley T, Biskaduros A, Paulchakrabarti M, et al
    Polyunsaturated Fatty Acids Mend Macrophage Transcriptome, Glycome, and Phenotype in the Patients with Neurodegenerative Diseases, Including Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 8. pii: JAD220764. doi: 10.3233/JAD-220764.
    PubMed     Abstract available


  708. JOHNSON AL, Seep E, Norton DL, Mundt MP, et al
    Wisconsin Healthcare Utilization Cost Among American Indians/Alaska Natives with and without Alzheimer's Disease and Related Dementias.
    J Alzheimers Dis. 2022 Nov 8. pii: JAD220393. doi: 10.3233/JAD-220393.
    PubMed     Abstract available


  709. GAUBERT F, Borg C, Chainay H
    Decision-Making in Alzheimer's Disease: The Role of Working Memory and Executive Functions in the Iowa Gambling Task and in Tasks Inspired by Everyday Situations.
    J Alzheimers Dis. 2022 Nov 3. pii: JAD220581. doi: 10.3233/JAD-220581.
    PubMed     Abstract available


  710. WALKER JM, Dehkordi SK, Schaffert J, Goette W, et al
    The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals.
    J Alzheimers Dis. 2022 Nov 3. doi: 10.3233/JAD-220898.
    PubMed     Abstract available


  711. CHEN X, Jiang S, Wang R, Bao X, et al
    Neural Stem Cells in the Treatment of Alzheimer's Disease: Current Status, Challenges, and Future Prospects.
    J Alzheimers Dis. 2022 Nov 2. pii: JAD220721. doi: 10.3233/JAD-220721.
    PubMed     Abstract available



  712. Erratum to: A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2022 Nov 1. pii: JAD229016. doi: 10.3233/JAD-229016.
    PubMed    


  713. KRISHNA G, Santhoshkumar R, Sivakumar PT, Alladi S, et al
    Pathological (Dis)Similarities in Neuronal Exosome-Derived Synaptic and Organellar Marker Levels Between Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2022 Nov 1. pii: JAD220829. doi: 10.3233/JAD-220829.
    PubMed     Abstract available


  714. HUANG L, Lu Z, Zhang H, Wen H, et al
    A Novel Strategy for Alzheimer's Disease Based on the Regulatory Effect of Amyloid-beta on Gut Flora.
    J Alzheimers Dis. 2022 Nov 1. pii: JAD220651. doi: 10.3233/JAD-220651.
    PubMed     Abstract available


    October 2022
  715. KLEIMAN MJ, Chang LC, Galvin JE
    The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2022 Oct 31. pii: JAD220927. doi: 10.3233/JAD-220927.
    PubMed     Abstract available


  716. GIRALDO DL, Smith RE, Struyfs H, Niemantsverdriet E, et al
    Investigating Tissue-Specific Abnormalities in Alzheimer's Disease with Multi-Shell Diffusion MRI.
    J Alzheimers Dis. 2022 Oct 31. pii: JAD220551. doi: 10.3233/JAD-220551.
    PubMed     Abstract available


  717. LATON J, Van Schependom J, Goossens J, Wiels W, et al
    Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study.
    J Alzheimers Dis. 2022 Oct 29. pii: JAD220693. doi: 10.3233/JAD-220693.
    PubMed     Abstract available


  718. MUSAEUS CS, Waldemar G, Andersen BB, Hogh P, et al
    Long-Term EEG Monitoring in Patients with Alzheimer's Disease Using Ear-EEG: A Feasibility Study.
    J Alzheimers Dis. 2022 Oct 29. pii: JAD220491. doi: 10.3233/JAD-220491.
    PubMed     Abstract available


  719. SCHAFFERT J, Bue CL, Hynan LS, Hart J, et al
    Erratum to: Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD229015. doi: 10.3233/JAD-229015.
    PubMed    


  720. GOLZARI-SORKHEH M, Weaver DF, Reed MA
    COVID-19 as a Risk Factor for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220800. doi: 10.3233/JAD-220800.
    PubMed     Abstract available


  721. GAO F, Zhang PF, Gao J, Song J, et al
    The CCL2 rs4586 SNP Is Associated with Slower Amyloid-beta Deposition and Faster Tau Accumulation of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220716. doi: 10.3233/JAD-220716.
    PubMed     Abstract available


  722. MA Y, Li W, Fan C, Wang Y, et al
    Comprehensive Analysis of Long Non-Coding RNAs N4-Acetylcytidine in Alzheimer's Disease Mice Model Using High-Throughput Sequencing.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220564. doi: 10.3233/JAD-220564.
    PubMed     Abstract available


  723. DISSANAYAKE AS, Tan YB, Bowie CR, Butters MA, et al
    Sex Modifies the Associations of APOEvarepsilon4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 25. pii: JAD220586. doi: 10.3233/JAD-220586.
    PubMed     Abstract available


  724. CHAUDHARY S, Zhornitsky S, Chao HH, van Dyck CH, et al
    Hypothalamic Functional Connectivity and Apathy in People with Alzheimer's Disease and Cognitively Normal Healthy Controls.
    J Alzheimers Dis. 2022 Oct 22. pii: JAD220708. doi: 10.3233/JAD-220708.
    PubMed     Abstract available


  725. GAITAN JM, Asthana S, Carlsson CM, Engelman CD, et al
    Circulating Klotho Is Higher in Cerebrospinal Fluid than Serum and Elevated Among KLOTHO Heterozygotes in a Cohort with Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 22. pii: JAD220571. doi: 10.3233/JAD-220571.
    PubMed     Abstract available


  726. JACOBS N, Theunissen B
    It's Groundhog Day! What Can the History of Science Say About the Crisis in Alzheimer's Disease Research?
    J Alzheimers Dis. 2022 Oct 21. pii: JAD220569. doi: 10.3233/JAD-220569.
    PubMed     Abstract available


  727. PONTRELLO CG, McWhirt JM, Glabe CG, Brewer GJ, et al
    Age-Related Oxidative Redox and Metabolic Changes Precede Intraneuronal Amyloid-beta Accumulation and Plaque Deposition in a Transgenic Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2022 Oct 19. pii: JAD220824. doi: 10.3233/JAD-220824.
    PubMed     Abstract available


  728. WANG YR, Wang MT, Zeng XQ, Liu YH, et al
    Associations of Naturally Occurring Antibodies to Presenilin-1 with Brain Amyloid-beta Load and Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 19. pii: JAD220775. doi: 10.3233/JAD-220775.
    PubMed     Abstract available


  729. EHLEN JC, Forman CM, Ostrowski D, Ostrowski TD, et al
    Autonomic Dysfunction Impairs Baroreflex Function in an Alzheimer's Disease Animal Model.
    J Alzheimers Dis. 2022 Oct 19. pii: JAD220496. doi: 10.3233/JAD-220496.
    PubMed     Abstract available


  730. HILUND-CARLSEN PF, Revheim ME, Alavi A, Satyamurthy N, et al
    Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials.
    J Alzheimers Dis. 2022 Oct 17. pii: JAD220841. doi: 10.3233/JAD-220841.
    PubMed     Abstract available


  731. SEGURA-URIBE JJ, Garcia-de la Torre P, Castillo-Mendieta T, Bribiesca-Cruz I, et al
    Tibolone Improves Memory and Decreases the Content of Amyloid-beta Peptides and Tau Protein in the Hippocampus of a Mice Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 17. pii: JAD220434. doi: 10.3233/JAD-220434.
    PubMed     Abstract available


  732. ROVETA F, Cermelli A, Boschi S, Ferrandes F, et al
    Synaptic Proteins as Fluid Biomarkers in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Oct 15. pii: JAD220515. doi: 10.3233/JAD-220515.
    PubMed     Abstract available


  733. XIA X, Qin Q, Peng Y, Wang M, et al
    Retinal Examinations Provides Early Warning of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 14. pii: JAD220596. doi: 10.3233/JAD-220596.
    PubMed     Abstract available


  734. RITCHIE M, Witbracht M, Nuno MM, Hoang D, et al
    Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer's Disease Trials.
    J Alzheimers Dis. 2022 Oct 12. pii: JAD220801. doi: 10.3233/JAD-220801.
    PubMed     Abstract available


  735. LI TR, Lyu DY, Liu FQ
    Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status.
    J Alzheimers Dis. 2022 Oct 6. pii: JAD220598. doi: 10.3233/JAD-220598.
    PubMed     Abstract available


  736. WELLER AE, Ferraro TN, Doyle GA, Reiner BC, et al
    Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220391. doi: 10.3233/JAD-220391.
    PubMed     Abstract available


  737. HUANG Y, Driedonks TAP, Cheng L, Rajapaksha H, et al
    Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220322. doi: 10.3233/JAD-220322.
    PubMed     Abstract available


  738. FUKUDA H, Maeda M, Murata F, Murata Y, et al
    Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer's Disease Patients in Japan: LIFE Study.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220200. doi: 10.3233/JAD-220200.
    PubMed     Abstract available


    September 2022
  739. LIN J, Yang S, Wang C, Yu E, et al
    Prediction of Alzheimer's Disease Using Patterns of Methylation Levels in Key Immunologic-Related Genes.
    J Alzheimers Dis. 2022 Sep 30. pii: JAD220701. doi: 10.3233/JAD-220701.
    PubMed     Abstract available


  740. VALVERDE A, Mitrofanis J
    Photobiomodulation for Hypertension and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 30. pii: JAD220632. doi: 10.3233/JAD-220632.
    PubMed     Abstract available


  741. GUO Q, Cai Q, Huang F, Wei Z, et al
    The Therapeutic Effects of Seven Lycophyte Compounds on Cell Models of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 29. pii: JAD220704. doi: 10.3233/JAD-220704.
    PubMed     Abstract available


  742. WU X, Peng C, Nelson PT, Cheng Q, et al
    Machine Learning Approach Predicts Probability of Time to Stage-Specific Conversion of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 27. pii: JAD220590. doi: 10.3233/JAD-220590.
    PubMed     Abstract available


  743. SHEN WB, Elahi M, Wang B, Zhan M, et al
    Oxidative Stress Kinase Activation and Impaired Insulin Receptor Signaling Precede Overt Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2022 Sep 26. pii: JAD215687. doi: 10.3233/JAD-215687.
    PubMed     Abstract available


  744. VILLAREJO-GALENDE A, Garcia-Arcelay E, Pinol-Ripoll G, Del Olmo-Rodriguez A, et al
    Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 23. pii: JAD220696. doi: 10.3233/JAD-220696.
    PubMed     Abstract available


  745. SABBIR MG, Speth RC, Albensi BC
    Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer's Disease, Parkinson's Disease, or Frontotemporal Dementia: Implications for Patient Survival.
    J Alzheimers Dis. 2022 Sep 22. pii: JAD220766. doi: 10.3233/JAD-220766.
    PubMed     Abstract available


  746. ALVAREZ XA, Winston CN, Barlow JW, Sarsoza FM, et al
    Modulation of Amyloid-beta and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin(R) and Donepezil.
    J Alzheimers Dis. 2022 Sep 22. pii: JAD220575. doi: 10.3233/JAD-220575.
    PubMed     Abstract available


  747. YAMADA Y, Kobayashi M, Shinkawa K, Nemoto M, et al
    Characteristics of Drawing Process Differentiate Alzheimer's Disease and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022 Sep 20. pii: JAD220546. doi: 10.3233/JAD-220546.
    PubMed     Abstract available


  748. XU C, Zhao L, Dong C
    A Review of Application of Abeta42/40 Ratio in Diagnosis and Prognosis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220673. doi: 10.3233/JAD-220673.
    PubMed     Abstract available


  749. KHEZRI MR, Esmaeili A, Ghasemnejad-Berenji M
    Platelet Activation and Alzheimer's Disease: The Probable Role of PI3K/AKT Pathway.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220663. doi: 10.3233/JAD-220663.
    PubMed     Abstract available


  750. DOWNEY J, Lam JCK, Li VOK, Gozes I, et al
    Somatic Mutations and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220643. doi: 10.3233/JAD-220643.
    PubMed     Abstract available


  751. ZARBOCK KR, Han JH, Singh AP, Thomas SP, et al
    Trimethylamine N-Oxide Reduces Neurite Density and Plaque Intensity in a Murine Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220413. doi: 10.3233/JAD-220413.
    PubMed     Abstract available


  752. DENTONI G, Naia L, Portal B, Leal NS, et al
    Mitochondrial Alterations in Neurons Derived from the Murine AppNL-F Knock-In Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220383. doi: 10.3233/JAD-220383.
    PubMed     Abstract available


  753. PALMER JA, Kaufman CS, Vidoni ED, Honea RA, et al
    Sex Differences in Resilience and Resistance to Brain Pathology and Dysfunction Moderated by Cerebrovascular Response to Exercise and Genetic Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220359. doi: 10.3233/JAD-220359.
    PubMed     Abstract available


  754. TRUMBORE CN, Raghunandan A
    An Alzheimer's Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease.
    J Alzheimers Dis. 2022 Sep 17. pii: JAD220622. doi: 10.3233/JAD-220622.
    PubMed     Abstract available


  755. MORROW A, Panyard DJ, Deming YK, Jonaitis E, et al
    Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.
    J Alzheimers Dis. 2022 Sep 17. pii: JAD220349. doi: 10.3233/JAD-220349.
    PubMed     Abstract available


  756. STURCHIO A, Dwivedi AK, Malm T, Wood MJA, et al
    High Soluble Amyloid-beta42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.
    J Alzheimers Dis. 2022 Sep 16. pii: JAD220808. doi: 10.3233/JAD-220808.
    PubMed     Abstract available


  757. BALDEIRAS I, Silva-Spinola A, Lima M, Leitao MJ, et al
    Alzheimer's Disease Diagnosis Based on the Amyloid, Tau, and Neurodegeneration Scheme (ATN) in a Real-Life Multicenter Cohort of General Neurological Centers.
    J Alzheimers Dis. 2022 Sep 16. pii: JAD220587. doi: 10.3233/JAD-220587.
    PubMed     Abstract available


  758. TARIOT PN, Braeckman R, Oh C
    Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil.
    J Alzheimers Dis. 2022 Sep 16. pii: JAD220530. doi: 10.3233/JAD-220530.
    PubMed     Abstract available


  759. OTA M, Sato N, Nakaya M, Shigemoto Y, et al
    Relationships Between the Deposition of Amyloid-beta and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study.
    J Alzheimers Dis. 2022 Sep 15. pii: JAD220534. doi: 10.3233/JAD-220534.
    PubMed     Abstract available


  760. YEH WC, Hsu CY, Li KY, Chien CF, et al
    Association between Subclinical Epileptiform Discharge and the Severity of Cognitive Decline in Alzheimer's Disease: A Longitudinal Cohort Study.
    J Alzheimers Dis. 2022 Sep 12. pii: JAD220567. doi: 10.3233/JAD-220567.
    PubMed     Abstract available


  761. NOLAN JM, Power R, Howard AN, Bergin P, et al
    Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220556. doi: 10.3233/JAD-220556.
    PubMed     Abstract available


  762. DU XL, Song L, Schulz PE, Xu H, et al
    Associations Between Vascular Diseases and Alzheimer's Disease or Related Dementias in a Large Cohort of Men and Women with Colorectal Cancer.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220548. doi: 10.3233/JAD-220548.
    PubMed     Abstract available


  763. LATGE-TOVAR S, Bertrand E, Cosentino S, Dourado MCN, et al
    Self- and Other-Evaluation in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220453. doi: 10.3233/JAD-220453.
    PubMed     Abstract available


  764. WANG G, Estrella A, Hakim O, Milazzo P, et al
    Mini-Mental State Examination and Montreal Cognitive Assessment as Tools for Following Cognitive Changes in Alzheimer's Disease Neuroimaging Initiative Participants.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220397. doi: 10.3233/JAD-220397.
    PubMed     Abstract available


  765. MIGLIORATI M, Manrique C, Rahrah M, Escoffier G, et al
    The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220281. doi: 10.3233/JAD-220281.
    PubMed     Abstract available


  766. AHULLO-FUSTER MA, Ortiz T, Varela-Donoso E, Nacher J, et al
    The Parietal Lobe in Alzheimer's Disease and Blindness.
    J Alzheimers Dis. 2022 Sep 8. pii: JAD220498. doi: 10.3233/JAD-220498.
    PubMed     Abstract available


  767. SAGUES-SESE E, Rioja J, Garzon-Maldonado FJ, Narvaez M, et al
    Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220688. doi: 10.3233/JAD-220688.
    PubMed     Abstract available


  768. CEJUDO JC, Samaniego M, Almeria M, Castrillo S, et al
    Ikos Test: New Tool for the Assessment of Semantic Knowledge in Early Alzheimer Disease.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220516. doi: 10.3233/JAD-220516.
    PubMed     Abstract available


  769. WANG X, Wang Y, Liu H, Zhu X, et al
    Macular Microvascular Density as a Diagnostic Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220482. doi: 10.3233/JAD-220482.
    PubMed     Abstract available


  770. CAMARGO MVZA, Pais MV, Bellan AFR, Tahira AC, et al
    Impact of Cognitive Demand on Eye Movement Pattern in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220385. doi: 10.3233/JAD-220385.
    PubMed     Abstract available


  771. SHELTON MG, Kerns KA, Castora FJ, Coleman RA, et al
    Incorporating Mitochondrial Gene Expression Changes Within a Testable Mathematical Model for Alzheimer's Disease: Stress Response Modulation Predicts Potential Therapeutic Targets.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220163. doi: 10.3233/JAD-220163.
    PubMed     Abstract available


  772. CASTORA FJ, Kerns KA, Pflanzer HK, Hitefield NL, et al
    Expression Changes in Mitochondrial Genes Affecting Mitochondrial Morphology, Transmembrane Potential, Fragmentation, Amyloidosis, and Neuronal Cell Death Found in Brains of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220161. doi: 10.3233/JAD-220161.
    PubMed     Abstract available


  773. BEHESHTI I, Geddert N, Perron J, Gupta V, et al
    Monitoring Alzheimer's Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods.
    J Alzheimers Dis. 2022 Sep 2. pii: JAD220585. doi: 10.3233/JAD-220585.
    PubMed     Abstract available


  774. WRIGHT JR, Deen QFE, Stevenson A, Telford-Cooke L, et al
    Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 1. pii: JAD220642. doi: 10.3233/JAD-220642.
    PubMed     Abstract available


  775. COMON M, Rouch I, Edjolo A, Padovan C, et al
    Impaired Facial Emotion Recognition and Gaze Direction Detection in Mild Alzheimer's Disease: Results from the PACO Study.
    J Alzheimers Dis. 2022 Sep 1. pii: JAD220401. doi: 10.3233/JAD-220401.
    PubMed     Abstract available


  776. SPINELLI G, Bakardjian H, Schwartz D, Potier MC, et al
    Theta Band-Power Shapes Amyloid-Driven Longitudinal EEG Changes in Elderly Subjective Memory Complainers At-Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 1. pii: JAD220204. doi: 10.3233/JAD-220204.
    PubMed     Abstract available


    August 2022
  777. BARDENHEIER BH, Resnik LJ, Jutkowitz E, Gravenstein S, et al
    Patterns of Limitation in Physical Function in Late Midlife Associated with Late-Onset Alzheimer's Disease and Related Dementias: A Cluster Analysis.
    J Alzheimers Dis. 2022 Aug 23. pii: JAD220573. doi: 10.3233/JAD-220573.
    PubMed     Abstract available


  778. LI S, Liu B, Li QH, Zhang Y, et al
    Evaluating the Bidirectional Causal Association Between Daytime Napping and Alzheimer's Disease Using Mendelian Randomization.
    J Alzheimers Dis. 2022 Aug 23. pii: JAD220497. doi: 10.3233/JAD-220497.
    PubMed     Abstract available


  779. WAWRZICZNY E, Picard S, Buquet A, Traversac E, et al
    Hypnosis Intervention for Couples Confronted with Alzheimer's Disease: Promising Results of a First Exploratory Study.
    J Alzheimers Dis. 2022 Aug 23. pii: JAD220430. doi: 10.3233/JAD-220430.
    PubMed     Abstract available


  780. KURASZ AM, De Wit L, Smith GE, Armstrong MJ, et al
    Neuropathological and Clinical Correlates of Lewy Body Disease Survival by Race and Ethnicity in the National Alzheimer's Coordinating Center.
    J Alzheimers Dis. 2022 Aug 22. pii: JAD220297. doi: 10.3233/JAD-220297.
    PubMed     Abstract available


  781. YANG J, Oveisgharan S, Liu X, Wilson RS, et al
    Risk Models Based on Non-Cognitive Measures May Identify Presymptomatic Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 17. pii: JAD220446. doi: 10.3233/JAD-220446.
    PubMed     Abstract available


  782. DOREY CK, Gierhart D, Fitch KA, Crandell I, et al
    Low Xanthophylls, Retinol, Lycopene, and Tocopherols in Gray and White Matter of Brains with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 16. pii: JAD220460. doi: 10.3233/JAD-220460.
    PubMed     Abstract available


  783. YOSHIDA K, Seo M, Luo Y, Sahker E, et al
    Personalized Prediction of Alzheimer's Disease and Its Treatment Effects by Donepezil: An Individual Participant Data Meta-Analysis of Eight Randomized Controlled Trials.
    J Alzheimers Dis. 2022 Aug 16. pii: JAD220263. doi: 10.3233/JAD-220263.
    PubMed     Abstract available


  784. ALA T, Bakir D, Goel S, Feller N, et al
    A Mini-Mental State Examination Formula May Help to Distinguish Alzheimer's Disease from Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022 Aug 12. pii: JAD220392. doi: 10.3233/JAD-220392.
    PubMed     Abstract available


  785. OU YN, Zhao B, Fu Y, Sheng ZH, et al
    The Association of Serum Uric Acid Level, Gout, and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Aug 11. pii: JAD220649. doi: 10.3233/JAD-220649.
    PubMed     Abstract available


  786. FINGERHUT H, Gozdas E, Hosseini SMH
    Quantitative MRI Evidence for Cognitive Reserve in Healthy Elders and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 11. pii: JAD220197. doi: 10.3233/JAD-220197.
    PubMed     Abstract available


  787. ROSENDE-ROCA M, Canabate P, Moreno M, Preckler S, et al
    Sex, Neuropsychiatric Profiles, and Caregiver Burden in Alzheimer's Disease Dementia: A Latent Class Analysis.
    J Alzheimers Dis. 2022 Aug 9. pii: JAD215648. doi: 10.3233/JAD-215648.
    PubMed     Abstract available


  788. FREBERG E, Taglialatela G
    Exercise as a Potential Therapeutic Strategy to Target the Clinical Link Between Depression and Alzheimer's Disease: A Narrative Review.
    J Alzheimers Dis. 2022 Aug 9. pii: JAD210632. doi: 10.3233/JAD-210632.
    PubMed     Abstract available


  789. BU K, Patel D, Morris R, Han W, et al
    Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System.
    J Alzheimers Dis. 2022 Aug 6. pii: JAD220583. doi: 10.3233/JAD-220583.
    PubMed     Abstract available


  790. SERRA L, Giancaterino G, Giulietti G, Petrosini L, et al
    Cognitive Reserve Modulates Brain Structure and Cortical Architecture in the Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 6. pii: JAD220377. doi: 10.3233/JAD-220377.
    PubMed     Abstract available


  791. SOARES JZ, Valeur J, Saltyte Benth J, Knapskog AB, et al
    Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD220407. doi: 10.3233/JAD-220407.
    PubMed     Abstract available


  792. PEREZ SD, Phillips JS, Norise C, Kinney NG, et al
    Neuropsychological and Neuroanatomical Features of Patients with Behavioral/Dysexecutive Variant Alzheimer's disease (AD): A Comparison to Behavioral Variant Frontotemporal Dementia and Amnestic AD Groups.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD215728. doi: 10.3233/JAD-215728.
    PubMed     Abstract available


  793. CANARIO E, Chen D, Han Y, Niu H, et al
    Global Network Analysis of Alzheimer's Disease with Minimum Spanning Trees.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD215573. doi: 10.3233/JAD-215573.
    PubMed     Abstract available


    July 2022
  794. TAHAMI MONFARED AA, Stern Y, Doogan S, Irizarry M, et al
    Stakeholder Insights in Alzheimer's Disease: Natural Language Processing of Social Media Conversations.
    J Alzheimers Dis. 2022 Jul 30. pii: JAD220422. doi: 10.3233/JAD-220422.
    PubMed     Abstract available


  795. HOFFMANN CM, Nianogo RA, Yaffe K, Rosenwohl-Mack A, et al
    Importance of Accounting for Regional Differences in Modifiable Risk Factors for Alzheimer's Disease and Related Dementias: The Case for Tailored Interventions.
    J Alzheimers Dis. 2022 Jul 30. pii: JAD220278. doi: 10.3233/JAD-220278.
    PubMed     Abstract available


  796. WANG L, Davis PB, Volkow ND, Berger NA, et al
    Association of COVID-19 with New-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 29. pii: JAD220717. doi: 10.3233/JAD-220717.
    PubMed     Abstract available


  797. CONTINI C, Serrao S, Manconi B, Olianas A, et al
    Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2022 Jul 26. pii: JAD220246. doi: 10.3233/JAD-220246.
    PubMed     Abstract available


  798. CAPRIOGLIO C, Garibotto V, Jessen F, Frolich L, et al
    The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey.
    J Alzheimers Dis. 2022 Jul 25. pii: JAD220333. doi: 10.3233/JAD-220333.
    PubMed     Abstract available


  799. ZHONG S, Zhao B, Ma YH, Sun Y, et al
    Associations of Physical Activity with Alzheimer's Disease Pathologies and Cognition: The CABLE Study.
    J Alzheimers Dis. 2022 Jul 22. pii: JAD220389. doi: 10.3233/JAD-220389.
    PubMed     Abstract available


  800. ARIAS JJ, Lin GA, Tyler AM, Douglas MP, et al
    Geriatricians' Perspectives on the Multiple Dimensions of Utility of Genetic Testing for Alzheimer's Disease: A Qualitative Study.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220674. doi: 10.3233/JAD-220674.
    PubMed     Abstract available


  801. ZALLEN DT
    Alzheimer's Disease: Risk Tests and the Medical Record.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220584. doi: 10.3233/JAD-220584.
    PubMed     Abstract available


  802. LUO W, Pryzbyl KJ, Bigio EH, Weintraub S, et al
    Reduced Hippocampal and Anterior Cingulate Expression of Antioxidant Enzymes and Membrane Progesterone Receptors in Alzheimer's Disease with Depression.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220574. doi: 10.3233/JAD-220574.
    PubMed     Abstract available


  803. YAO W, Zhang X, Zhao H, Xu Y, et al
    Inflammation Disrupts Cognitive Integrity via Plasma Neurofilament Light Chain Coupling Brain Networks in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220475. doi: 10.3233/JAD-220475.
    PubMed     Abstract available


  804. OMANA H, Madou E, Hunter SW
    The Effects on Gait of 4-Wheeled Walker Use in People with Alzheimer's Disease Dementia and Gait Impairment: A Pilot Study.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220331. doi: 10.3233/JAD-220331.
    PubMed     Abstract available


  805. CERESETTI R, Rouch I, Laurent B, Getenet JC, et al
    Processing of Facial Expressions of Emotions and Pain in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220236. doi: 10.3233/JAD-220236.
    PubMed     Abstract available


  806. DRENTHEN GS, Backes WH, Freeze WM, Jacobs HIL, et al
    Rich-Club Connectivity of the Structural Covariance Network Relates to Memory Processes in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 18. pii: JAD220175. doi: 10.3233/JAD-220175.
    PubMed     Abstract available


  807. SONG C, Li F, Wang LY, Shi YQ, et al
    Incidental Finding: Urine Alzheimer-Associated Neuronal Thread Protein (AD7c-NTP) and Serum Vitamin D25.
    J Alzheimers Dis. 2022 Jul 18. pii: JAD220165. doi: 10.3233/JAD-220165.
    PubMed     Abstract available


  808. TIMSINA J, Gomez-Fonseca D, Wang L, Do A, et al
    Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.
    J Alzheimers Dis. 2022 Jul 16. pii: JAD220399. doi: 10.3233/JAD-220399.
    PubMed     Abstract available



  809. Janina Krell-Roesch, PhD, and Yonas E. Geda, MD recipients of the 2022 Alzheimer Award.
    J Alzheimers Dis. 2022 Jul 15. pii: JAD229009. doi: 10.3233/JAD-229009.
    PubMed    


  810. PEZZOLI S, Manca R, Cagnin A, Venneri A, et al
    A Multimodal Neuroimaging and Neuropsychological Study of Visual Hallucinations in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 15. pii: JAD215107. doi: 10.3233/JAD-215107.
    PubMed     Abstract available


  811. XUE F, Gao L, Chen T, Chen H, et al
    Parkinson's Disease rs117896735 Variant Regulates INPP5F Expression in Brain Tissues and Increases Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 13. pii: JAD220086. doi: 10.3233/JAD-220086.
    PubMed     Abstract available


  812. CLARK K, Yee Leung Y, Lee WP, Voight B, et al
    Polygenic Risk Scores in Alzheimer's Disease Genetics: Methodology, Applications, Inclusion, and Diversity.
    J Alzheimers Dis. 2022 Jul 12. pii: JAD220025. doi: 10.3233/JAD-220025.
    PubMed     Abstract available


  813. LIU Q, Liu H, Zhang S, Yang Q, et al
    Cerebrospinal Fluid Synaptosomal-Associated Protein 25 Levels in Patients with Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2022 Jul 12. pii: JAD215696. doi: 10.3233/JAD-215696.
    PubMed     Abstract available


  814. WONG GC, Chow KH
    DNA Damage Response-Associated Cell Cycle Re-Entry and Neuronal Senescence in Brain Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 11. pii: JAD220203. doi: 10.3233/JAD-220203.
    PubMed     Abstract available


  815. CARNEMOLLA S, Kumfor F, Liang CT, Foxe D, et al
    Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 11. pii: JAD220080. doi: 10.3233/JAD-220080.
    PubMed     Abstract available


  816. VLEGELS N, Ossenkoppele R, van der Flier WM, Koek HL, et al
    Does Loss of Integrity of the Cingulum Bundle Link Amyloid-beta Accumulation and Neurodegeneration in Alzheimer's Disease?
    J Alzheimers Dis. 2022 Jul 11. pii: JAD220024. doi: 10.3233/JAD-220024.
    PubMed     Abstract available


  817. XUE C, Tang Y, Wang C, Yang H, et al
    The Effects of Normal Aging, Subjective Cognitive Decline, Mild Cognitive Impairment, or Alzheimer's Disease on Visual Search.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220209. doi: 10.3233/JAD-220209.
    PubMed     Abstract available


  818. RAMANAN VK, Heckman MG, Przybelski SA, Lesnick TG, et al
    Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220164. doi: 10.3233/JAD-220164.
    PubMed     Abstract available


  819. NABIROTCHKIN S, Bouaziz J, Glibert F, Mandel J, et al
    Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220120. doi: 10.3233/JAD-220120.
    PubMed     Abstract available


  820. KRISHNADAS N, Huang K, Schultz SA, Dore V, et al
    Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD215558. doi: 10.3233/JAD-215558.
    PubMed     Abstract available


  821. MOTAZEDI E, Cheng W, Thomassen JQ, Frei O, et al
    Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220174. doi: 10.3233/JAD-220174.
    PubMed     Abstract available


  822. BLEAKLEY A, Maloney EK, Harkins K, Nelson MN, et al
    An Elicitation Study to Understand Black, Hispanic, and Male Older Adults' Willingness to Participate in Alzheimer's Disease-Focused Research Registries.
    J Alzheimers Dis. 2022 Jul 5. pii: JAD220196. doi: 10.3233/JAD-220196.
    PubMed     Abstract available


  823. CHIA SY, Vipin A, Ng KP, Tu H, et al
    Upregulated Blood miR-150-5p in Alzheimer's Disease Dementia Is Associated with Cognition, Cerebrospinal Fluid Amyloid-beta, and Cerebral Atrophy.
    J Alzheimers Dis. 2022 Jul 5. pii: JAD220116. doi: 10.3233/JAD-220116.
    PubMed     Abstract available


  824. SUN W, Wu Q, Chen H, Yu L, et al
    A Validation Study of the Hong Kong Brief Cognitive Test for Screening Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 4. pii: JAD220417. doi: 10.3233/JAD-220417.
    PubMed     Abstract available


  825. TOUPS K, Hathaway A, Gordon D, Chung H, et al
    Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.
    J Alzheimers Dis. 2022 Jul 4. pii: JAD215707. doi: 10.3233/JAD-215707.
    PubMed     Abstract available


    June 2022
  826. HAN SW, Park YH, Jang ES, Nho K, et al
    Implications of Liver Enzymes in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220343. doi: 10.3233/JAD-220343.
    PubMed     Abstract available


  827. WOJDALA AL, Chiasserini D, Bellomo G, Paciotti S, et al
    Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220323. doi: 10.3233/JAD-220323.
    PubMed     Abstract available


  828. ALMULLA AF, Supasitthumrong T, Amrapala A, Tunvirachaisakul C, et al
    The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220295. doi: 10.3233/JAD-220295.
    PubMed     Abstract available


  829. LUO A, Ning P, Lu H, Huang H, et al
    Association Between Metformin and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Clinical Observational Studies.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220180. doi: 10.3233/JAD-220180.
    PubMed     Abstract available


  830. BABILONI C
    The Dark Side of Alzheimer's Disease: Neglected Physiological Biomarkers of Brain Hyperexcitability and Abnormal Consciousness Level.
    J Alzheimers Dis. 2022 Jun 24. pii: JAD220582. doi: 10.3233/JAD-220582.
    PubMed    


  831. KRANCE SH, Wu CY, Chan ACY, Kwong S, et al
    Endosomal-Lysosomal and Autophagy Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Jun 23. pii: JAD220360. doi: 10.3233/JAD-220360.
    PubMed     Abstract available


  832. PLANTONE D, Pardini M, Locci S, Nobili F, et al
    B Lymphocytes in Alzheimer's Disease-A Comprehensive Review.
    J Alzheimers Dis. 2022 Jun 23. pii: JAD220261. doi: 10.3233/JAD-220261.
    PubMed     Abstract available


  833. ALI DG, Bahrani AA, Barber JM, El Khouli RH, et al
    Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer's Disease Prior to Overt Global Amyloid Positivity.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220294. doi: 10.3233/JAD-220294.
    PubMed     Abstract available


  834. CAIRNS DM, Itzhaki RF, Kaplan DL
    Potential Involvement of Varicella Zoster Virus in Alzheimer's Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220287. doi: 10.3233/JAD-220287.
    PubMed     Abstract available


  835. KHEDR EM, Omeran N, Karam-Allah Ramadan H, Ahmed GK, et al
    Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220176. doi: 10.3233/JAD-220176.
    PubMed     Abstract available


  836. PAN R, Luo S, Huang Q, Li W, et al
    The Associations of Cerebrospinal Fluid Ferritin with Neurodegeneration and Neuroinflammation Along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220002. doi: 10.3233/JAD-220002.
    PubMed     Abstract available


  837. GAN J, Liu S, Chen Z, Yang Y, et al
    Elevated Plasma Orexin-A Levels in Prodromal Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022;1.
    PubMed     Abstract available


  838. TIAN J, Wang T, Jia K, Guo L, et al
    Nonobese Male Patients with Alzheimer's Disease Are Vulnerable to Decrease in Plasma Leptin.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220447. doi: 10.3233/JAD-220447.
    PubMed     Abstract available


  839. BUKHBINDER AS, Ling Y, Hasan O, Jiang X, et al
    Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220361. doi: 10.3233/JAD-220361.
    PubMed     Abstract available


  840. WEISSBERGER GH, Samek A, Mosqueda L, Nguyen AL, et al
    Increased Financial Altruism is Associated with Alzheimer's Disease Neurocognitive Profile in Older Adults.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220187. doi: 10.3233/JAD-220187.
    PubMed     Abstract available


  841. MIELKE MM, Ransom JE, Mandrekar J, Turcano P, et al
    Traumatic Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the Population.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220159. doi: 10.3233/JAD-220159.
    PubMed     Abstract available


  842. KOBAYASHI M, Yamada Y, Shinkawa K, Nemoto M, et al
    Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215714. doi: 10.3233/JAD-215714.
    PubMed     Abstract available


  843. LEONHARDI J, Barthel H, Speerforck S, Dietzel J, et al
    Differential Diagnosis Between Alzheimer's Disease-Related Depression and Pseudo-Dementia in Depression: A New Indication for Amyloid-beta Imaging?
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215619. doi: 10.3233/JAD-215619.
    PubMed     Abstract available


  844. JESTER H, Gosrani S, Ding H, Zhou X, et al
    Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215303. doi: 10.3233/JAD-215303.
    PubMed     Abstract available


  845. ZHU LY, Shi L, Luo Y, Leung J, et al
    Brain MRI Biomarkers to Predict Cognitive Decline in Older People with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215189. doi: 10.3233/JAD-215189.
    PubMed     Abstract available


  846. HORVATH A, Quinlan P, Eckerstrom C, Aberg ND, et al
    Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 11. pii: JAD220292. doi: 10.3233/JAD-220292.
    PubMed     Abstract available


  847. BABILONI C, Noce G, Di Bonaventura C, Lizio R, et al
    Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022 Jun 9. pii: JAD220442. doi: 10.3233/JAD-220442.
    PubMed     Abstract available


  848. DUAN W, Sehrawat P, Zhou TD, Becker JT, et al
    Pattern of Altered Magnetization Transfer Rate in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 9. pii: JAD220335. doi: 10.3233/JAD-220335.
    PubMed     Abstract available


  849. MA X, Zhang Y, Gou D, Ma J, et al
    Metabolic Reprogramming of Microglia Enhances Proinflammatory Cytokine Release through EphA2/p38 MAPK Pathway in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 7. pii: JAD220227. doi: 10.3233/JAD-220227.
    PubMed     Abstract available


  850. GARCIA-ALBERCA JM, Gris E, de la Guia P, Mendoza S, et al
    Effects of Tianeptine Treatment on Depression and Cognitive Function in Patients with Alzheimer's Disease: A 12-Month Retrospective Observational Study.
    J Alzheimers Dis. 2022 Jun 6. pii: JAD215630. doi: 10.3233/JAD-215630.
    PubMed     Abstract available


  851. WESSELS AM, Belger M, Johnston JA, Yu Y, et al
    Demonstration of Clinical Meaningfulness of the Integrated Alzheimer's Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220303. doi: 10.3233/JAD-220303.
    PubMed     Abstract available


  852. SUN L, Guo C, Song Y, Sheng J, et al
    Blood BMP6 Associated with Cognitive Performance and Alzheimer's Disease Diagnosis: A Longitudinal Study of Elders.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220279. doi: 10.3233/JAD-220279.
    PubMed     Abstract available


  853. GOMEZ LR, Albers MW, Baena A, Vila-Castelar C, et al
    Olfactory Function and Markers of Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220075. doi: 10.3233/JAD-220075.
    PubMed     Abstract available


  854. AGARWAL P, Holland TM, James BD, Cherian LJ, et al
    Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD215600. doi: 10.3233/JAD-215600.
    PubMed     Abstract available


  855. ARAUJO DC, Veloso AA, Gomes KB, Souza LC, et al
    A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220256. doi: 10.3233/JAD-220256.
    PubMed     Abstract available


  856. WANG Q, Shi Y, Qi X, Qi L, et al
    Platelet-Derived Amyloid-beta Protein Precursor as a Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220122. doi: 10.3233/JAD-220122.
    PubMed     Abstract available


  857. HUDA TI, Diaz MJ, Gozlan EC, Chobrutskiy A, et al
    Immunogenomics Parameters for Patient Stratification in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220119. doi: 10.3233/JAD-220119.
    PubMed     Abstract available


  858. HANNONEN S, Andberg S, Karkkainen V, Rusanen M, et al
    Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD215551. doi: 10.3233/JAD-215551.
    PubMed     Abstract available


    May 2022
  859. SERWER P, Wright ET, Hunter B
    Additions to Alpha-Sheet Based Hypotheses for the Cause of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 30. pii: JAD220311. doi: 10.3233/JAD-220311.
    PubMed     Abstract available


  860. WANG Y, Li L, Zhao X, Sui S, et al
    Intestinal Microflora Changes in Patients with Mild Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2022 May 30. pii: JAD220076. doi: 10.3233/JAD-220076.
    PubMed     Abstract available


  861. RIPHAGEN JM, van Hooren RWE, Kenis G, Verhey FRJ, et al
    Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2022 May 28. pii: JAD215353. doi: 10.3233/JAD-215353.
    PubMed     Abstract available


  862. MCGRATTAN A, Stewart CJ, Cassidy A, Woodside JV, et al
    Diet Patterns, the Gut Microbiome, and Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 23. pii: JAD220205. doi: 10.3233/JAD-220205.
    PubMed     Abstract available


  863. TSAI YL, Yen CT, Wang YF
    Astrocyte Dysregulation and Calcium Ion Imbalance May Link the Development of Osteoporosis and Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 18. pii: JAD220218. doi: 10.3233/JAD-220218.
    PubMed     Abstract available


  864. FRAME G, Schuller A, Smith MA, Crish SD, et al
    Alterations in Retinal Signaling Across Age and Sex in 3xTg Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 May 18. pii: JAD220016. doi: 10.3233/JAD-220016.
    PubMed     Abstract available


  865. HAO J, Guo Y, Guo K, Yang Q, et al
    Peripheral Inflammatory Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 18. pii: JAD215422. doi: 10.3233/JAD-215422.
    PubMed     Abstract available


  866. WITTFELD K, Raman MR, Conner SC, Aslam A, et al
    Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults.
    J Alzheimers Dis. 2022 May 16. pii: JAD220356. doi: 10.3233/JAD-220356.
    PubMed     Abstract available


  867. HOILUND-CARLSEN PF, Revheim ME, Alavi A
    Alzheimer's Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects- Atherosclerosis for a Start.
    J Alzheimers Dis. 2022 May 16. pii: JAD220190. doi: 10.3233/JAD-220190.
    PubMed     Abstract available


  868. CHENG Y, Jian JM, He CY, Ren JR, et al
    The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-beta and Tau Levels in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 16. pii: JAD220126. doi: 10.3233/JAD-220126.
    PubMed     Abstract available


  869. TANCHEVA L, Lazarova M, Velkova L, Dolashki A, et al
    Beneficial Effects of Snail Helix aspersa Extract in an Experimental Model of Alzheimer's Type Dementia.
    J Alzheimers Dis. 2022 May 16. pii: JAD215693. doi: 10.3233/JAD-215693.
    PubMed     Abstract available


  870. HELBOE L, Rosenqvist N, Volbracht C, Pedersen LO, et al
    Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer's Disease and Primary Tauopathy Postmortem Brains.
    J Alzheimers Dis. 2022 May 9. pii: JAD220125. doi: 10.3233/JAD-220125.
    PubMed     Abstract available


  871. WELTY S, Thathiah A, Levine AS
    DNA Damage Increases Secreted Abeta40 and Abeta42 in Neuronal Progenitor Cells: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 9. pii: JAD220030. doi: 10.3233/JAD-220030.
    PubMed     Abstract available


  872. ZHANG Y, Hu Y, Han Z, Geng Y, et al
    Cattle Encephalon Glycoside and Ignotin Ameliorate Palmitoylation of PSD-95 and Enhance Expression of Synaptic Proteins in the Frontal Cortex of a APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 9. pii: JAD220009. doi: 10.3233/JAD-220009.
    PubMed     Abstract available


  873. FERNANDES M, Chiaravalloti A, Manfredi N, Placidi F, et al
    Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2022 May 9. pii: JAD215734. doi: 10.3233/JAD-215734.
    PubMed     Abstract available


  874. ZHANG X, Guan Q, Li Y, Zhang J, et al
    Aberrant Cross-Tissue Functional Connectivity in Alzheimer's Disease: Static, Dynamic, and Directional Properties.
    J Alzheimers Dis. 2022 May 9. pii: JAD215649. doi: 10.3233/JAD-215649.
    PubMed     Abstract available


  875. DAS TK, Blasco-Conesa MP, Korf J, Honarpisheh P, et al
    Bacterial Amyloid Curli Associated Gut Epithelial Neuroendocrine Activation Predominantly Observed in Alzheimer's Disease Mice with Central Amyloid-beta Pathology.
    J Alzheimers Dis. 2022 May 6. pii: JAD220106. doi: 10.3233/JAD-220106.
    PubMed     Abstract available


  876. DUAN L, Qian X, Wang Q, Huang L, et al
    Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer's Disease Rat Model.
    J Alzheimers Dis. 2022 May 6. pii: JAD215720. doi: 10.3233/JAD-215720.
    PubMed     Abstract available


  877. KALARI M, Abbasi Z, Shasaltaneh MD, Khaleghian A, et al
    A Cobalt-Containing Compound as a Stronger Inhibitor than Galantamine to Inhibit Acetylcholinesterase Activity: A New Drug Candidate for Alzheimer's Disease Treatment.
    J Alzheimers Dis. 2022 May 6. pii: JAD215588. doi: 10.3233/JAD-215588.
    PubMed     Abstract available


  878. NARUKAWA M, Mori Y, Nishida R, Takahashi S, et al
    Expression of Olfactory-Related Genes in the Olfactory Epithelium of an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2022 May 4. pii: JAD220213. doi: 10.3233/JAD-220213.
    PubMed     Abstract available


  879. MANDAL PK, Dwivedi D, Shukla D, Samkaria A, et al
    Interplay Between Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 4. pii: JAD215729. doi: 10.3233/JAD-215729.
    PubMed     Abstract available


  880. LIO CT, Kacprowski T, Klaedtke M, Jensen LR, et al
    Small RNA Sequencing in the Tg4-42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 2. pii: JAD220110. doi: 10.3233/JAD-220110.
    PubMed     Abstract available


    April 2022
  881. KIM H, Levine A, Cohen D, Gehrman P, et al
    The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.
    J Alzheimers Dis. 2022 Apr 28. pii: JAD215417. doi: 10.3233/JAD-215417.
    PubMed     Abstract available


  882. LENG F, Zhan Z, Sun Y, Liu F, et al
    Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD220102. doi: 10.3233/JAD-220102.
    PubMed     Abstract available


  883. DIAS IHK, Shokr H, Shephard F, Chakrabarti L, et al
    Oxysterols and Oxysterol Sulfates in Alzheimer's Disease Brain and Cerebrospinal Fluid.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD220083. doi: 10.3233/JAD-220083.
    PubMed     Abstract available


  884. SALEHIPOUR A, Bagheri M, Sabahi M, Dolatshahi M, et al
    Combination Therapy in Alzheimer's Disease: Is It Time?
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215680. doi: 10.3233/JAD-215680.
    PubMed     Abstract available


  885. CHEN D, Yi F, Qin Y, Zhang J, et al
    A Stacking Framework for Multi-Classification of Alzheimer's Disease Using Neuroimaging and Clinical Features.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215654. doi: 10.3233/JAD-215654.
    PubMed     Abstract available


  886. TONGSIRI S, Levkoff S, Gallagher-Thompson D, Teri L, et al
    Cultural Adaptation of the Reducing Disability in Alzheimer's Disease (RDAD) Protocol for an Intervention to Reduce Behavioral and Psychological Symptoms of Dementia in Thailand.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215253. doi: 10.3233/JAD-215253.
    PubMed     Abstract available


  887. DONG L, Liu C, Sha L, Mao C, et al
    PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer's Disease: Data from PUMCH Dementia Cohort.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220194. doi: 10.3233/JAD-220194.
    PubMed     Abstract available


  888. BOSE A, Dutta M, Dash NS, Nandi R, et al
    Importance of Task Selection for Connected Speech Analysis in Patients with Alzheimer's Disease from an Ethnically Diverse Sample.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220166. doi: 10.3233/JAD-220166.
    PubMed     Abstract available


  889. LOBUE C, Kelley BJ, Hart J, Helphrey J, et al
    Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220112. doi: 10.3233/JAD-220112.
    PubMed     Abstract available


  890. GRAHAM A, Livingston G, Purnell L, Huntley J, et al
    Mild Traumatic Brain Injuries and Future Risk of Developing Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220069. doi: 10.3233/JAD-220069.
    PubMed     Abstract available


  891. LLAMAS-RODRIGUEZ J, Oltmer J, Greve DN, Williams E, et al
    Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD215567. doi: 10.3233/JAD-215567.
    PubMed     Abstract available


  892. SALAZAR CR, Ritchie M, Gillen DL, Grill JD, et al
    Strategies Associated with Retaining Participants in the Longitudinal National Alzheimer's Coordinating Center Uniform Data Set Study.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD215537. doi: 10.3233/JAD-215537.
    PubMed     Abstract available


  893. KARIKARI TK
    Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance.
    J Alzheimers Dis. 2022 Apr 23. pii: JAD215730. doi: 10.3233/JAD-215730.
    PubMed     Abstract available


  894. CATO S, Ramer S, Hajjar I, Kulshreshtha A, et al
    Alzheimer's Disease Mortality as a Function of Urbanization Level: 1999-2019.
    J Alzheimers Dis. 2022 Apr 22. pii: JAD215586. doi: 10.3233/JAD-215586.
    PubMed     Abstract available


  895. HUTTEN DR, Bos JHJ, de Vos S, Hak E, et al
    Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer's Disease: A Retrospective Inception Cohort Study.
    J Alzheimers Dis. 2022 Apr 18. pii: JAD215057. doi: 10.3233/JAD-215057.
    PubMed     Abstract available


  896. RAMSDEN CE, Keyes GS, Calzada E, Horowitz MS, et al
    Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer's Disease in Humans.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD220071. doi: 10.3233/JAD-220071.
    PubMed     Abstract available


  897. MIRABNAHRAZAM G, Ma D, Lee S, Popuri K, et al
    Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD220021. doi: 10.3233/JAD-220021.
    PubMed     Abstract available


  898. KETCHUM FB, Erickson CM, Chin NA, Gleason CE, et al
    What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD215521. doi: 10.3233/JAD-215521.
    PubMed     Abstract available


  899. WONG HY, Zhong H, Zhong M, Zhou X, et al
    Demographics and Medication Use of Patients with Late-Onset Alzheimer's Disease in Hong Kong.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD215312. doi: 10.3233/JAD-215312.
    PubMed     Abstract available


  900. DALY T, Mastroleo I
    The First Survivors of Alzheimer's: How Patients Recovered Life and Hope in Their Own Words by Dale Bredesen, Avery, 2021, 272 pp.
    J Alzheimers Dis. 2022 Apr 13. pii: JAD220185. doi: 10.3233/JAD-220185.
    PubMed    


  901. KAWARABAYASHI T, Nakamura T, Sato K, Seino Y, et al
    Lipid Rafts Act as a Common Platform for Amyloid-beta Oligomer-Induced Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2022 Apr 12. pii: JAD215662. doi: 10.3233/JAD-215662.
    PubMed     Abstract available


  902. MARINELLI L, Trompetto C, Puce L, Monacelli F, et al
    Electromyographic Patterns of Paratonia in Normal Subjects and in Patients with Mild Cognitive Impairment or Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 11. pii: JAD215526. doi: 10.3233/JAD-215526.
    PubMed     Abstract available


  903. HONE-BLANCHET A, Bhosali A, Krishnamurthy LC, Shahid SS, et al
    Frontal Metabolites and Alzheimer's Disease Biomarkers in Healthy Older Women and Women Diagnosed with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022 Apr 11. pii: JAD215431. doi: 10.3233/JAD-215431.
    PubMed     Abstract available


  904. MOZERSKY J, Roberts SJ, Rumbaugh M, Chhatwal J, et al
    Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD220113. doi: 10.3233/JAD-220113.
    PubMed     Abstract available


  905. ISELLA V, Rosazza C, Ferri F, Gazzotti M, et al
    Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD220053. doi: 10.3233/JAD-220053.
    PubMed     Abstract available


  906. GARCIA PRETELT FJ, Suarez Relevo JX, Aguillon D, Lopera F, et al
    Automatic Classification of Subjects of the PSEN1-E280A Family at Risk of Developing Alzheimer's Disease Using Machine Learning and Resting State Electroencephalography.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD210148. doi: 10.3233/JAD-210148.
    PubMed     Abstract available


  907. GHERARDELLI C, Cisternas P, Vera-Salazar RF, Mendez-Orellana C, et al
    Age- and Sex-Associated Glucose Metabolism Decline in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 7. pii: JAD215273. doi: 10.3233/JAD-215273.
    PubMed     Abstract available


  908. GABEL M, Bollinger RM, Coble DW, Grill JD, et al
    Retaining Participants in Longitudinal Studies of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215710. doi: 10.3233/JAD-215710.
    PubMed     Abstract available


  909. PILOTTO A, Parigi M, Bonzi G, Battaglio B, et al
    Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215646. doi: 10.3233/JAD-215646.
    PubMed     Abstract available


  910. UENO M, Yoshino Y, Mori H, Funahashi Y, et al
    Association Study and Meta-Analysis of Polymorphisms and Blood mRNA Expression of the ALDH2 Gene in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215627. doi: 10.3233/JAD-215627.
    PubMed     Abstract available


  911. HANYU H, Koyama Y, Horita H, Aoki T, et al
    Characterization of Alzheimer's Disease Subtypes Based on Magnetic Resonance Imaging and Perfusion Single-Photon Emission Computed Tomography.
    J Alzheimers Dis. 2022 Apr 1. pii: JAD215674. doi: 10.3233/JAD-215674.
    PubMed     Abstract available


  912. LAZAROU I, Georgiadis K, Nikolopoulos S, Oikonomou VP, et al
    Exploring Network Properties Across Preclinical Stages of Alzheimer's Disease Using a Visual Short-Term Memory and Attention Task with High-Density Electroencephalography: A Brain-Connectome Neurophysiological Study.
    J Alzheimers Dis. 2022 Apr 1. pii: JAD215421. doi: 10.3233/JAD-215421.
    PubMed     Abstract available


    March 2022
  913. WEI T, Guo Z, Wang Z, Li C, et al
    Five Major Psychiatric Disorders and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 31. pii: JAD220010. doi: 10.3233/JAD-220010.
    PubMed     Abstract available


  914. GONZALEZ CORDERO EM, Cuevas-Budhart MA, Perez-Moran D, Trejo Villeda MA, et al
    Relationship Between the Gut Microbiota and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2022 Mar 28. pii: JAD215224. doi: 10.3233/JAD-215224.
    PubMed     Abstract available



  915. Erratum to: Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer's Disease Patients: A Meta-Analysis and Critical Discussion.
    J Alzheimers Dis. 2022 Mar 25. pii: JAD229002. doi: 10.3233/JAD-229002.
    PubMed    


  916. KIM CK, Lee YR, Ong L, Gold M, et al
    Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures.
    J Alzheimers Dis. 2022 Mar 22. pii: JAD215699. doi: 10.3233/JAD-215699.
    PubMed     Abstract available


  917. ZHANG PF, Wang ZT, Liu Y, Hu H, et al
    Peripheral Immune Cells and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD220057. doi: 10.3233/JAD-220057.
    PubMed     Abstract available


  918. JIAN JM, Fan DY, Cheng Y, Shen YY, et al
    Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215611. doi: 10.3233/JAD-215611.
    PubMed     Abstract available


  919. MURCHISON CF, Jaeger BC, Szychowski JM, Cutter GR, et al
    Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215553. doi: 10.3233/JAD-215553.
    PubMed     Abstract available


  920. WANG X, Sun H, Pan S, Bai X, et al
    Causal Relationships Between Relative Intake from the Macronutrients and Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215535. doi: 10.3233/JAD-215535.
    PubMed     Abstract available


  921. LARGENT EA, Bhardwaj T, Clapp JT, Sykes OS, et al
    You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research.
    J Alzheimers Dis. 2022 Mar 18. pii: JAD220061. doi: 10.3233/JAD-220061.
    PubMed     Abstract available


  922. DOBROMYSLIN VI, Megherbi DB
    Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.
    J Alzheimers Dis. 2022 Mar 15. pii: JAD215640. doi: 10.3233/JAD-215640.
    PubMed     Abstract available


  923. DE OLIVEIRA FF, Bertolucci PHF, Chen ES, Smith MC, et al
    Pharmacogenetic Analyses of Therapeutic Effects of Lipophilic Statins on Cognitive and Functional Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215735. doi: 10.3233/JAD-215735.
    PubMed     Abstract available


  924. DU XL, Song L, Schulz PE, Xu H, et al
    Risk of Developing Alzheimer's Disease and Related Dementias in Association with Cardiovascular Disease, Stroke, Hypertension, and Diabetes in a Large Cohort of Women with Breast Cancer and with up to 26 Years of Follow-Up.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215657. doi: 10.3233/JAD-215657.
    PubMed     Abstract available


  925. LUPPI JJ, Schoonhoven DN, van Nifterick AM, Gouw AA, et al
    Oscillatory Activity of the Hippocampus in Prodromal Alzheimer's Disease: A Source-Space Magnetoencephalography Study.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215464. doi: 10.3233/JAD-215464.
    PubMed     Abstract available


  926. HUANG SY, Yang YX, Zhang YR, Kuo K, et al
    Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD220050. doi: 10.3233/JAD-220050.
    PubMed     Abstract available


  927. TERNAK G, Nemeth M, Rozanovic M, Bogar L, et al
    Alzheimer's Disease-Related Dysbiosis Might Be Triggered by Certain Classes of Antibiotics with Time-Lapse: New Insights into the Pathogenesis?
    J Alzheimers Dis. 2022 Mar 11. pii: JAD220018. doi: 10.3233/JAD-220018.
    PubMed     Abstract available


  928. CAO M, Liu J, Zhang X, Yang T, et al
    ABI3 Is a Novel Early Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215635. doi: 10.3233/JAD-215635.
    PubMed     Abstract available


  929. KRAUSE-SORIO B, Siddarth P, Kilpatrick L, Milillo MM, et al
    Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215563. doi: 10.3233/JAD-215563.
    PubMed     Abstract available


  930. NICSANU R, Cervellati C, Benussi L, Squitti R, et al
    Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215542. doi: 10.3233/JAD-215542.
    PubMed     Abstract available


  931. WOLFSGRUBER S, Kleineidam L, Weyrauch AS, Barkhoff M, et al
    Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215416. doi: 10.3233/JAD-215416.
    PubMed     Abstract available


  932. CHUNG SJ, Chang Y, Jeon J, Shin JI, et al
    Association of Alzheimer's Disease with COVID-19 Susceptibility and Severe Complications: A Nationwide Cohort Study.
    J Alzheimers Dis. 2022 Mar 10. pii: JAD220031. doi: 10.3233/JAD-220031.
    PubMed     Abstract available


  933. SHIM Y, Han HJ, Park KW, Kim BC, et al
    A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Mode
    J Alzheimers Dis. 2022 Mar 10. pii: JAD215277. doi: 10.3233/JAD-215277.
    PubMed     Abstract available



  934. Erratum to "Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease".
    J Alzheimers Dis. 2022 Mar 8. pii: JAD229001. doi: 10.3233/JAD-229001.
    PubMed    


  935. ANDROUIN A, Thierry M, Boluda S, Baskaran A, et al
    Alterations of Neuronal Lysosomes in Alzheimer's Disease and in APPxPS1-KI Mice.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215692. doi: 10.3233/JAD-215692.
    PubMed     Abstract available


  936. CIRSTEA MS, Kliger D, MacLellan AD, Yu AC, et al
    The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215520. doi: 10.3233/JAD-215520.
    PubMed     Abstract available


  937. WANG X, Li F, Gao Q, Jiang Z, et al
    Evaluation of the Accuracy of Cognitive Screening Tests in Detecting Dementia Associated with Alzheimer's Disease: A Hierarchical Bayesian Latent Class Meta-Analysis.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215394. doi: 10.3233/JAD-215394.
    PubMed     Abstract available


  938. KOK FK, van Leerdam SL, de Lange ECM
    Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD210607. doi: 10.3233/JAD-210607.
    PubMed     Abstract available


  939. LACORTE E, Ancidoni A, Zaccaria V, Remoli G, et al
    Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.
    J Alzheimers Dis. 2022 Mar 5. pii: JAD220046. doi: 10.3233/JAD-220046.
    PubMed     Abstract available


  940. LIU Y, Han PR, Hu H, Wang ZT, et al
    A Multi-Dimensional Comparison of Alzheimer's Disease Neurodegenerative Biomarkers.
    J Alzheimers Dis. 2022 Mar 5. pii: JAD215724. doi: 10.3233/JAD-215724.
    PubMed     Abstract available


  941. XIAO Y, Gong X, Deng R, Liu W, et al
    Iron Chelation Remits Memory Deficits Caused by the High-Fat Diet in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215705. doi: 10.3233/JAD-215705.
    PubMed     Abstract available


  942. ARMSTRONG MJ, Song S, Kurasz AM, Li Z, et al
    Predictors of Mortality in Individuals with Dementia in the National Alzheimer's Coordinating Center.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215587. doi: 10.3233/JAD-215587.
    PubMed     Abstract available


  943. FENG T, Hu X, Fukui Y, Bian Z, et al
    Clinical and Pathological Benefits of Scallop-Derived Plasmalogen in a Novel Mouse Model of Alzheimer's Disease with Chronic Cerebral Hypoperfusion.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215246. doi: 10.3233/JAD-215246.
    PubMed     Abstract available


  944. BROUSSARD JI, Redell JB, Maynard ME, Zhao J, et al
    Impaired Experience-Dependent Refinement of Place Cells in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215023. doi: 10.3233/JAD-215023.
    PubMed     Abstract available


  945. BABULAL GM, Chen L, Doherty JM, Murphy SA, et al
    Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215708. doi: 10.3233/JAD-215708.
    PubMed     Abstract available


  946. MEYSAMI S, Raji CA, Mendez MF
    Quantified Brain Magnetic Resonance Imaging Volumes Differentiates Behavioral Variant Frontotemporal Dementia from Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215667. doi: 10.3233/JAD-215667.
    PubMed     Abstract available


  947. SHI Y, Bao Q, Chen W, Wang L, et al
    Potential Roles of Extracellular Vesicles as Diagnosis Biomarkers and Therapeutic Approaches for Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215666. doi: 10.3233/JAD-215666.
    PubMed     Abstract available


  948. MI Y, Qin Q, Xing Y, Tang Y, et al
    Capgras Syndrome as the Core Manifestation of Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215565. doi: 10.3233/JAD-215565.
    PubMed     Abstract available


  949. JACUS JP, Voltzenlogel V, Antoine P, Cuervo-Lombard CV, et al
    Apathy Is the Best Dimension to Consider for Awareness Assessment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215550. doi: 10.3233/JAD-215550.
    PubMed     Abstract available


  950. ESCOBAR YH, O'Piela D, Wold LE, Mackos AR, et al
    Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215290. doi: 10.3233/JAD-215290.
    PubMed     Abstract available


  951. ALVES SR, da Cruz E Silva C, Martins I, Henriques AG, et al
    A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215059. doi: 10.3233/JAD-215059.
    PubMed     Abstract available


    February 2022
  952. KRISHNA-K K, Behnisch T, Sajikumar S
    Modulation of the Ubiquitin-Proteasome System Restores Plasticity in Hippocampal Pyramidal Neurons of the APP/PS1 Alzheimer's Disease-Like Mice.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215718. doi: 10.3233/JAD-215718.
    PubMed     Abstract available


  953. LI W, Yang D, Yan C, Chen M, et al
    Characterizing Network Selectiveness to the Dynamic Spreading of Neuropathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215596. doi: 10.3233/JAD-215596.
    PubMed     Abstract available


  954. KALECKY K, German DC, Montillo AA, Bottiglieri T, et al
    Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215448. doi: 10.3233/JAD-215448.
    PubMed     Abstract available


  955. CAO H, Zhou X, Chen Y, Ip FCF, et al
    Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer's Disease Risk.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215311. doi: 10.3233/JAD-215311.
    PubMed     Abstract available


  956. COLVERSON AJ, Trifilio E, Williamson JB
    Music, Mind, Mood, and Mingling in Alzheimer's Disease and Related Dementias: A Scoping Review.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215199. doi: 10.3233/JAD-215199.
    PubMed     Abstract available


  957. PAYNE S, Shofer JB, Shutes-David A, Li G, et al
    Correlates of Conversion from Mild Cognitive Impairment to Dementia with Lewy Bodies: Data from the National Alzheimer Coordinating Center.
    J Alzheimers Dis. 2022 Feb 23. pii: JAD215428. doi: 10.3233/JAD-215428.
    PubMed     Abstract available


  958. CHOI H, Lee D, Mook-Jung I
    Gut Microbiota as a Hidden Player in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 22. pii: JAD215235. doi: 10.3233/JAD-215235.
    PubMed     Abstract available


  959. ALVAREZ-SANCHEZ L, Pena-Bautista C, Baquero M, Chafer-Pericas C, et al
    Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer's Disease Blood Biomarkers.
    J Alzheimers Dis. 2022 Feb 22. pii: JAD215093. doi: 10.3233/JAD-215093.
    PubMed     Abstract available


  960. SCHINDLER SE
    Predicting Symptom Onset in Sporadic Alzheimer's Disease: "How Long Do I Have?"
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215722. doi: 10.3233/JAD-215722.
    PubMed     Abstract available


  961. AKSNES M, Aass HCD, Tiiman A, Terenius L, et al
    Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215504. doi: 10.3233/JAD-215504.
    PubMed     Abstract available


  962. TSAMOU M, Carpi D, Pistollato F, Roggen EL, et al
    Sporadic Alzheimer's Disease- and Neurotoxicity-Related microRNAs Affecting Key Events of Tau-Driven Adverse Outcome Pathway Toward Memory Loss.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215434. doi: 10.3233/JAD-215434.
    PubMed     Abstract available


  963. JACOBS HIL, O'Donnell A, Satizabal CL, Lois C, et al
    Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215372. doi: 10.3233/JAD-215372.
    PubMed     Abstract available


  964. LIU Z, Paek EJ, Yoon SO, Casenhiser D, et al
    Detecting Alzheimer's Disease Using Natural Language Processing of Referential Communication Task Transcripts.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215137. doi: 10.3233/JAD-215137.
    PubMed     Abstract available


  965. HUA X, Church K, Walker W, L'Hostis P, et al
    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.
    J Alzheimers Dis. 2022 Feb 18. pii: JAD215511. doi: 10.3233/JAD-215511.
    PubMed     Abstract available


  966. SOARES JZ, Valeur J, Saltyte Benth J, Knapskog AB, et al
    Vitamin D in Alzheimer's Disease: Low Levels in Cerebrospinal Fluid Despite Normal Amounts in Serum.
    J Alzheimers Dis. 2022 Feb 15. pii: JAD215536. doi: 10.3233/JAD-215536.
    PubMed     Abstract available


  967. HANG Z, Cai S, Lei T, Zhang X, et al
    Transfer of Tumor-Bearing Mice Intestinal Flora Can Ameliorate Cognition in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 Feb 15. pii: JAD215495. doi: 10.3233/JAD-215495.
    PubMed     Abstract available


  968. GALLUCCI M, Cenesi L, White C, Antuono P, et al
    Lights and Shadows of Cerebrospinal Fluid Biomarkers in the Current Alzheimer's Disease Framework.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215432. doi: 10.3233/JAD-215432.
    PubMed     Abstract available


  969. SUAREZ-MENDEZ I, Bruna R, Lopez-Sanz D, Montejo P, et al
    Cognitive Training Modulates Brain Hypersynchrony in a Population at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215406. doi: 10.3233/JAD-215406.
    PubMed     Abstract available


  970. BIJU K, Oh E, Rosenberg P, Xue QL, et al
    Vestibular Function Predicts Balance and Fall Risk in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215366. doi: 10.3233/JAD-215366.
    PubMed     Abstract available


  971. ATAYDE AL, Fischer CE, Schweizer TA, Munoz DG, et al
    Neuropsychiatric Inventory-Questionnaire Assessed Nighttime Behaviors in Cognitively Asymptomatic Patients with Pathologically Confirmed Alzheimer's Disease Predict More Rapid Cognitive Deterioration.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215276. doi: 10.3233/JAD-215276.
    PubMed     Abstract available


  972. WANG J, Ma SF, Yun Q, Liu WJ, et al
    FOXG1 as a Potential Therapeutic Target for Alzheimer's Disease with a Particular Focus on Cell Cycle Regulation.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215144. doi: 10.3233/JAD-215144.
    PubMed     Abstract available


  973. KELBERMAN MA, Anderson CR, Chlan E, Rorabaugh JM, et al
    Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215546. doi: 10.3233/JAD-215546.
    PubMed     Abstract available


  974. TICINESI A, Mancabelli L, Carnevali L, Nouvenne A, et al
    Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer's Disease: Focus on Polyphenols and Dietary Fibers.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215493. doi: 10.3233/JAD-215493.
    PubMed     Abstract available


  975. GALASKO DR, Grill JD, Lingler JH, Heidebrink JL, et al
    A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215490. doi: 10.3233/JAD-215490.
    PubMed     Abstract available


  976. PARRA MA
    Barriers to Effective Memory Assessments for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215445. doi: 10.3233/JAD-215445.
    PubMed     Abstract available


  977. DE PAULA FRANCA RESENDE E, Ketelle R, Karydas A, Allen I, et al
    Late-Onset Alcohol Abuse as a Presenting Symptom of Neurodegenerative Diseases.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215369. doi: 10.3233/JAD-215369.
    PubMed     Abstract available


  978. XU A, Kouznetsova VL, Tsigelny IF
    Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning.
    J Alzheimers Dis. 2022 Feb 5. pii: JAD215502. doi: 10.3233/JAD-215502.
    PubMed     Abstract available


  979. TU MC, Chung HW, Hsu YH, Yang JJ, et al
    Stage-Dependent Cerebral Blood Flow and Leukoaraiosis Couplings in Subcortical Ischemic Vascular Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 3. pii: JAD215405. doi: 10.3233/JAD-215405.
    PubMed     Abstract available


  980. JANSSON D, Wang M, Thomas R, Erickson MA, et al
    Markers of Cerebrovascular Injury, Inflammation, and Plasma Lipids Are Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Cognitively Normal Persons.
    J Alzheimers Dis. 2022 Feb 2. pii: JAD215400. doi: 10.3233/JAD-215400.
    PubMed     Abstract available


  981. ASSOGNA M, Motta C, Bonni S, Borghi I, et al
    Isolated Amyloid-beta Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients.
    J Alzheimers Dis. 2022 Feb 2. pii: JAD215218. doi: 10.3233/JAD-215218.
    PubMed     Abstract available


  982. THOMPSON RE, Tuchman AJ, Alkon DL
    Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer's Disease in the Absence of Memantine1.
    J Alzheimers Dis. 2022 Feb 1. pii: JAD215545. doi: 10.3233/JAD-215545.
    PubMed     Abstract available


    January 2022
  983. GEORGE DR, Whitehouse PJ
    How Not to Study a Disease: The Story of Alzheimer's by Karl Herrup, The MIT Press, 2021, 245 pp.
    J Alzheimers Dis. 2022 Jan 31. pii: JAD220035. doi: 10.3233/JAD-220035.
    PubMed    


  984. JUTTEN RJ, Thompson L, Sikkes SAM, Maruff P, et al
    A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach.
    J Alzheimers Dis. 2022 Jan 31. pii: JAD215098. doi: 10.3233/JAD-215098.
    PubMed     Abstract available


  985. UM YH, Wang SM, Kang DW, Kim NY, et al
    Subcortical and Cerebellar Neural Correlates of Prodromal Alzheimer's Disease with Prolonged Sleep Latency.
    J Alzheimers Dis. 2022 Jan 21. pii: JAD215460. doi: 10.3233/JAD-215460.
    PubMed     Abstract available


  986. MESA-HERRERA F, Marin R, Torrealba E, Diaz M, et al
    Multivariate Assessment of Lipoxidative Metabolites, Trace Biometals, and Antioxidant and Detoxifying Activities in the Cerebrospinal Fluid Define a Fingerprint of Preclinical Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215437. doi: 10.3233/JAD-215437.
    PubMed     Abstract available


  987. ZHANG W, Zhang M, Wu Q, Shi JS, et al
    Dendrobium nobile Lindl. Alkaloids Ameliorate Abeta25-35-Induced Synaptic Deficits by Targeting Wnt/beta-Catenin Pathway in Alzheimer's Disease Models.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215433. doi: 10.3233/JAD-215433.
    PubMed     Abstract available


  988. TEIXEIRA AL, Salem H, Martins LB, Gonzales MM, et al
    Factors Associated with Apathy in Alzheimer's Disease: A Cross-Sectional Analysis of the Texas Alzheimer's Research and Care Consortium (TARCC) Study.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215314. doi: 10.3233/JAD-215314.
    PubMed     Abstract available


  989. PEDERSEN FN, Stokholm L, Pouwer F, Hass Rubin K, et al
    Diabetic Retinopathy Predicts Risk of Alzheimer's Disease: A Danish Registry-Based Nationwide Cohort Study.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215313. doi: 10.3233/JAD-215313.
    PubMed     Abstract available


  990. RICHTER N, David LS, Grothe MJ, Teipel S, et al
    Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD210261. doi: 10.3233/JAD-210261.
    PubMed     Abstract available


  991. MCNERNEY MW, Heath A, Narayanan S, Yesavage J, et al
    Repetitive Transcranial Magnetic Stimulation Improves Brain-Derived Neurotrophic Factor and Cholinergic Signaling in the 3xTgAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 18. pii: JAD215361. doi: 10.3233/JAD-215361.
    PubMed     Abstract available


  992. KUKSA PP, Liu CL, Fu W, Qu L, et al
    Alzheimer's Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 18. pii: JAD215055. doi: 10.3233/JAD-215055.
    PubMed     Abstract available


  993. MIRON J, Picard C, Labonte A, Auld D, et al
    MSR1 and NEP Are Correlated with Alzheimer's Disease Amyloid Pathology and Apolipoprotein Alterations.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215410. doi: 10.3233/JAD-215410.
    PubMed     Abstract available


  994. EASTMAN G, Sharlow ER, Lazo JS, Bloom GS, et al
    Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215357. doi: 10.3233/JAD-215357.
    PubMed     Abstract available


  995. STEPLER KE, Gillyard TR, Reed CB, Avery TM, et al
    ABCA7, a Genetic Risk Factor Associated with Alzheimer's Disease Risk in African Americans.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215306. doi: 10.3233/JAD-215306.
    PubMed     Abstract available


  996. SCHAFFERT J, LoBue C, Hynan LS, Hart J, et al
    Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215200. doi: 10.3233/JAD-215200.
    PubMed     Abstract available


  997. PARK M, Baik K, Lee YG, Kang SW, et al
    Erratum to: Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.
    J Alzheimers Dis. 2022 Jan 11. pii: JAD219020. doi: 10.3233/JAD-219020.
    PubMed    


  998. BIAN Z, Liu X, Feng T, Yu H, et al
    Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 Jan 5. pii: JAD215318. doi: 10.3233/JAD-215318.
    PubMed     Abstract available


  999. DALY T, Mastroleo I, Henry V, Bourdenx M, et al
    An Argument for Simple Tests of Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 4. pii: JAD215492. doi: 10.3233/JAD-215492.
    PubMed     Abstract available


  1000. BENCA R, Herring WJ, Khandker R, Qureshi Z, et al
    Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.
    J Alzheimers Dis. 2022 Jan 4. pii: JAD215324. doi: 10.3233/JAD-215324.
    PubMed     Abstract available


  1001. CONTARINO VE, Siggillino S, Arighi A, Scola E, et al
    Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia.
    J Alzheimers Dis. 2022;85:431-442.
    PubMed     Abstract available


  1002. WILKINS HM, Troutwine BR, Menta BW, Manley SJ, et al
    Mitochondrial Membrane Potential Influences Amyloid-beta Protein Precursor Localization and Amyloid-beta Secretion.
    J Alzheimers Dis. 2022;85:381-394.
    PubMed     Abstract available


  1003. YAN XD, Qu XS, Yin J, Qiao J, et al
    Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice.
    J Alzheimers Dis. 2022;85:343-357.
    PubMed     Abstract available


  1004. SCHWARZ CG, Knopman DS, Ramanan VK, Lowe VJ, et al
    Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual.
    J Alzheimers Dis. 2022;85:59-64.
    PubMed     Abstract available


  1005. SONG Y, Du Z, Chen X, Zhang W, et al
    Astrocytic N-Methyl-D-Aspartate Receptors Protect the Hippocampal Neurons Against Amyloid-beta142-Induced Synaptotoxicity by Regulating Nerve Growth Factor.
    J Alzheimers Dis. 2022;85:167-178.
    PubMed     Abstract available


  1006. JUNG KH, Park KI, Lee WJ, Son H, et al
    Association of Plasma Oligomerized Amyloid-beta and Cerebral White Matter Lesions in a Health Screening Population.
    J Alzheimers Dis. 2022;85:1835-1844.
    PubMed     Abstract available


  1007. STREIT WJ, Rotter J, Winter K, Muller W, et al
    Droplet Degeneration of Hippocampal and Cortical Neurons Signifies the Beginning of Neuritic Plaque Formation.
    J Alzheimers Dis. 2022;85:1701-1720.
    PubMed     Abstract available


  1008. KURANO M, Tsukamoto K, Sakai E, Hara M, et al
    Isoform-Dependent Effects of Apolipoprotein E on Sphingolipid Metabolism in Neural Cells.
    J Alzheimers Dis. 2022;85:1529-1544.
    PubMed     Abstract available


  1009. SUN Y, Wang M, Zhao Y, Hu K, et al
    A Pathway-Specific Polygenic Risk Score Is Associated with Tau Pathology and Cognitive Decline.
    J Alzheimers Dis. 2022;85:1745-1754.
    PubMed     Abstract available


  1010. KHAN N, Alimova Y, Clark SJ, Vekaria HJ, et al
    Human APOE varepsilon3 and APOE varepsilon4 Alleles Have Differential Effects on Mouse Olfactory Epithelium.
    J Alzheimers Dis. 2022;85:1481-1494.
    PubMed     Abstract available


  1011. KHORANI M, Bobe G, Matthews DG, Magana AA, et al
    The Impact of the hAPP695SW Transgene and Associated Amyloid-beta Accumulation on Murine Hippocampal Biochemical Pathways.
    J Alzheimers Dis. 2022;85:1601-1619.
    PubMed     Abstract available


  1012. CHENG J, Fairchild JK, McNerney MW, Noda A, et al
    Repetitive Transcranial Magnetic Stimulation as a Treatment for Veterans with Cognitive Impairment and Multiple Comorbidities.
    J Alzheimers Dis. 2022;85:1593-1600.
    PubMed     Abstract available


  1013. GAO Z, Zhang R, Jiang L, Zhou H, et al
    Administration of miR-195 Inhibitor Enhances Memory Function Through Improving Synaptic Degradation and Mitochondrial Dysfunction of the Hippocampal Neurons in SAMP8 Mice.
    J Alzheimers Dis. 2022;85:1495-1509.
    PubMed     Abstract available


  1014. WANG G, Zhou W, Kong D, Qu Z, et al
    Studying APOE varepsilon4 Allele Dose Effects with a Univariate Morphometry Biomarker.
    J Alzheimers Dis. 2022;85:1233-1250.
    PubMed     Abstract available


  1015. ZHOU AL, Sharda N, Sarma VV, Ahlschwede KM, et al
    Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-beta Peptides and Insulin.
    J Alzheimers Dis. 2022;85:1031-1044.
    PubMed     Abstract available


  1016. ZHANG XX, Ma YH, Hu HY, Ma LZ, et al
    Late-Life Obesity Associated with Tau Pathology in Cognitively Normal Individuals: The CABLE Study.
    J Alzheimers Dis. 2022;85:877-887.
    PubMed     Abstract available


  1017. BAO J, Liang Z, Gong X, Yu J, et al
    High Fat Diet Mediates Amyloid-beta Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice.
    J Alzheimers Dis. 2022;85:863-876.
    PubMed     Abstract available


  1018. KHAJEHPIRI B, Moghaddam HA, Forouzanfar M, Lashgari R, et al
    Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression.
    J Alzheimers Dis. 2022;85:837-850.
    PubMed     Abstract available


  1019. SHANG X, Hill E, Zhu Z, Liu J, et al
    Macronutrient Intake and Risk of Dementia in Community-Dwelling Older Adults: A Nine-Year Follow-Up Cohort Study.
    J Alzheimers Dis. 2022;85:791-804.
    PubMed     Abstract available


  1020. SIL A, Erfani A, Lamb N, Copland R, et al
    Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model.
    J Alzheimers Dis. 2022;85:755-778.
    PubMed     Abstract available


  1021. TALAN J
    Obituary for John Q. Trojanowski, leading Alzheimer's Disease Researcher.
    J Alzheimers Dis. 2022;86:1-3.
    PubMed    


  1022. SHAFIR A, Ritchie CS, Garrett SB, Bernstein Sideman A, et al
    "Captive by the Uncertainty"-Experiences with Anticipatory Guidance for People Living with Dementia and Their Caregivers at a Specialty Dementia Clinic.
    J Alzheimers Dis. 2022;86:787-800.
    PubMed     Abstract available


  1023. KUNDU P, Zimmerman B, Quinn JF, Kaye J, et al
    Serum Levels of alpha-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function.
    J Alzheimers Dis. 2022;86:1471-1481.
    PubMed     Abstract available


  1024. WEINSTEIN G, O'Donnell A, Davis-Plourde K, Zelber-Sagi S, et al
    Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-beta and Tau Pathology in Middle-Aged Adults: The Framingham Study.
    J Alzheimers Dis. 2022;86:1371-1383.
    PubMed     Abstract available


  1025. CHAN CK, Pettigrew C, Soldan A, Zhu Y, et al
    Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden.
    J Alzheimers Dis. 2022;86:1415-1426.
    PubMed     Abstract available


  1026. OWENS L, Bracewell J, Benedetto A, Dawson N, et al
    BACE1 Overexpression Reduces SH-SY5Y Cell Viability Through a Mechanism Distinct from Amyloid-beta Peptide Accumulation: Beta Prime-Mediated Competitive Depletion of sAbetaPPalpha.
    J Alzheimers Dis. 2022;86:1201-1220.
    PubMed     Abstract available


  1027. TANAKA T, Gyanwali B, Villaraza SG, Saridin FN, et al
    The Association Between Standard Electrocardiography and Cerebral Small Vessel Disease in a Memory Clinic Study.
    J Alzheimers Dis. 2022;86:1093-1105.
    PubMed     Abstract available


  1028. SAJI N, Murotani K, Sato N, Tsuduki T, et al
    Relationship Between Plasma Neurofilament Light Chain, Gut Microbiota, and Dementia: A Cross-Sectional Study.
    J Alzheimers Dis. 2022;86:1323-1335.
    PubMed     Abstract available


  1029. TIAN Q, Bilgel M, Moghekar AR, Ferrucci L, et al
    Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2022;86:1275-1285.
    PubMed     Abstract available


  1030. O'BRYANT SE, Zhang F, Petersen M, Hall JR, et al
    Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.
    J Alzheimers Dis. 2022;86:1243-1254.
    PubMed     Abstract available


  1031. DORAISWAMY PM, Goldberg TE, Qian M, Linares AR, et al
    Validity of the Web-Based, Self-Directed, NeuroCognitive Performance Test in Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:1131-1136.
    PubMed     Abstract available


  1032. RICE M, Davalos D, Thomas ML
    A Systematic Review of Prospective Memory Interventions Across Stages of Dementia-Related Disorders.
    J Alzheimers Dis. 2022;86:1001-1024.
    PubMed     Abstract available


  1033. ZHU Z, Zeng Q, Zhang R, Luo X, et al
    White Matter Free Water Outperforms Cerebral Small Vessel Disease Total Score in Predicting Cognitive Decline in Persons with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:741-751.
    PubMed     Abstract available


  1034. CEYZERIAT K, Tournier BB, Millet P, Dipasquale G, et al
    Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice.
    J Alzheimers Dis. 2022;86:641-653.
    PubMed     Abstract available


  1035. CHEN WT, Chi NF, Cheng HM, Ko YT, et al
    Associations Between Cerebral Vasoreactivity and Cognitive Function in the Middle-Aged Non-Demented Population.
    J Alzheimers Dis. 2022;86:679-690.
    PubMed     Abstract available


  1036. HSU YH, Huang SM, Lin SY, Yang JJ, et al
    Prospective Memory and Default Mode Network Functional Connectivity in Normal and Pathological Aging.
    J Alzheimers Dis. 2022;86:753-762.
    PubMed     Abstract available


  1037. CARDOSO S, Silva D, Alves L, Guerreiro M, et al
    The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:629-640.
    PubMed     Abstract available


  1038. YANG Z, Sheng X, Qin R, Chen H, et al
    Cognitive Improvement via Left Angular Gyrus-Navigated Repetitive Transcranial Magnetic Stimulation Inducing the Neuroplasticity of Thalamic System in Amnesic Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2022;86:537-551.
    PubMed     Abstract available


  1039. JOSEPHS KA, Pham NTT, Graff-Radford J, Machulda MM, et al
    Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.
    J Alzheimers Dis. 2022;86:491-498.
    PubMed     Abstract available


  1040. LEVY B, Priest A, Delaney T, Hogan J, et al
    Toward Pre-Diagnostic Detection of Dementia in Primary Care.
    J Alzheimers Dis. 2022;86:479-490.
    PubMed     Abstract available


  1041. SOHN BK, Byun MS, Yi D, Jeon SY, et al
    Late-Life Physical Activities Moderate the Relationship of Amyloid-beta Pathology with Neurodegeneration in Individuals Without Dementia.
    J Alzheimers Dis. 2022;86:441-450.
    PubMed     Abstract available


  1042. LIU M, Guo S, Huang D, Hu D, et al
    Chronic Alcohol Exposure Alters Gene Expression and Neurodegeneration Pathways in the Brain of Adult Mice.
    J Alzheimers Dis. 2022;86:315-331.
    PubMed     Abstract available


  1043. ZHANG LN, Li MJ, Shang YH, Liu YR, et al
    Zeaxanthin Attenuates the Vicious Circle Between Endoplasmic Reticulum Stress and Tau Phosphorylation: Involvement of GSK-3beta Activation.
    J Alzheimers Dis. 2022;86:191-204.
    PubMed     Abstract available


  1044. DENNISON JL, Volmar CH, Ke D, Wang J, et al
    JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model.
    J Alzheimers Dis. 2022;86:173-190.
    PubMed     Abstract available


  1045. LERCH O, Laczo M, Vyhnalek M, Nedelska Z, et al
    APOEvarepsilon4 Allele Moderates the Association Between Basal Forebrain Nuclei Volumes and Allocentric Navigation in Older Adults Without Dementia.
    J Alzheimers Dis. 2022;86:155-171.
    PubMed     Abstract available


  1046. ZHANG Q, Zhang M, Chen Y, Cao Y, et al
    Nonlinear Relationship of Non-High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011-2014).
    J Alzheimers Dis. 2022;86:125-134.
    PubMed     Abstract available


  1047. HENDERSON C, Knapp M, Martyr A, Gamble LD, et al
    The Use and Costs of Paid and Unpaid Care for People with Dementia: Longitudinal Findings from the IDEAL Cohort.
    J Alzheimers Dis. 2022;86:135-153.
    PubMed     Abstract available


  1048. O'BRYANT SE, Petersen M, Hall J, Johnson L, et al
    Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study.
    J Alzheimers Dis. 2022;86:1745-1750.
    PubMed     Abstract available


  1049. HU H, Fu JT, Bi YL, Ma YH, et al
    Tau Pathologies Mediate the Association of Cigarette Smoking with Cognitive Impairment in Older Adults Without Dementia: The CABLE Study.
    J Alzheimers Dis. 2022;86:1849-1859.
    PubMed     Abstract available


  1050. ZHANG L, Fu Y, Zhao Z, Cong Z, et al
    Analysis of Hippocampus Evolution Patterns and Prediction of Conversion in Mild Cognitive Impairment Using Multivariate Morphometry Statistics.
    J Alzheimers Dis. 2022;86:1695-1710.
    PubMed     Abstract available


  1051. PARKER AF, Ohlhauser L, Scarapicchia V, Smart CM, et al
    A Systematic Review of Neuroimaging Studies Comparing Individuals with Subjective Cognitive Decline to Healthy Controls.
    J Alzheimers Dis. 2022;86:1545-1567.
    PubMed     Abstract available


  1052. SANDBERG AA, Manning E, Wilkins HM, Mazzarino R, et al
    Mitochondrial Targeting of Amyloid-beta Protein Precursor Intracellular Domain Induces Hippocampal Cell Death via a Mechanism Distinct from Amyloid-beta.
    J Alzheimers Dis. 2022;86:1727-1744.
    PubMed     Abstract available


  1053. LI C, Liu M, Xia J, Mei L, et al
    Predicting Brain Amyloid-beta PET Grades with Graph Convolutional Networks Based on Functional MRI and Multi-Level Functional Connectivity.
    J Alzheimers Dis. 2022;86:1679-1693.
    PubMed     Abstract available


  1054. KONCZ R, Wen W, Makkar SR, Lam BCP, et al
    The Interaction Between Vascular Risk Factors, Cerebral Small Vessel Disease, and Amyloid Burden in Older Adults.
    J Alzheimers Dis. 2022;86:1617-1628.
    PubMed     Abstract available


  1055. RAHMANI F, Wang Q, McKay NS, Keefe S, et al
    Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.
    J Alzheimers Dis. 2022;86:1831-1848.
    PubMed     Abstract available


  1056. ASHFORD JW, Schmitt FA, Bergeron MF, Bayley PJ, et al
    Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement.
    J Alzheimers Dis. 2022;87:305-315.
    PubMed     Abstract available


  1057. MORTON H, Basu T, Bose C, Reddy PH, et al
    Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study.
    J Alzheimers Dis. 2022;87:33-49.
    PubMed     Abstract available


  1058. CLEMENT A, Madsen MJ, Kastaniegaard K, Wiborg O, et al
    Chronic Stress Induces Hippocampal Mitochondrial Damage in APPPS1 Model Mice and Wildtype Littermates.
    J Alzheimers Dis. 2022;87:259-272.
    PubMed     Abstract available


  1059. SOO SA, Zailan FZ, Tan JY, Sandhu GK, et al
    Safety and Usefulness of Lumbar Puncture for the Diagnosis and Management of Young-Onset Cognitive Disorders.
    J Alzheimers Dis. 2022;87:479-488.
    PubMed     Abstract available


  1060. NING J, Huang SY, Chen SD, Zhang YR, et al
    Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.
    J Alzheimers Dis. 2022;87:211-222.
    PubMed     Abstract available


  1061. KUCIKIENE D, Costa AS, Banning LCP, van Gils V, et al
    The Role of Vascular Risk Factors in Biomarker-Based AT(N) Groups: A German-Dutch Memory Clinic Study.
    J Alzheimers Dis. 2022;87:185-195.
    PubMed     Abstract available


  1062. DHARMARAJ GL, Arigo FD, Young KA, Martins R, et al
    Novel Amylin Analogues Reduce Amyloid-beta Cross-Seeding Aggregation and Neurotoxicity.
    J Alzheimers Dis. 2022;87:373-390.
    PubMed     Abstract available


  1063. MARINO GAMMAZZA A, Restivo V, Baschi R, Caruso Bavisotto C, et al
    Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabut Aging Project.
    J Alzheimers Dis. 2022;87:161-172.
    PubMed     Abstract available


  1064. HOSSEINI AA, Brown T, Mannino L, Gran B, et al
    Clinical Utility of Cerebrospinal Fluid Abeta42 and Tau Measures in Diagnosing Mild Cognitive Impairment in Early Onset Dementia.
    J Alzheimers Dis. 2022;87:771-780.
    PubMed     Abstract available


  1065. ZHANG R, Jiang L, Li G, Wu J, et al
    Advanced Glycosylation End Products Induced Synaptic Deficits and Cognitive Decline Through ROS-JNK-p53/miR-34c/SYT1 Axis in Diabetic Encephalopathy.
    J Alzheimers Dis. 2022;87:843-861.
    PubMed     Abstract available


  1066. GIRTLER N, Chincarini A, Brugnolo A, Doglione E, et al
    The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort.
    J Alzheimers Dis. 2022;87:887-899.
    PubMed     Abstract available


  1067. LIU X, Yan J, Liu F, Zhou P, et al
    Overexpression of REST Causes Neuronal Injury and Decreases Cofilin Phosphorylation in Mice.
    J Alzheimers Dis. 2022;87:873-886.
    PubMed     Abstract available


  1068. SOLOMON V, Hafez M, Xian H, Harrington MG, et al
    An Association Between Saturated Fatty Acid-Containing Phosphatidylcholine in Cerebrospinal Fluid with Tau Phosphorylation.
    J Alzheimers Dis. 2022;87:609-617.
    PubMed     Abstract available


  1069. MARTINEZ-HERRERA M, Figueroa-Gerstenmaier S, Lopez-Camacho PY, Millan-Pacheco C, et al
    Multiadducts of C60 Modulate Amyloid-beta Fibrillation with Dual Acetylcholinesterase Inhibition and Antioxidant Properties: In Vitro and In Silico Studies.
    J Alzheimers Dis. 2022;87:741-759.
    PubMed     Abstract available


  1070. GRANGEON L, Paquet C, Guey S, Zarea A, et al
    Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Abeta42, and Abeta40 in Probable Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;87:791-802.
    PubMed     Abstract available


  1071. SIVASARAVANAPARAN M, Olesen LO, Severino M, von Linstow CU, et al
    Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1DeltaE9 Transgenic Mice.
    J Alzheimers Dis. 2022;87:685-699.
    PubMed     Abstract available


  1072. GE X, Qiao Y, Choi J, Raman R, et al
    Enhanced Association of Tau Pathology and Cognitive Impairment in Mild Cognitive Impairment Subjects with Behavior Symptoms.
    J Alzheimers Dis. 2022;87:557-568.
    PubMed     Abstract available


  1073. ICHIMATA S, Yoshida K, Visanji NP, Lang AE, et al
    Patterns of Mixed Pathologies in Down Syndrome.
    J Alzheimers Dis. 2022;87:595-607.
    PubMed     Abstract available


  1074. WHITEHOUSE PJ, Saini V
    Making the Case for the Accelerated Withdrawal of Aducanumab.
    J Alzheimers Dis. 2022;87:999-1001.
    PubMed     Abstract available


  1075. SCHWERTNER E, Pereira JB, Xu H, Secnik J, et al
    Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals.
    J Alzheimers Dis. 2022;87:1307-1318.
    PubMed     Abstract available


  1076. HAN SH, Noh DH, Jo EJ, Kam KY, et al
    Effects of Apolipoprotein E varepsilon4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia.
    J Alzheimers Dis. 2022;87:1181-1188.
    PubMed     Abstract available


  1077. RIPPON B, Palta P, Tahmi M, Sherwood G, et al
    Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.
    J Alzheimers Dis. 2022;87:1229-1238.
    PubMed     Abstract available


  1078. SHIMOSAKA M, Nishimoto H, Kinoshita A
    Analysis of the Clock-Reading Ability in Patients with Cognitive Impairment: Comparison of Analog Clocks and Digital Clocks.
    J Alzheimers Dis. 2022;87:1151-1165.
    PubMed     Abstract available


  1079. SHENG C, Yang K, He B, Li T, et al
    Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design.
    J Alzheimers Dis. 2022;87:1319-1333.
    PubMed     Abstract available


  1080. JEONG S, Huang LK, Tsai MJ, Liao YT, et al
    Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways.
    J Alzheimers Dis. 2022;87:1115-1130.
    PubMed     Abstract available


  1081. WHITEHOUSE P, Gandy S, Saini V, George DR, et al
    Making the Case for Accelerated Withdrawal of Aducanumab.
    J Alzheimers Dis. 2022;87:1003-1007.
    PubMed     Abstract available


  1082. SARTO J, Maya G, Molina-Porcel L, Balasa M, et al
    Evolution of Clinical-Pathological Correlations in Early-Onset Alzheimer's Disease Over a 25-Year Period in an Academic Brain Bank.
    J Alzheimers Dis. 2022;87:1659-1669.
    PubMed     Abstract available


  1083. MCCARTER SJ, Lesnick TG, Lowe VJ, Rabinstein AA, et al
    Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.
    J Alzheimers Dis. 2022;87:1537-1547.
    PubMed     Abstract available


  1084. SHAW BC, Snider HC, Turner AK, Zajac DJ, et al
    An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain.
    J Alzheimers Dis. 2022;87:1647-1657.
    PubMed     Abstract available


  1085. ZHAO X, Du W, Jiang J, Han Y, et al
    Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study.
    J Alzheimers Dis. 2022;87:1581-1589.
    PubMed     Abstract available


  1086. CASTILLO-PASSI RI, Vergara RC, Rogers NK, Ponce DP, et al
    Cancer History Is Associated with Slower Speed of Cognitive Decline in Patients with Amnestic Cognitive Impairment.
    J Alzheimers Dis. 2022;87:1695-1711.
    PubMed     Abstract available


  1087. MCGRATH ER, Beiser AS, O'Donnell A, Yang Q, et al
    Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults.
    J Alzheimers Dis. 2022;87:1517-1526.
    PubMed     Abstract available


  1088. BOMMARITO G, Garibotto V, Frisoni GB, Ribaldi F, et al
    The Biological Substrate of the Motoric Cognitive Risk Syndrome: A Pilot Study Using Amyloid-/Tau-PET and MR Imaging.
    J Alzheimers Dis. 2022;87:1483-1490.
    PubMed     Abstract available


  1089. LIBON DJ, Swenson R, Lamar M, Price CC, et al
    The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future Directions.
    J Alzheimers Dis. 2022;87:1419-1432.
    PubMed     Abstract available


  1090. YEUNG MK, Lee TL, Chan AS
    Prefrontal Activation During Effortful Processing Differentiates Memory Abilities in Adults with Memory Complaints.
    J Alzheimers Dis. 2022;88:301-310.
    PubMed     Abstract available


  1091. ZHANG K, Ma X, Zhang R, Liu Z, et al
    Crosstalk Between Gut Microflora and Vitamin D Receptor SNPs Are Associated with the Risk of Amnestic Mild Cognitive Impairment in a Chinese Elderly Population.
    J Alzheimers Dis. 2022;88:357-373.
    PubMed     Abstract available


  1092. RODDICK KM, Fertan E, Schellinck HM, Brown RE, et al
    A Signal Detection Analysis of Olfactory Learning in 12-Month-Old 5xFAD Mice.
    J Alzheimers Dis. 2022;88:37-44.
    PubMed     Abstract available


  1093. BLUJUS JK, Korthauer LE, Awe E, Frahmand M, et al
    BDNF and KIBRA Polymorphisms Are Related to Altered Resting State Network Connectivity in Middle Age.
    J Alzheimers Dis. 2022;88:323-334.
    PubMed     Abstract available


  1094. AGGER MP, Carstensen MS, Henney MA, Hansen LS, et al
    Novel Invisible Spectral Flicker Induces 40 Hz Neural Entrainment with Similar Spatial Distribution as 40 Hz Stroboscopic Light.
    J Alzheimers Dis. 2022;88:335-344.
    PubMed     Abstract available


  1095. DROUIN SM, McFall GP, Potvin O, Bellec P, et al
    Data-Driven Analyses of Longitudinal Hippocampal Imaging Trajectories: Discrimination and Biomarker Prediction of Change Classes.
    J Alzheimers Dis. 2022;88:97-115.
    PubMed     Abstract available


  1096. HARPER JD, Fan KH, Aslam MM, Snitz BE, et al
    Genome-Wide Association Study of Incident Dementia in a Community-Based Sample of Older Subjects.
    J Alzheimers Dis. 2022;88:787-798.
    PubMed     Abstract available


  1097. HAEHNER A, Chen B, Espin M, Haussmann R, et al
    Training with Odors Impacts Hippocampal Thickness in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:743-755.
    PubMed     Abstract available


  1098. GARCIA-ROLDAN E, Arriola-Infante JE, Mendez-Barrio C, Montiel-Herrera F, et al
    Testing Visual Binding by the TMA-93 in People Aged 75 and Over.
    J Alzheimers Dis. 2022;88:503-512.
    PubMed     Abstract available


  1099. WANIGATUNGA AA, Liu F, Wang H, Urbanek JK, et al
    Daily Physical Activity Patterns as a Window on Cognitive Diagnosis in the Baltimore Longitudinal Study of Aging (BLSA).
    J Alzheimers Dis. 2022;88:459-469.
    PubMed     Abstract available


  1100. AGUILAR-CALVO P, Sevillano AM, Rasool S, Cao KJ, et al
    Noninvasive Antemortem Detection of Retinal Prions by a Fluorescent Tracer.
    J Alzheimers Dis. 2022;88:1137-1145.
    PubMed     Abstract available


  1101. NOVOTNY JS, Gonzalez-Rivas JP, Vassilaki M, Krell-Roesch J, et al
    Natural Pattern of Cognitive Aging.
    J Alzheimers Dis. 2022;88:1147-1155.
    PubMed     Abstract available


  1102. LORETO F, Fitzgerald A, Golemme M, Gunning S, et al
    Prevalence of Depressive Symptoms in a Memory Clinic Cohort: A Retrospective Study.
    J Alzheimers Dis. 2022;88:1179-1187.
    PubMed     Abstract available


  1103. MABROUK R, Gotkiewicz M, Rauramaa T, Tanila H, et al
    DAPI (4',6-diamidino-2-phenylindole) Stains Compact Amyloid Plaques.
    J Alzheimers Dis. 2022;88:949-955.
    PubMed     Abstract available


  1104. STOILJKOVIC M, Gutierrez KO, Kelley C, Horvath TL, et al
    TREM2 Deficiency Disrupts Network Oscillations Leading to Epileptic Activity and Aggravates Amyloid-beta-Related Hippocampal Pathophysiology in Mice.
    J Alzheimers Dis. 2022;88:837-847.
    PubMed     Abstract available


  1105. BOUJELBANE MA, Trabelsi K, Boukhris O, Kacem FH, et al
    The Use of Digital Technology to Assess Cognitive Function in Tunisian Adults.
    J Alzheimers Dis. 2022;88:1545-1552.
    PubMed     Abstract available


  1106. ZHU MH, Jogdand AH, Jang J, Nagella SC, et al
    Evoked Cortical Depolarizations Before and After the Amyloid Plaque Accumulation: Voltage Imaging Study.
    J Alzheimers Dis. 2022;88:1443-1458.
    PubMed     Abstract available


  1107. ZHANG X, Cong R, Geng T, Zhang J, et al
    Assessment of the Causal Effect of IgG N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2022;88:1435-1441.
    PubMed     Abstract available


  1108. TSUJIMOTO M, Suzuki K, Saji N, Sakurai T, et al
    Organized Registration for the Assessment of Dementia by the Nationwide General Consortium Toward Effective Treatment (ORANGE) Registry: Current Status and Perspectives of Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1423-1433.
    PubMed     Abstract available


  1109. POLCHER A, Wolfsgruber S, Peters O, Frolich L, et al
    A Comparison of Operational Definitions for Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1663-1678.
    PubMed     Abstract available


  1110. HE XY, Dobkin C, Brown WT, Yang SY, et al
    3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17beta-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
    J Alzheimers Dis. 2022;88:1487-1497.
    PubMed     Abstract available


  1111. RUBIN-NOROWITZ M, Lipton RB, Petersen K, Ezzati A, et al
    Association of Depressive Symptoms and Cognition in Older Adults Without Dementia Across Different Biomarker Profiles.
    J Alzheimers Dis. 2022;88:1385-1395.
    PubMed     Abstract available


  1112. GOLDBERG SM, Zhao Y, Cheng Y, Weinstein AM, et al
    Clinical Progression of Baseline Risk States for Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1377-1384.
    PubMed     Abstract available


  1113. VYHNALEK M, Jester DJ, Andel R, Horakova H, et al
    Contribution of Memory Tests to Early Identification of Conversion from Amnestic Mild Cognitive Impairment to Dementia.
    J Alzheimers Dis. 2022;88:1397-1409.
    PubMed     Abstract available


  1114. SAITO S, Yamashiro T, Yamauchi M, Yamamoto Y, et al
    Complement 3 Is a Potential Biomarker for Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;89:381-387.
    PubMed     Abstract available


  1115. ZHANG DD, Ou YN, Fu Y, Wang ZB, et al
    Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies.
    J Alzheimers Dis. 2022;89:367-380.
    PubMed     Abstract available


  1116. WANG S, Gustafson S, Deckelman C, Sampene E, et al
    Dysphagia Profiles Among Inpatients with Dementia Referred for Swallow Evaluation.
    J Alzheimers Dis. 2022;89:351-358.
    PubMed     Abstract available


  1117. ZHANG Y, Yang Y, Hu Z, Zhu M, et al
    Long-Term Depression-Inducing Low Frequency Stimulation Enhances p-Tau181 and p-Tau217 in an Age-Dependent Manner in Live Rats.
    J Alzheimers Dis. 2022;89:335-350.
    PubMed     Abstract available


  1118. HUFFELS CFM, van Dijk RE, Karst H, Meye FJ, et al
    Systemic Injection of Aged Blood Plasma in Adult C57BL/6 Mice Induces Neurophysiological Impairments in the Hippocampal CA1.
    J Alzheimers Dis. 2022;89:283-297.
    PubMed     Abstract available


  1119. HEAL M, McFall GP, Vergote D, Jhamandas JH, et al
    Bridging Integrator 1 (BIN1, rs6733839) and Sex Are Moderators of Vascular Health Predictions of Memory Aging Trajectories.
    J Alzheimers Dis. 2022;89:265-281.
    PubMed     Abstract available


  1120. KAMATH V, Senjem ML, Spychalla AJ, Chen H, et al
    The Neuroanatomic Correlates of Olfactory Identification Impairment in Healthy Older Adults and in Persons with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;89:233-245.
    PubMed     Abstract available


  1121. CERAMI C, Perdixi E, Meli C, Marcone A, et al
    Early Identification of Different Behavioral Phenotypes in the Behavioral Variant of Frontotemporal Dementia with the Aid of the Mini-Frontal Behavioral Inventory (mini-FBI).
    J Alzheimers Dis. 2022;89:299-308.
    PubMed     Abstract available


  1122. MIOTTO EC, Brucki SMD, Cerqueira CT, Bazan PR, et al
    Episodic Memory, Hippocampal Volume, and Function for Classification of Mild Cognitive Impairment Patients Regarding Amyloid Pathology.
    J Alzheimers Dis. 2022;89:181-192.
    PubMed     Abstract available


  1123. FAN Y, Liu W, Chen S, Li M, et al
    Association Between High Serum Tetrahydrofolate and Low Cognitive Functions in the United States: A Cross-Sectional Study.
    J Alzheimers Dis. 2022;89:163-179.
    PubMed     Abstract available


  1124. SANDHU GK, Zailan FZ, Vipin A, Ann SS, et al
    Correlation Between Plasma Oligomeric Amyloid-beta and Performance on the Language Neutral Visual Cognitive Assessment Test in a Southeast Asian Population.
    J Alzheimers Dis. 2022;89:25-29.
    PubMed     Abstract available


  1125. ZHOU K, Wu P
    Osteoarthritis and APOE4 Interact to Influence Memory Decline in Non-Demented Older People.
    J Alzheimers Dis. 2022;89:79-86.
    PubMed     Abstract available


  1126. LI C, Li Y, Wu J, Wu M, et al
    Triple Network Model-Based Analysis on Abnormal Core Brain Functional Network Dynamics in Different Stage of Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;89:519-533.
    PubMed     Abstract available


  1127. WEIGAND AJ, Macomber AJ, Walker KS, Edwards L, et al
    Interactive Effects of Pulse Pressure and Tau Imaging on Longitudinal Cognition.
    J Alzheimers Dis. 2022;89:633-640.
    PubMed     Abstract available


  1128. CAO QL, Sun Y, Hu H, Wang ZT, et al
    Association of Cerebral Small Vessel Disease Burden with Neuropsychiatric Symptoms in Non-Demented Elderly: A Longitudinal Study.
    J Alzheimers Dis. 2022;89:583-592.
    PubMed     Abstract available


  1129. RUSSO M, Santilli M, De Rosa MA, Calisi D, et al
    A Young Man with Cognitive Impairment and a Heart Condition.
    J Alzheimers Dis. 2022;89:405-410.
    PubMed     Abstract available


  1130. LIU S, Liu C, Hu W, Ji Y, et al
    Frequency, Severity, and Duration of Autonomic Symptoms in Patients of Prodromal Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022;89:923-929.
    PubMed     Abstract available


  1131. DARTORA CM, de Moura LV, Koole M, Marques da Silva AM, et al
    Discriminating Aging Cognitive Decline Spectrum Using PET and Magnetic Resonance Image Features.
    J Alzheimers Dis. 2022;89:977-991.
    PubMed     Abstract available


  1132. ZHANG S, Wei D, Lv S, Wang L, et al
    Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice.
    J Alzheimers Dis. 2022;89:955-975.
    PubMed     Abstract available


  1133. KANG DW, Wang SM, Um YH, Kim NY, et al
    Associations Between Sub-Threshold Amyloid-beta Deposition, Cortical Volume, and Cognitive Function Modulated by APOE varepsilon4 Carrier Status in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2022;89:1003-1016.
    PubMed     Abstract available


  1134. VASSILAKI M, Crowson CS, Davis Iii JM, Duong SQ, et al
    Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.
    J Alzheimers Dis. 2022;89:943-954.
    PubMed     Abstract available


  1135. DIAZ A, Martin-Jimenez C, Woo Y, Merino P, et al
    Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical Neurons.
    J Alzheimers Dis. 2022;89:877-891.
    PubMed     Abstract available


  1136. WATTS A, Chalise P, Hu J, Hui D, et al
    A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change.
    J Alzheimers Dis. 2022;89:913-922.
    PubMed     Abstract available


  1137. PICCARDUCCI R, Caselli MC, Zappelli E, Ulivi L, et al
    The Role of Amyloid-beta, Tau, and alpha-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;89:1039-1049.
    PubMed     Abstract available


  1138. MATSUZAKI TADA A, Hamezah HS, Pahrudin Arrozi A, Abu Bakar ZH, et al
    Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice.
    J Alzheimers Dis. 2022;89:835-848.
    PubMed     Abstract available


  1139. JUAREZ-CEDILLO T, Gonzelez-Figueroa E, Gutierez-Gutierez L, Aguilar-Navarro SG, et al
    Prevalence of Dementia and Main Subtypes in Mexico: The Study on Aging and Dementia in Mexico (SADEM).
    J Alzheimers Dis. 2022;89:931-941.
    PubMed     Abstract available


  1140. SANCHEZ-DE-LARA-SANCHEZ S, Sanchez-Perez AM
    Probiotics Treatment Can Improve Cognition in Patients with Mild Cognitive Impairment: A Systematic Review.
    J Alzheimers Dis. 2022;89:1173-1191.
    PubMed     Abstract available


  1141. MORROW CB, Chaney GS, Capuzzi D, Bakker A, et al
    Hyperorality in Frontotemporal Dementia: Cognitive and Psychiatric Symptom Profiles in Early-Stage Disease.
    J Alzheimers Dis. 2022;89:1203-1209.
    PubMed     Abstract available


  1142. NYHOLM E, Torkpoor R, Frolich K, Londos E, et al
    A Retrospective Study on Clinical Assessment of Cognitive Impairment in a Swedish Cohort: Is There Inequality Between Natives and Foreign-Born?
    J Alzheimers Dis. 2022;89:1403-1412.
    PubMed     Abstract available


  1143. ZAWAR I, Mattos MK, Manning C, Quigg M, et al
    Sleep Disturbances, Cognitive Status, and Biomarkers of Dementia.
    J Alzheimers Dis. 2022;89:1367-1374.
    PubMed     Abstract available


  1144. WEIBLE AP, Wehr M
    Amyloid Pathology in the Central Auditory Pathway of 5XFAD Mice Appears First in Auditory Cortex.
    J Alzheimers Dis. 2022;89:1385-1402.
    PubMed     Abstract available


  1145. MICHOPOULOU S, Prosser A, Kipps C, Dickson J, et al
    Biomarkers of Inflammation Increase with Tau and Neurodegeneration but not with Amyloid-beta in a Heterogenous Clinical Cohort.
    J Alzheimers Dis. 2022;89:1303-1314.
    PubMed     Abstract available


  1146. GENTREAU M, Reynes C, Sabatier R, Maller JJ, et al
    Glucometabolic Changes Are Associated with Structural Gray Matter Alterations in Prodromal Dementia.
    J Alzheimers Dis. 2022;89:1293-1302.
    PubMed     Abstract available


  1147. KANAGASINGAM S, von Ruhland C, Welbury R, Singhrao SK, et al
    Antimicrobial, Polarizing Light, and Paired Helical Filament Properties of Fragmented Tau Peptides of Selected Putative Gingipains.
    J Alzheimers Dis. 2022;89:1279-1291.
    PubMed     Abstract available


  1148. BERDYNSKI M, Ludwiczak J, Barczak A, Barcikowska-Kotowicz M, et al
    TREM2 Gene Compound Heterozygosity in Neurodegenerative Disorders.
    J Alzheimers Dis. 2022;89:1211-1219.
    PubMed     Abstract available


  1149. MIAO Y, Cui L, Li J, Chen Y, et al
    Cognitive Improvement After Multi-Domain Lifestyle Interventions in an APOE varepsilon4 Homozygous Carrier with Mild Cognitive Impairment: A Case Report and Literature Review.
    J Alzheimers Dis. 2022;89:1131-1142.
    PubMed     Abstract available


  1150. LACHNER C, Day GS, Camsari GB, Kouri N, et al
    Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.
    J Alzheimers Dis. 2022;90:405-417.
    PubMed     Abstract available


  1151. MATTIOLI P, Pardini M, Girtler N, Brugnolo A, et al
    Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-Synucleinopathy.
    J Alzheimers Dis. 2022;90:433-444.
    PubMed     Abstract available


  1152. LOEWENSTEIN DA, Curiel Cid RE, Kitaigorodsky M, Ortega A, et al
    Persistent Failure to Recover from Proactive Semantic Interference on the Cognitive Stress Test Differentiates Between Amnestic Mild Cognitive Impairment, Pre-Mild Cognitive Impairment, and Cognitively Unimpaired Older Adults.
    J Alzheimers Dis. 2022;90:313-322.
    PubMed     Abstract available


  1153. THOMAS KR, Bangen KJ, Weigand AJ, Ortiz G, et al
    Cognitive Heterogeneity and Risk of Progression in Data-Driven Subtle Cognitive Decline Phenotypes.
    J Alzheimers Dis. 2022;90:323-331.
    PubMed     Abstract available


  1154. FU J, Zhu Y, Sun Y, Liu Q, et al
    Circulating Amyloid-beta and Methionine-Related Metabolites to Predict the Risk of Mild Cognitive Impairment: A Nested Case-Control Study.
    J Alzheimers Dis. 2022;90:389-404.
    PubMed     Abstract available


  1155. VAN HARTEN TW, Heijmans A, van Rooden S, Wermer MJH, et al
    Brain Deep Medullary Veins on 7T MRI in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;90:381-388.
    PubMed     Abstract available


  1156. BOLSEWIG K, Hok-A-Hin YS, Sepe FN, Boonkamp L, et al
    A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
    J Alzheimers Dis. 2022;90:363-380.
    PubMed     Abstract available


  1157. WEI S, Dang L, Gao F, Wang J, et al
    Effects of Simvastatin on Plasma Amyloid-beta Transport in Patients with Hyperlipidemia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial.
    J Alzheimers Dis. 2022;90:349-362.
    PubMed     Abstract available


  1158. PENG Y, Zhang L, Zhou F, Wang Y, et al
    Scavenging Reactive Oxygen Species Decreases Amyloid-beta Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells.
    J Alzheimers Dis. 2022;90:185-198.
    PubMed     Abstract available


  1159. VALLES-SALGADO M, Cabrera-Martin MN, Curiel-Cid RE, Delgado-Alvarez A, et al
    Neuropsychological, Metabolic, and Connectivity Underpinnings of Semantic Interference Deficits Using the LASSI-L.
    J Alzheimers Dis. 2022;90:823-840.
    PubMed     Abstract available


  1160. SHEPHERD-BANIGAN ME, Ford CB, Smith VA, Belanger E, et al
    Amyloid-beta PET Scan Results Disclosure and Care-Partner Emotional Well-Being Over Time.
    J Alzheimers Dis. 2022;90:775-782.
    PubMed     Abstract available


  1161. RABI R, Chow R, Paracha S, Hasher L, et al
    Time of Day Effects on Inhibitory Functioning: Cognitive and Neural Evidence of Sundowning in Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;90:869-890.
    PubMed     Abstract available


  1162. BLIVET G, Relano-Gines A, Wachtel M, Touchon J, et al
    A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance.
    J Alzheimers Dis. 2022;90:811-822.
    PubMed     Abstract available


  1163. AERQIN Q, Jia SS, Shen XN, Li Q, et al
    Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study.
    J Alzheimers Dis. 2022;90:761-773.
    PubMed     Abstract available


  1164. YANG YH, Hsieh SW, Chang HW, Sung JL, et al
    Gamma Frequency Inhibits the Secretion and Aggregation of Amyloid-beta and Decreases the Phosphorylation of mTOR and Tau Proteins in vitro.
    J Alzheimers Dis. 2022;90:917-928.
    PubMed     Abstract available


  1165. O'BRYANT SE, Petersen M, Hall J, Johnson LA, et al
    Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites.
    J Alzheimers Dis. 2022;90:905-915.
    PubMed     Abstract available


  1166. ROVCANIN DRAGOVIC I, Popovic N, Zdralevic M, Radulovic L, et al
    Inflammation-Related microRNAs-146a and -155 Are Upregulated in Mild Cognitive Impairment Subjects Among Older Age Population in Montenegro.
    J Alzheimers Dis. 2022;90:625-638.
    PubMed     Abstract available


  1167. WANG Z, Wang J, Liu N, Liu C, et al
    Learning Cognitive-Test-Based Interpretable Rules for Prediction and Early Diagnosis of Dementia Using Neural Networks.
    J Alzheimers Dis. 2022;90:609-624.
    PubMed     Abstract available


  1168. VIPIN A, Koh CL, Wong BYX, Zailan FZ, et al
    Amyloid-Tau-Neurodegeneration Profiles and Longitudinal Cognition in Sporadic Young-Onset Dementia.
    J Alzheimers Dis. 2022;90:543-551.
    PubMed     Abstract available


  1169. SONG Y, Quan M, Li T, Jia J, et al
    Serum Homocysteine, Vitamin B12, Folate, and Their Association with Mild Cognitive Impairment and Subtypes of Dementia.
    J Alzheimers Dis. 2022;90:681-691.
    PubMed     Abstract available


  1170. JOSHI MS, Galvin JE
    Cognitive Resilience in Brain Health and Dementia Research.
    J Alzheimers Dis. 2022;90:461-473.
    PubMed     Abstract available


  1171. WALTER S, Taylor A, Tyrone J, Langer S, et al
    Disclosing Individual Results in Dementia Research: A Proposed Study Participant's Bill of Rights.
    J Alzheimers Dis. 2022;90:945-952.
    PubMed     Abstract available


  1172. SHEN J, Li M, Long C, Yang L, et al
    Altered Odor-Evoked Electrophysiological Responses in the Anterior Piriform Cortex of Conscious APP/PS1 Mice.
    J Alzheimers Dis. 2022;90:1277-1289.
    PubMed     Abstract available


  1173. GAN J, Chen Z, Shi Z, Li X, et al
    Temporal Variation in Disease Onset and Clinical Features of Lewy Body Disease in China.
    J Alzheimers Dis. 2022;90:1263-1275.
    PubMed     Abstract available


  1174. HARRISON KL, Garrett SB, Halim M, Bernstein Sideman A, et al
    "I Didn't Sign Up for This": Perspectives from Persons Living with Dementia and Care Partners on Challenges, Supports, and Opportunities to Add Geriatric Neuropalliative Care to Dementia Specialty Care.
    J Alzheimers Dis. 2022;90:1301-1320.
    PubMed     Abstract available


  1175. SHI X, Zhou N, Sun B, Wu Y, et al
    Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology.
    J Alzheimers Dis. 2022;90:1329-1337.
    PubMed     Abstract available


  1176. WU S, Hu L, Lin J, Li K, et al
    Excretion of Amyloid-beta in the Gastrointestinal Tract and Regulation by the Gut Microbiota.
    J Alzheimers Dis. 2022;90:1153-1162.
    PubMed     Abstract available


  1177. ROSEN AC, Arias JJ, Ashford JW, Blacker D, et al
    The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All.
    J Alzheimers Dis. 2022;90:953-962.
    PubMed     Abstract available


  1178. WALTER S, Kim AB, Flores M, Ziolkowski J, et al
    Including General Audiences in a Virtual Scientific Dementia Conference: Will They Get Anything From It?
    J Alzheimers Dis. 2022;90:1001-1009.
    PubMed     Abstract available


  1179. LERNER AJ
    Biomarkers and Mindfulness: A Way Forward.
    J Alzheimers Dis. 2022;90:993-996.
    PubMed     Abstract available


  1180. DALY T, Mastroleo I, Migliaccio R
    Avoiding Over-Reliance on Multi-Domain Interventions for Dementia Prevention.
    J Alzheimers Dis. 2022;90:989-992.
    PubMed     Abstract available


  1181. REN S, Hu J, Huang L, Li J, et al
    Graph Analysis of Functional Brain Topology Using Minimum Spanning Tree in Subjective Cognitive Decline.
    J Alzheimers Dis. 2022;90:1749-1759.
    PubMed     Abstract available


  1182. LIBARD S, Giedraitis V, Kilander L, Ingelsson M, et al
    Mixed Pathologies in a Subject with a Novel PSEN1 G206R Mutation.
    J Alzheimers Dis. 2022;90:1601-1614.
    PubMed     Abstract available


    December 2021
  1183. DAY S, Roberts S, Launder NH, Goh AMY, et al
    Age of Symptom Onset and Longitudinal Course of Sporadic Alzheimer's Disease, Frontotemporal Dementia, and Vascular Dementia: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215360. doi: 10.3233/JAD-215360.
    PubMed     Abstract available


  1184. WANG J, Wang P, Jiang Y, Wang Z, et al
    Hippocampus-Based Dynamic Functional Connectivity Mapping in the Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215239. doi: 10.3233/JAD-215239.
    PubMed     Abstract available


  1185. GIANNAKOPOULOS P, Rodriguez C, Montandon ML, Garibotto V, et al
    Personality Impact on Alzheimer's Disease-Signature and Vascular Imaging Markers: A PET-MRI Study.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215062. doi: 10.3233/JAD-215062.
    PubMed     Abstract available


  1186. BLACK SAG, Stepanchuk AA, Templeton GW, Hernandez Y, et al
    Diagnosing Alzheimer's Disease from Circulating Blood Leukocytes Using a Fluorescent Amyloid Probe.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215402. doi: 10.3233/JAD-215402.
    PubMed     Abstract available


  1187. LIU Q, Ling Z, Zhang J, Yu H, et al
    lncRNA MIR600HG Knockdown Alleviates Cognitive Impairment in Alzheimer's Disease Through NEDD4L Mediated PINK1 Degradation.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215194. doi: 10.3233/JAD-215194.
    PubMed     Abstract available


  1188. BROBERG D, Wong D, Bellyou M, Montero-Odasso M, et al
    Effects of Memantine and High Dose Vitamin D on Gait in Male APP/PS1 Alzheimer's Disease Mice Following Vitamin D Deprivation.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215188. doi: 10.3233/JAD-215188.
    PubMed     Abstract available


  1189. JANG H, Park YH, Choe YS, Kang SH, et al
    Amyloid Positive Hydrocephalus: A Hydrocephalic Variant of Alzheimer's Disease?
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215110. doi: 10.3233/JAD-215110.
    PubMed     Abstract available


  1190. DUNK MM, Driscoll I
    Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215091. doi: 10.3233/JAD-215091.
    PubMed     Abstract available


  1191. AHN H, Yi D, Chu K, Joung H, et al
    Functional Neural Correlates of Semantic Fluency Task Performance in Mild Cognitive Impairment and Alzheimer's Disease: An FDG-PET Study.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215292. doi: 10.3233/JAD-215292.
    PubMed     Abstract available


  1192. DHAYNAUT M, Sprugnoli G, Cappon D, Macone J, et al
    Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer's Disease: A Case Series.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215072. doi: 10.3233/JAD-215072.
    PubMed     Abstract available


  1193. DONG L, Mao C, Liu C, Li J, et al
    Association Between Common Variants of APOE, ABCA7, A2M, BACE1, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: Data from the PUMCH Dementia Cohort.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215067. doi: 10.3233/JAD-215067.
    PubMed     Abstract available


  1194. ZHAO Y, Bao J, Liu W, Gong X, et al
    Spatial Training Attenuates Long-Term Alzheimer's Disease-Related Pathogenic Processes in APP/PS1 Mice.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215016. doi: 10.3233/JAD-215016.
    PubMed     Abstract available


  1195. MASSETTI N, Russo M, Franciotti R, Nardini D, et al
    A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD210573. doi: 10.3233/JAD-210573.
    PubMed     Abstract available


  1196. GOLDSMITH HS
    Alzheimer's Disease: A Decreased Cerebral Blood Flow to Critical Intraneuronal Elements is the Cause.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215479. doi: 10.3233/JAD-215479.
    PubMed     Abstract available


  1197. ZHANG H, Lyu D, Jia J
    The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer's Disease Continuum: A Longitudinal Study.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215456. doi: 10.3233/JAD-215456.
    PubMed     Abstract available


  1198. SUO WZ
    GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215379. doi: 10.3233/JAD-215379.
    PubMed     Abstract available


  1199. SCHAEFER SY, Malek-Ahmadi M, Hooyman A, King JB, et al
    Association Between Motor Task Performance and Hippocampal Atrophy Across Cognitively Unimpaired, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease Individuals.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD210665. doi: 10.3233/JAD-210665.
    PubMed     Abstract available


  1200. YUEN SC, Lee SM, Leung SW
    Putative Factors Interfering Cell Cycle Re-Entry in Alzheimer's Disease: An Omics Study with Differential Expression Meta-Analytics and Co-Expression Profiling.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215349. doi: 10.3233/JAD-215349.
    PubMed     Abstract available


  1201. KWAK S, Oh DJ, Jeon YJ, Oh DY, et al
    Utility of Machine Learning Approach with Neuropsychological Tests in Predicting Functional Impairment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215244. doi: 10.3233/JAD-215244.
    PubMed     Abstract available


  1202. TROPEA MR, Sanfilippo G, Giannino F, Davi V, et al
    Innate Preferences Affect Results of Object Recognition Task in Wild Type and Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215209. doi: 10.3233/JAD-215209.
    PubMed     Abstract available


  1203. RAMOS C, Villalba C, Garcia J, Lanata S, et al
    Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215169. doi: 10.3233/JAD-215169.
    PubMed     Abstract available


  1204. YANG L, Xuan C, Yu C, Zheng P, et al
    Diagnostic Model of Alzheimer's Disease in the Elderly Based on Protein and Metabolic Biomarkers.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215119. doi: 10.3233/JAD-215119.
    PubMed     Abstract available


  1205. SUN HL, Zhou FY, Chen DW, Tan CR, et al
    The Correlation of Tau Levels with Blood Monocyte Count in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD210692. doi: 10.3233/JAD-210692.
    PubMed     Abstract available


  1206. SALAMI A, Adolfsson R, Andersson M, Blennow K, et al
    Association of APOE varepsilon4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
    J Alzheimers Dis. 2021 Dec 16. pii: JAD210673. doi: 10.3233/JAD-210673.
    PubMed     Abstract available


  1207. VON LINSTOW CU, Waider J, Bergh MS, Anzalone M, et al
    The Combined Effects of Amyloidosis and Serotonin Deficiency by Tryptophan Hydroxylase-2 Knockout Impacts Viability of the APP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 16. pii: JAD210581. doi: 10.3233/JAD-210581.
    PubMed     Abstract available


  1208. FAN F, Liu H, Shi X, Ai Y, et al
    The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215423. doi: 10.3233/JAD-215423.
    PubMed     Abstract available


  1209. CHAUDHARY S, Zhornitsky S, Chao HH, van Dyck CH, et al
    Cerebral Volumetric Correlates of Apathy in Alzheimer's Disease and Cognitively Normal Older Adults: Meta-Analysis, Label-Based Review, and Study of an Independent Cohort.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215316. doi: 10.3233/JAD-215316.
    PubMed     Abstract available


  1210. TEIPEL SJ, Dyrba M, Ballarini T, Brosseron F, et al
    Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215196. doi: 10.3233/JAD-215196.
    PubMed     Abstract available


  1211. SMITH CA, Smith H, Roberts L, Coward L, et al
    Probiotic Releasing Angiotensin (1-7) in a Drosophila Model of Alzheimer's Disease Produces Sex-Specific Effects on Cognitive Function.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD210464. doi: 10.3233/JAD-210464.
    PubMed     Abstract available


  1212. SUN X, Zhang H, Yao D, Xu Y, et al
    Integrated Bioinformatics Analysis Identifies Hub Genes Associated with Viral Infection and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215232. doi: 10.3233/JAD-215232.
    PubMed     Abstract available


  1213. WEN C, Bi YL, Hu H, Huang SY, et al
    Association of Subjective Cognitive Decline with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215178. doi: 10.3233/JAD-215178.
    PubMed     Abstract available


  1214. SCHUBERT CR, Paulsen AJ, Pinto AA, Merten N, et al
    Effect of Long-Term Storage on the Reliability of Blood Biomarkers for Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215096. doi: 10.3233/JAD-215096.
    PubMed     Abstract available


  1215. LI W, Zhao Z, Liu M, Yan S, et al
    Multimodal Classification of Alzheimer's Disease and Amnestic Mild Cognitive Impairment: Integrated 18F-FDG PET and DTI Study.
    J Alzheimers Dis. 2021 Dec 10. pii: JAD215338. doi: 10.3233/JAD-215338.
    PubMed     Abstract available


  1216. TALAN J
    Reactive Astrocytes and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215436. doi: 10.3233/JAD-215436.
    PubMed    


  1217. YOO TJ
    Anti-Inflammatory Gene Therapy Improves Spatial Memory Performance in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215270. doi: 10.3233/JAD-215270.
    PubMed     Abstract available


  1218. CUTULI D, Landolfo E, Petrosini L, Gelfo F, et al
    Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215193. doi: 10.3233/JAD-215193.
    PubMed     Abstract available


  1219. KOUKI MA, Pritchard AB, Alder JE, Crean S, et al
    Do Periodontal Pathogens or Associated Virulence Factors Have a Deleterious Effect on the Blood-Brain Barrier, Contributing to Alzheimer's Disease?
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215103. doi: 10.3233/JAD-215103.
    PubMed     Abstract available


  1220. BRITZ J, Ojo E, Dhukhwa A, Saito T, et al
    Assessing Sex-Specific Circadian, Metabolic, and Cognitive Phenotypes in the AbetaPP/PS1 and APPNL - F/NL - F Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210629. doi: 10.3233/JAD-210629.
    PubMed     Abstract available


  1221. SACCHI L, Carandini T, Fumagalli GG, Pietroboni AM, et al
    Unravelling the Association Between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+?
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210593. doi: 10.3233/JAD-210593.
    PubMed     Abstract available


  1222. KOTHAPALLI SVVN, Benzinger TL, Aschenbrenner AJ, Perrin RJ, et al
    Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210503. doi: 10.3233/JAD-210503.
    PubMed     Abstract available


  1223. SAKR F, Dyrba M, Brauer AU, Teipel S, et al
    Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD201504. doi: 10.3233/JAD-201504.
    PubMed     Abstract available


  1224. SENEJANI AG, Maghsoudlou J, El-Zohiry D, Gaur G, et al
    Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues.
    J Alzheimers Dis. 2021 Dec 5. pii: JAD215398. doi: 10.3233/JAD-215398.
    PubMed     Abstract available


  1225. KURODA T, Honma M, Mori Y, Futamura A, et al
    White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 2. pii: JAD215187. doi: 10.3233/JAD-215187.
    PubMed     Abstract available


  1226. LIU XX, Wu PF, Liu YZ, Jiang YL, et al
    Association Between Serum Vitamins and the Risk of Alzheimer's Disease in Chinese Populatio.
    J Alzheimers Dis. 2021 Dec 2. pii: JAD215104. doi: 10.3233/JAD-215104.
    PubMed     Abstract available


    November 2021
  1227. METSLA K, Kirss S, Laks K, Sildnik G, et al
    alpha-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 30. pii: JAD215026. doi: 10.3233/JAD-215026.
    PubMed     Abstract available


  1228. CHEN L, Shen Q, Xu S, Yu H, et al
    5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215217. doi: 10.3233/JAD-215217.
    PubMed     Abstract available


  1229. CRESTINI A, Santilli F, Martellucci S, Carbone E, et al
    Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215171. doi: 10.3233/JAD-215171.
    PubMed     Abstract available


  1230. SAPKOTA S, McFall GP, Masellis M, Dixon RA, et al
    Differential Cognitive Decline in Alzheimer's Disease Is Predicted by Changes in Ventricular Size but Moderated by Apolipoprotein E and Pulse Pressure.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215068. doi: 10.3233/JAD-215068.
    PubMed     Abstract available


  1231. HAOUDY S, Jonveaux T, Puisieux S, Epstein J, et al
    Epilepsy in Early Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD210681. doi: 10.3233/JAD-210681.
    PubMed     Abstract available


  1232. NESHAN M, Malakouti SK, Kamalzadeh L, Makvand M, et al
    Alterations in T-Cell Transcription Factors and Cytokine Gene Expression in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD210480. doi: 10.3233/JAD-210480.
    PubMed     Abstract available


  1233. GE F, Dong L, Zhu D, Lin X, et al
    Comparison of Serum Triiodothyronine with Biomarkers for Alzheimer's Disease Continuum in Euthyroid Subjects.
    J Alzheimers Dis. 2021 Nov 27. pii: JAD215092. doi: 10.3233/JAD-215092.
    PubMed     Abstract available


  1234. ALTOMARI N, Bruno F, Lagana V, Smirne N, et al
    A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 27. pii: JAD215061. doi: 10.3233/JAD-215061.
    PubMed     Abstract available


  1235. WANG L, Chen H, Tang J, Guo Z, et al
    Peptidylarginine Deiminase and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 23. pii: JAD215302. doi: 10.3233/JAD-215302.
    PubMed     Abstract available


  1236. LARNER AJ, Marson AG
    Epileptic Seizures in Alzheimer's Disease: What Are the Implications of SANAD II?
    J Alzheimers Dis. 2021 Nov 23. pii: JAD215154. doi: 10.3233/JAD-215154.
    PubMed     Abstract available


  1237. BROD SA
    Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD215125. doi: 10.3233/JAD-215125.
    PubMed     Abstract available


  1238. SUN X, Suo X, Xia X, Yu C, et al
    Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD215074. doi: 10.3233/JAD-215074.
    PubMed     Abstract available


  1239. LYNN J, Park M, Ogunwale C, Acquaah-Mensah GK, et al
    A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD210612. doi: 10.3233/JAD-210612.
    PubMed     Abstract available


  1240. QIAO Y, Sun Y, Guo J, Chen Y, et al
    Disrupted White Matter Integrity and Cognitive Functions in Amyloid-beta Positive Alzheimer's Disease with Concomitant Lobar Cerebral Microbleeds.
    J Alzheimers Dis. 2021 Nov 20. pii: JAD215251. doi: 10.3233/JAD-215251.
    PubMed     Abstract available


  1241. BERGAMINO M, Keeling EG, Baxter LC, Sisco NJ, et al
    Sex Differences in Alzheimer's Disease Revealed by Free-Water Diffusion Tensor Imaging and Voxel-Based Morphometry.
    J Alzheimers Dis. 2021 Nov 20. pii: JAD210406. doi: 10.3233/JAD-210406.
    PubMed     Abstract available


  1242. REALE M, Carrarini C, Russo M, Dono F, et al
    Muscarinic Receptors Expression in the Peripheral Blood Cells Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD215285. doi: 10.3233/JAD-215285.
    PubMed     Abstract available


  1243. BARTHELEMY NR, Toth B, Manser PT, Sanabria-Bohorquez S, et al
    Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD210677. doi: 10.3233/JAD-210677.
    PubMed     Abstract available


  1244. HOY KE, Emonson MRL, Bailey NW, Humble G, et al
    Investigating Neurophysiological Markers of Symptom Severity in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD210401. doi: 10.3233/JAD-210401.
    PubMed     Abstract available


  1245. NOGUCHI-SHINOHARA M, Yuki-Nozaki S, Abe C, Mori A, et al
    Diabetes Mellitus, Elevated Hemoglobin A1c, and Glycated Albumin Are Associated with the Presence of All-Cause Dementia and Alzheimer's Disease: The JPSC-AD Study.
    J Alzheimers Dis. 2021 Nov 15. pii: JAD215153. doi: 10.3233/JAD-215153.
    PubMed     Abstract available


  1246. CHUM PP, Hakim MA, Behringer EJ
    Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.
    J Alzheimers Dis. 2021 Nov 12. pii: JAD215223. doi: 10.3233/JAD-215223.
    PubMed     Abstract available


  1247. KUMARI S, Singh A, Singh AK, Yadav Y, et al
    Circulatory GSK-3beta: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215347. doi: 10.3233/JAD-215347.
    PubMed     Abstract available


  1248. MULLER EG, Edwin TH, Strand BH, Stokke C, et al
    Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215046. doi: 10.3233/JAD-215046.
    PubMed     Abstract available


  1249. NIHASHI T, Sakurai K, Kato T, Iwata K, et al
    Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215024. doi: 10.3233/JAD-215024.
    PubMed     Abstract available


  1250. TAN Y, Zhang J, Yang K, Xu Z, et al
    Anti-Stroke Chinese Herbal Medicines Inhibit Abnormal Amyloid-beta Protein Precursor Processing in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD210652. doi: 10.3233/JAD-210652.
    PubMed     Abstract available


  1251. DIPROSPERO ND, Keator DB, Phelan M, van Erp TGM, et al
    Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD210572. doi: 10.3233/JAD-210572.
    PubMed     Abstract available


  1252. FRANKLIN GL, Meira AT, Barbosa MT, Teive HAG, et al
    When My Child Has Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215234. doi: 10.3233/JAD-215234.
    PubMed     Abstract available


  1253. FATIMA SHAD K, Soubra W, Cordato DJ
    The Auditory Afferent Pathway as a Clinical Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215206. doi: 10.3233/JAD-215206.
    PubMed     Abstract available


  1254. CHEN KL, Li PX, Sun YM, Chen SF, et al
    Very Early-Onset Alzheimer's Disease in the Third Decade of Life with de novo PSEN1 Mutations.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215167. doi: 10.3233/JAD-215167.
    PubMed     Abstract available


  1255. WANG F, Xu J, Xu SJ, Guo JJ, et al
    Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215086. doi: 10.3233/JAD-215086.
    PubMed     Abstract available


  1256. PAVLIK VN, Burnham SC, Kass JS, Helmer C, et al
    Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration Network.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD210525. doi: 10.3233/JAD-210525.
    PubMed     Abstract available


  1257. FU X, Liu Q, Sun X, Chang H, et al
    Research Advances in the Treatment of Alzheimer's Disease with Polysaccharides of Danggui-Shaoyao-San.
    J Alzheimers Dis. 2021 Nov 7. pii: JAD210656. doi: 10.3233/JAD-210656.
    PubMed     Abstract available


    October 2021
  1258. MANDAL PK, Perry G
    SWADESH: A Comprehensive Platform for Multimodal Data and Analytics for Advanced Research in Alzheimer's Disease and Other Brain Disorders.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD215354. doi: 10.3233/JAD-215354.
    PubMed    


  1259. SAKURAI K, Iwase T, Kaneda D, Uchida Y, et al
    Sloping Shoulders Sign: A Practical Radiological Sign for the Differentiation of Alzheimer's Disease and Argyrophilic Grain Disease.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD210638. doi: 10.3233/JAD-210638.
    PubMed    


  1260. MATTHIESEN ST, Rosenkjaer S, Ponten M, Jensen KB, et al
    Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer's Disease Patients: A Meta-Analysis and Critical Discussion.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD210108. doi: 10.3233/JAD-210108.
    PubMed     Abstract available


  1261. BJORKLI C, Louet C, Flo TH, Hemler M, et al
    In Vivo Microdialysis in Mice Captures Changes in Alzheimer's Disease Cerebrospinal Fluid Biomarkers Consistent with Developing Pathology.
    J Alzheimers Dis. 2021 Oct 29. pii: JAD210715. doi: 10.3233/JAD-210715.
    PubMed     Abstract available


  1262. JEONG HJ, Lee YM, Park JM, Lee BD, et al
    Reduced Thickness of the Anterior Cingulate Cortex as a Predictor of Amnestic-Mild Cognitive Impairment Conversion to Alzheimer's Disease with Psychosis.
    J Alzheimers Dis. 2021 Oct 26. pii: JAD215005. doi: 10.3233/JAD-215005.
    PubMed     Abstract available


  1263. SCHULTZ B, Taday J, Menezes L, Cigerce A, et al
    Calpain-Mediated Alterations in Astrocytes Before and During Amyloid Chaos in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD215182. doi: 10.3233/JAD-215182.
    PubMed     Abstract available


  1264. TORRES AK, Jara C, Park-Kang HS, Polanco CM, et al
    Synaptic Mitochondria: An Early Target of Amyloid-beta and Tau in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD215139. doi: 10.3233/JAD-215139.
    PubMed     Abstract available


  1265. RUSANEN M, Selander T, Karkkainen V, Koivisto A, et al
    The Positive Effects of Pet Ownership on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210557. doi: 10.3233/JAD-210557.
    PubMed     Abstract available


  1266. HIN N, Newman M, Pederson S, Lardelli M, et al
    Iron Responsive Element-Mediated Responses to Iron Dyshomeostasis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210200. doi: 10.3233/JAD-210200.
    PubMed     Abstract available


  1267. SHOJAIE M, Tabarestani S, Cabrerizo M, DeKosky ST, et al
    PET Imaging of Tau Pathology and Amyloid-beta, and MRI for Alzheimer's Disease Feature Fusion and Multimodal Classification.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210064. doi: 10.3233/JAD-210064.
    PubMed     Abstract available


  1268. KARAMI V, Nittari G, Traini E, Amenta F, et al
    An Optimized Decision Tree with Genetic Algorithm Rule-Based Approach to Reveal the Brain's Changes During Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Oct 23. pii: JAD210626. doi: 10.3233/JAD-210626.
    PubMed     Abstract available


  1269. ZHANG Q, Schultz JL, Aldridge GM, Simmering JE, et al
    COVID-19 Case Fatality and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD215161. doi: 10.3233/JAD-215161.
    PubMed     Abstract available


  1270. BRUUS AE, Waldemar G, Vogel A
    Impairment of Episodic-Specific Autobiographical Memory in Individuals with Subjective Cognitive Decline and in Patients with Prodromal or Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD215113. doi: 10.3233/JAD-215113.
    PubMed     Abstract available


  1271. CLUTE-REINIG N, Jayadev S, Rhoads K, Ny AL, et al
    Alzheimer's Disease Diagnostics Must Be Globally Accessible.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD210663. doi: 10.3233/JAD-210663.
    PubMed     Abstract available


  1272. VRILLON A, Deramecourt V, Pasquier F, Magnin E, et al
    Association of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: New Entity or Coincidence? A Case Series.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215226. doi: 10.3233/JAD-215226.
    PubMed     Abstract available


  1273. ISMAEL S, Mirzahosseini G, Ahmed HA, Yoo A, et al
    Renin-Angiotensin System Alterations in the Human Alzheimer's Disease Brain.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215051. doi: 10.3233/JAD-215051.
    PubMed     Abstract available


  1274. SWERDLOW NR, Kotz JE, Joshi YB, Talledo J, et al
    Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215029. doi: 10.3233/JAD-215029.
    PubMed     Abstract available


  1275. HAN F, Zhao J, Zhao G
    Prolonged Volatile Anesthetic Exposure Exacerbates Cognitive Impairment and Neuropathology in the 5xFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD210374. doi: 10.3233/JAD-210374.
    PubMed     Abstract available


  1276. HU D, Liu C, Xia K, Abramowitz A, et al
    Characterizing the Resilience Effect of Neurodegeneration for the Mechanistic Pathway of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD215160. doi: 10.3233/JAD-215160.
    PubMed     Abstract available


  1277. LIU H, Lutz M, Luo S
    Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD210700. doi: 10.3233/JAD-210700.
    PubMed     Abstract available


  1278. HOFMANN C, Sander A, Wang XX, Buerge M, et al
    Inhalational Anesthetics Do Not Deteriorate Amyloid-beta-Derived Pathophysiology in Alzheimer's Disease: Investigations on the Molecular, Neuronal, and Behavioral Level.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD201185. doi: 10.3233/JAD-201185.
    PubMed     Abstract available


  1279. KURKINEN M, Tran L
    Aduhelm: The Best Hope for Alzheimer's Disease Patients or the Worst Decision the FDA Has Ever Made?
    J Alzheimers Dis. 2021 Oct 10. pii: JAD215105. doi: 10.3233/JAD-215105.
    PubMed    


  1280. ARANDELOVIC J, Santrac A, Batinic B, Todorovic L, et al
    Positive and Negative Selective Allosteric Modulators of alpha5 GABAA Receptors: Effects on Emotionality, Motivation, and Motor Function in the 5xFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 10. pii: JAD215079. doi: 10.3233/JAD-215079.
    PubMed     Abstract available


  1281. OH C
    Single-Task or Dual-Task? Gait Assessment as a Potential Diagnostic Tool for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 8. pii: JAD210690. doi: 10.3233/JAD-210690.
    PubMed     Abstract available


  1282. SILHAN D, Pashkovska O, Bartos A
    Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 8. pii: JAD210372. doi: 10.3233/JAD-210372.
    PubMed     Abstract available


  1283. SHUKLA D, Mandal PK, Mishra R, Punjabi K, et al
    Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease: An in vivo MRS Study.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD215032. doi: 10.3233/JAD-215032.
    PubMed     Abstract available


  1284. WASHIDA K, Kitajima E, Tanaka T, Ikeda S, et al
    A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD215006. doi: 10.3233/JAD-215006.
    PubMed     Abstract available


  1285. KIM H, Jun S, Kim BS, Kim IJ, et al
    Serum Adiponectin in Alzheimer's Disease (AD): Association with AD Biomarkers and Cognitive Outcome.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD210722. doi: 10.3233/JAD-210722.
    PubMed     Abstract available


  1286. PACHECO-HERRERO M, Soto-Rojas LO, Reyes-Sabater H, Garces-Ramirez L, et al
    Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD200863. doi: 10.3233/JAD-200863.
    PubMed     Abstract available


  1287. SHAFIEE N, Dadar M, Ducharme S, Collins DL, et al
    Automatic Prediction of Cognitive and Functional Decline Can Significantly Decrease the Number of Subjects Required for Clinical Trials in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 1. pii: JAD210664. doi: 10.3233/JAD-210664.
    PubMed     Abstract available


    September 2021
  1288. PANDEY JP, Namboodiri AM, Nietert PJ, Barnes LL, et al
    Inhibitory Fcgamma Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 30. pii: JAD215174. doi: 10.3233/JAD-215174.
    PubMed     Abstract available


  1289. ROBINSON AC, Davidson YS, Roncaroli F, Minshull J, et al
    Telephone Interview for Cognitive Status Scores Associate with Cognitive Impairment and Alzheimer's Disease Pathology at Death.
    J Alzheimers Dis. 2021 Sep 30. pii: JAD215102. doi: 10.3233/JAD-215102.
    PubMed     Abstract available


  1290. LARGENT EA, Bhardwaj T, Abera M, Stites SD, et al
    Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II).
    J Alzheimers Dis. 2021 Sep 30. pii: JAD210675. doi: 10.3233/JAD-210675.
    PubMed     Abstract available


  1291. STANITSA E, Economou A, Beratis I, Kontaxopoulou D, et al
    Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Sep 29. pii: JAD210622. doi: 10.3233/JAD-210622.
    PubMed     Abstract available


  1292. SONG XJ, Zhou HY, Sun YY, Huang HC, et al
    Phosphorylation and Glycosylation of Amyloid-beta Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 29. pii: JAD210337. doi: 10.3233/JAD-210337.
    PubMed     Abstract available


  1293. SONG J, Yang X, Zhang M, Wang C, et al
    Glutamate Metabolism in Mitochondria is Closely Related to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210595. doi: 10.3233/JAD-210595.
    PubMed     Abstract available


  1294. HAO J, Qiao Y, Li T, Yang J, et al
    Investigating Changes in the Serum Inflammatory Factors in Alzheimer's Disease and Their Correlation with Cognitive Function.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210552. doi: 10.3233/JAD-210552.
    PubMed     Abstract available


  1295. MATSUZONO K, Suzuki M, Miura K, Ozawa T, et al
    Internal Jugular Vein Velocity and Spontaneous Echo Contrast Correlate with Alzheimer's Disease and Cognitive Function.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210490. doi: 10.3233/JAD-210490.
    PubMed     Abstract available


  1296. FUKUDA H, Ono R, Maeda M, Murata F, et al
    Medical Care and Long-Term Care Expenditures Attributable to Alzheimer's Disease Onset: Results from the LIFE Study.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD201508. doi: 10.3233/JAD-201508.
    PubMed     Abstract available


  1297. LENNON MJ, Rigney G, Raymont V, Sachdev P, et al
    Genetic Therapies for Alzheimer's Disease: A Scoping Review.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD215145. doi: 10.3233/JAD-215145.
    PubMed     Abstract available


  1298. WANG Q, Dong X, Zhang R, Zhao C, et al
    Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD210735. doi: 10.3233/JAD-210735.
    PubMed     Abstract available


  1299. NAN H, Kim YJ, Tsuchiya M, Fukao T, et al
    A Novel Heterozygous Missense Variant in the CIAO1 Gene in a Family with Alzheimer's Disease: The Val67Ile Variant Promotes the Interaction of CIAO1 and Amyloid-beta Protein Precursor.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD210706. doi: 10.3233/JAD-210706.
    PubMed     Abstract available


  1300. BLOCK ML, Kodavanti UP
    The Use of Standardized Diesel Exhaust Particles in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215201. doi: 10.3233/JAD-215201.
    PubMed     Abstract available


  1301. CULIBRK RA, Arabiyat AS, DeKalb CA, Hahn MS, et al
    Modeling Sympathetic Hyperactivity in Alzheimer's Related Bone Loss.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215007. doi: 10.3233/JAD-215007.
    PubMed     Abstract available


  1302. KATZ J, Gao H
    The Alzheimer-E. coli Axis: What Can We Learn from an Electronic Health Record Platform.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215004. doi: 10.3233/JAD-215004.
    PubMed     Abstract available


  1303. CHEN H, Chen F, Zhang M, Chen Y, et al
    A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD210602. doi: 10.3233/JAD-210602.
    PubMed     Abstract available


  1304. KANG SH, Cho H, Shin J, Kim HR, et al
    Clinical Characteristic in Primary Progressive Aphasia in Relation to Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD210392. doi: 10.3233/JAD-210392.
    PubMed     Abstract available


  1305. GOLZARI-SORKHEH M, Brown C, Weaver DF, Reed M, et al
    The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 21. pii: JAD210660. doi: 10.3233/JAD-210660.
    PubMed     Abstract available


  1306. MULAK A
    Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 21. pii: JAD210608. doi: 10.3233/JAD-210608.
    PubMed     Abstract available


  1307. SEO SJ, Chang WS, Jeon JG, Choi Y, et al
    Proton Stimulation Targeting Plaque Magnetite Reduces Amyloid-beta Plaque and Iron Redox Toxicity and Improves Memory in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210739. doi: 10.3233/JAD-210739.
    PubMed     Abstract available


  1308. BRUGULAT-SERRAT A, Canas A, Canals L, Marne P, et al
    Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210640. doi: 10.3233/JAD-210640.
    PubMed     Abstract available


  1309. TARAWNEH HY, Mulders WHAM, Sohrabi HR, Martins RN, et al
    Investigating Auditory Electrophysiological Measures of Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Event-Related Potential Studies.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210556. doi: 10.3233/JAD-210556.
    PubMed     Abstract available


  1310. CIANFLONE A, Coppola L, Mirabelli P, Salvatore M, et al
    Predictive Accuracy of Blood-Derived Biomarkers for Amyloid-beta Brain Deposition Along with the Alzheimer's Disease Continuum: A Systematic Review.
    J Alzheimers Dis. 2021 Sep 17. pii: JAD210496. doi: 10.3233/JAD-210496.
    PubMed     Abstract available


  1311. YAMADA Y, Shinkawa K, Kobayashi M, Caggiano V, et al
    Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Sep 16. pii: JAD210684. doi: 10.3233/JAD-210684.
    PubMed     Abstract available


  1312. ALLEN HB
    A Novel Approach to the Treatment and Prevention of Alzheimer's Disease Based on the Pathology and Microbiology.
    J Alzheimers Dis. 2021 Sep 14. pii: JAD210429. doi: 10.3233/JAD-210429.
    PubMed     Abstract available


  1313. KOLINKO Y, Marsalova L, Pena SP, Kralickova M, et al
    Stereological Changes in Microvascular Parameters in Hippocampus of a Transgenic Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210738. doi: 10.3233/JAD-210738.
    PubMed     Abstract available


  1314. SATO T, Hanyu H, Koyama Y, Horita H, et al
    Discrepancy Between the Degree of Cognitive Impairment and Brain Imaging Abnormalities in Alzheimer's Disease Patients Is Associated with Cognitive Reserve.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210728. doi: 10.3233/JAD-210728.
    PubMed     Abstract available


  1315. ABDULKADIR TS, Dawud FA, Isa AS, Ayo JO, et al
    Taurine and Camel Milk Modulate Neurobehavioral and Biochemical Changes in Aluminum Chloride-Induced Alzheimer's Disease in Rats.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210130. doi: 10.3233/JAD-210130.
    PubMed     Abstract available


  1316. SRIWICHAIIN S, Chattipakorn N, Chattipakorn SC
    Metabolomic Alterations in the Blood and Brain in Association with Alzheimer's Disease: Evidence from in vivo to Clinical Studies.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210737. doi: 10.3233/JAD-210737.
    PubMed     Abstract available


  1317. COLATO E, Chiotis K, Ferreira D, Mazrina MS, et al
    Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210614. doi: 10.3233/JAD-210614.
    PubMed     Abstract available


  1318. WERBER T, Bata Z, Vaszine ES, Berente DB, et al
    The Association of Periodontitis and Alzheimer's Disease: How to Hit Two Birds with One Stone.
    J Alzheimers Dis. 2021 Sep 8. pii: JAD210491. doi: 10.3233/JAD-210491.
    PubMed     Abstract available


  1319. ZHANG XQ, Xu L, Yang SY, Hu LB, et al
    Reduced Synaptic and Intrinsic Excitability of a Subtype of Pyramidal Neurons in the Medial Prefrontal Cortex in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 2. pii: JAD210585. doi: 10.3233/JAD-210585.
    PubMed     Abstract available


  1320. CALDIERARO MA, Laufer-Silva T, Cassano P
    Dosimetry and Clinical Efficacy of Transcranial Photobiomodulation for Major Depression Disorder: Could they Guide Dosimetry for Alzheimer's Disease?
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210586. doi: 10.3233/JAD-210586.
    PubMed     Abstract available


  1321. HE F, Zhang Y, Wu X, Li Y, et al
    Early Microstructure Changes of White Matter Fiber Bundles in Patients with Amnestic Mild Cognitive Impairment Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210495. doi: 10.3233/JAD-210495.
    PubMed     Abstract available


  1322. HADDAD M, Perrotte M, Ben Khedher MR, Madec E, et al
    Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210441. doi: 10.3233/JAD-210441.
    PubMed     Abstract available


    August 2021
  1323. FARACE P, Tamburin S
    Combining Low-Dose Radiation Therapy and Magnetic Resonance Guided Focused Ultrasound to Reduce Amyloid-beta Deposition in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 30. pii: JAD215041. doi: 10.3233/JAD-215041.
    PubMed     Abstract available


  1324. KATZOUROU I, Leonenko G, Ivanov D, Meggy A, et al
    Cognitive Decline in Alzheimer's Disease Is Not Associated with APOE.
    J Alzheimers Dis. 2021 Aug 30. pii: JAD210685. doi: 10.3233/JAD-210685.
    PubMed     Abstract available


  1325. PIEVANI M, Mega A, Quattrini G, Guidali G, et al
    Targeting Default Mode Network Dysfunction in Persons at Risk of Alzheimer's Disease with Transcranial Magnetic Stimulation (NEST4AD): Rationale and Study Design.
    J Alzheimers Dis. 2021 Aug 27. pii: JAD210659. doi: 10.3233/JAD-210659.
    PubMed     Abstract available


  1326. HANDY A, Lord J, Green R, Xu J, et al
    Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 25. pii: JAD210462. doi: 10.3233/JAD-210462.
    PubMed     Abstract available


  1327. LIU Z, Maiti T, Bender AR
    A Role for Prior Knowledge in Statistical Classification of the Transition from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 25. pii: JAD201398. doi: 10.3233/JAD-201398.
    PubMed     Abstract available


  1328. HAMBLIN MR, Salehpour F
    Photobiomodulation of the Brain: Shining Light on Alzheimer's and Other Neuropathological Diseases.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210743. doi: 10.3233/JAD-210743.
    PubMed    


  1329. ZHANG Z, Wang M, Yuan S, Cai H, et al
    Genetically Predicted Coffee Consumption and Risk of Alzheimer's Disease and Stroke.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210678. doi: 10.3233/JAD-210678.
    PubMed     Abstract available


  1330. BOMMARITO G, Van De Ville D, Frisoni GB, Garibotto V, et al
    Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210534. doi: 10.3233/JAD-210534.
    PubMed     Abstract available


  1331. SYVERSTAD SKAARAAS GHE, Melbye C, Puchades MA, Yi Leung DS, et al
    Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer's Disease Associates with Upregulated Angiopoietin and Downregulated Hypoxia-Inducible Factor.
    J Alzheimers Dis. 2021 Aug 21. pii: JAD210571. doi: 10.3233/JAD-210571.
    PubMed     Abstract available


  1332. QURESHI ZP, Thiel E, Nelson J, Khandker R, et al
    Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210713. doi: 10.3233/JAD-210713.
    PubMed     Abstract available


  1333. TOK S, Ahnaou A, Drinkenburg W
    Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210397. doi: 10.3233/JAD-210397.
    PubMed     Abstract available


  1334. GE F, Zhu D, Tian M, Shi J, et al
    The Role of Thyroid Function in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210339. doi: 10.3233/JAD-210339.
    PubMed     Abstract available


  1335. TOFIQ A, Zetterberg H, Blennow K, Basun H, et al
    Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210007. doi: 10.3233/JAD-210007.
    PubMed     Abstract available


  1336. ROBAKIS NK
    On the Nomenclature of the Alzheimer's Disease Amyloid and Its Precursor1.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD215138. doi: 10.3233/JAD-215138.
    PubMed    


  1337. CIOFFI F, Ibrahim Adam RH, Bansal R, Broersen K, et al
    A Review of Oxidative Stress Products and Related Genes in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD210497. doi: 10.3233/JAD-210497.
    PubMed     Abstract available


  1338. MOMMAERTS K, Willemse EAJ, Marchese M, Larue C, et al
    A Cystatin C Cleavage ELISA Assay as a Quality Control Tool for Determining Sub-Optimal Storage Conditions of Cerebrospinal Fluid Samples in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210741. doi: 10.3233/JAD-210741.
    PubMed     Abstract available


  1339. ZANGROSSI A, Montemurro S, Altoe G, Mondini S, et al
    Heterogeneity and Factorial Structure in Alzheimer's Disease: A Cognitive Perspective.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210719. doi: 10.3233/JAD-210719.
    PubMed     Abstract available


  1340. WANG H, Xu Y, Ren R, Yao F, et al
    Ambulatory Blood Pressure Characteristics of Patients with Alzheimer's Disease: A Multicenter Study from China.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210679. doi: 10.3233/JAD-210679.
    PubMed     Abstract available


  1341. YANG HJ, Lee S, Koh MJ, Lee HK, et al
    The Association of White Matter Hyperintensities with Frailty in Patients with Very Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210494. doi: 10.3233/JAD-210494.
    PubMed     Abstract available


  1342. WIMO A, Belger M, Bon J, Jessen F, et al
    A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210303. doi: 10.3233/JAD-210303.
    PubMed     Abstract available


  1343. BARTHOLD D, Gibbons LE, Marcum ZA, Gray SL, et al
    Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.
    J Alzheimers Dis. 2021 Aug 14. pii: JAD210059. doi: 10.3233/JAD-210059.
    PubMed     Abstract available


  1344. SCARTH M, Rissanen I, Scholten RJPM, Geerlings MI, et al
    Biomarkers of Alzheimer's Disease and Cerebrovascular Lesions and Clinical Progression in Patients with Subjective Cognitive Decline: A Systematic Review.
    J Alzheimers Dis. 2021 Aug 13. pii: JAD210218. doi: 10.3233/JAD-210218.
    PubMed     Abstract available


  1345. SCHILD AK, Volk J, Scharfenberg D, Schuermann K, et al
    Social Cognition in Patients with Amnestic Mild Cognitive Impairment and Mild Dementia of the Alzheimer Type.
    J Alzheimers Dis. 2021 Aug 13. pii: JAD201126. doi: 10.3233/JAD-201126.
    PubMed     Abstract available


  1346. REHAN S, Giroud N, Al-Yawer F, Wittich W, et al
    Visual Performance and Cortical Atrophy in Vision-Related Brain Regions Differ Between Older Adults with (or at Risk for) Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 11. pii: JAD201521. doi: 10.3233/JAD-201521.
    PubMed     Abstract available


  1347. FOTE G, Wu J, Mapstone M, Macciardi F, et al
    Plasma Sphingomyelins in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 11. pii: JAD200871. doi: 10.3233/JAD-200871.
    PubMed     Abstract available


  1348. YU Y, Gao Y, Winblad B, Tjernberg L, et al
    A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD215008. doi: 10.3233/JAD-215008.
    PubMed     Abstract available


  1349. PARK M, Baik K, Lee YG, Kang SW, et al
    Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD210669. doi: 10.3233/JAD-210669.
    PubMed     Abstract available


  1350. PUDUMJEE SB, Lundt ES, Albertson SM, Machulda MM, et al
    A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer's Disease Based on Cogstate One Card Learning Accuracy Performance.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD210251. doi: 10.3233/JAD-210251.
    PubMed     Abstract available


  1351. KIM HR, Jang JH, Ham H, Choo SH, et al
    A Case of Early-Onset Alzheimer's Disease Mimicking Schizophrenia in a Patient with Presenilin 1 Mutation (S170P).
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210650. doi: 10.3233/JAD-210650.
    PubMed     Abstract available


  1352. AGUERO P, Sainz MJ, Tellez R, Lorda I, et al
    De Novo PS1 Mutation (Pro436Gln) in a Very Early-Onset Posterior Variant of Alzheimer's Disease Associated with Spasticity: A Case Report.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210420. doi: 10.3233/JAD-210420.
    PubMed     Abstract available


  1353. LI Y, Wang R, Li Q, Wang YJ, et al
    Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210381. doi: 10.3233/JAD-210381.
    PubMed     Abstract available


  1354. RASMUSSEN ID, Boayue NM, Mittner M, Bystad M, et al
    High-Definition Transcranial Direct Current Stimulation Improves Delayed Memory in Alzheimer's Disease Patients: A Pilot Study Using Computational Modeling to Optimize Electrode Position.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210378. doi: 10.3233/JAD-210378.
    PubMed     Abstract available


  1355. TADOKORO K, Yamashita T, Kimura S, Nomura E, et al
    Retinal Amyloid Imaging for Screening Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210327. doi: 10.3233/JAD-210327.
    PubMed     Abstract available


  1356. HE H, Liu A, Zhang W, Yang H, et al
    Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210307. doi: 10.3233/JAD-210307.
    PubMed     Abstract available


  1357. VAN ZELLER M, Dias DM, Sebastiao AM, Valente CA, et al
    NLRP3 Inflammasome: A Starring Role in Amyloid-beta- and Tau-Driven Pathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 4. pii: JAD210268. doi: 10.3233/JAD-210268.
    PubMed     Abstract available


  1358. CAI HY, Yang D, Qiao J, Yang JT, et al
    A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 4. pii: JAD210256. doi: 10.3233/JAD-210256.
    PubMed     Abstract available


  1359. MUKHOPADHYAY S, Banerjee D
    A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD215065. doi: 10.3233/JAD-215065.
    PubMed     Abstract available


  1360. NOUS A, Wittens MMJ, Vermeiren Y, De Deyn PP, et al
    Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer's Disease but Are Not Correlated with Cognitive Decline.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210562. doi: 10.3233/JAD-210562.
    PubMed     Abstract available


  1361. VAN DE MORTEL LA, Thomas RM, van Wingen GA
    Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210173. doi: 10.3233/JAD-210173.
    PubMed     Abstract available


  1362. CARCAMO J, Kociolek AJ, Fernandez KK, Gu Y, et al
    Neuropsychological Predictors of Severe Functional Dependency in a Multiethnic Community Cohort of Individuals with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210019. doi: 10.3233/JAD-210019.
    PubMed     Abstract available


    July 2021
  1363. QIN W, Li W, Wang Q, Gong M, et al
    Race-Related Association between APOE Genotype and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210549. doi: 10.3233/JAD-210549.
    PubMed     Abstract available


  1364. WATSON Y, Nelson B, Kluesner JH, Tanzy C, et al
    Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer's Disease Mice.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210492. doi: 10.3233/JAD-210492.
    PubMed     Abstract available


  1365. LIU P, Yang Q, Yu N, Cao Y, et al
    Phenylalanine Metabolism is Dysregulated in Human Hippocampus with Alzheimer's Disease Related Pathological Changes.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210461. doi: 10.3233/JAD-210461.
    PubMed     Abstract available


  1366. WITTENS MMJ, Sima DM, Houbrechts R, Ribbens A, et al
    Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER Study.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210450. doi: 10.3233/JAD-210450.
    PubMed     Abstract available


  1367. LUCKEY AM, Robertson IH, Lawlor B, Mohan A, et al
    Sex Differences in Locus Coeruleus: A Heuristic Approach That May Explain the Increased Risk of Alzheimer's Disease in Females.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210404. doi: 10.3233/JAD-210404.
    PubMed     Abstract available


  1368. WALDEN LM, Hu S, Madabhushi A, Prescott JW, et al
    Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210308. doi: 10.3233/JAD-210308.
    PubMed     Abstract available


  1369. HLAVKA JP, Kinoshita AT, Fang S, Hunt A, et al
    Clinical Outcome Measure Crosswalks in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210060. doi: 10.3233/JAD-210060.
    PubMed     Abstract available


  1370. SMAILOVIC U, Kareholt I, Koenig T, Ashton NJ, et al
    Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 25. pii: JAD201234. doi: 10.3233/JAD-201234.
    PubMed     Abstract available


  1371. CROSS DJ, Huber BR, Silverman MA, Cline MM, et al
    Intranasal Paclitaxel Alters Alzheimer's Disease Phenotypic Features in 3xTg-AD Mice.
    J Alzheimers Dis. 2021 Jul 23. pii: JAD210109. doi: 10.3233/JAD-210109.
    PubMed     Abstract available


  1372. WANG F, Xu CS, Chen WH, Duan SW, et al
    Identification of Blood-Based Glycolysis Gene Associated with Alzheimer's Disease by Integrated Bioinformatics Analysis.
    J Alzheimers Dis. 2021 Jul 19. pii: JAD210540. doi: 10.3233/JAD-210540.
    PubMed     Abstract available


  1373. NARA PL, Sindelar D, Penn MS, Potempa J, et al
    Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 16. pii: JAD210448. doi: 10.3233/JAD-210448.
    PubMed     Abstract available


  1374. ALEXOPOULOS P, Skondra M, Kontogianni E, Vratsista A, et al
    Validation of the Cognitive Telephone Screening Instruments COGTEL and COGTEL+ in Identifying Clinically Diagnosed Neurocognitive Disorder Due to Alzheimer's Disease in a Naturalistic Clinical Setting.
    J Alzheimers Dis. 2021 Jul 15. pii: JAD210477. doi: 10.3233/JAD-210477.
    PubMed     Abstract available


  1375. DE LA TORRE JC, Gonzalez-Lima F
    The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210736. doi: 10.3233/JAD-210736.
    PubMed    


  1376. CHEN S, Song Y, Xu W, Hu G, et al
    Impaired Memory Awareness and Loss Integration in Self-Referential Network Across the Progression of Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210541. doi: 10.3233/JAD-210541.
    PubMed     Abstract available


  1377. SIBLE IJ, Bangen KJ, Blanken AE, Ho JK, et al
    Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 7. pii: JAD210435. doi: 10.3233/JAD-210435.
    PubMed     Abstract available


  1378. JOSEPH S, Patterson R, Wang W, Blumberger DM, et al
    Quantitative Assessment of Cortical Excitability in Alzheimer's Dementia and Its Association with Clinical Symptoms: A Systematic Review and Meta-Analyses.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210311. doi: 10.3233/JAD-210311.
    PubMed     Abstract available


  1379. BEARDMORE R, Hou R, Darekar A, Holmes C, et al
    The Locus Coeruleus in Aging and Alzheimer's Disease: A Postmortem and Brain Imaging Review.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210191. doi: 10.3233/JAD-210191.
    PubMed     Abstract available


  1380. SQUITTI R, Faller P, Hureau C, Granzotto A, et al
    Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD201556. doi: 10.3233/JAD-201556.
    PubMed     Abstract available


  1381. HOJJATI SH, Feiz F, Ozoria S, Razlighi QR, et al
    Topographical Overlapping of the Amyloid-beta and Tau Pathologies in the Default Mode Network Predicts Alzheimer's Disease with Higher Specificity.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210419. doi: 10.3233/JAD-210419.
    PubMed     Abstract available


  1382. KUWAR R, Rolfe A, Di L, Blevins H, et al
    A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210400. doi: 10.3233/JAD-210400.
    PubMed     Abstract available


    June 2021
  1383. GABRIEL A, Lehner CT, Hohler C, Schneider T, et al
    Anticipatory and Reactive Grip Force Control in Patients with Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210387. doi: 10.3233/JAD-210387.
    PubMed     Abstract available


  1384. BAENA A, Bocanegra Y, Torres V, Vila-Castelar C, et al
    Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210185. doi: 10.3233/JAD-210185.
    PubMed     Abstract available


  1385. FRANK M, Hensel J, Baak L, Schramm S, et al
    Interaction of Alzheimer's Disease-Associated Genetic Risk with Indicators of Socioeconomic Position on Mild Cognitive Impairment in the Heinz Nixdorf Recall Study.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210244. doi: 10.3233/JAD-210244.
    PubMed     Abstract available


  1386. MANCINI G, Dias C, Lourenco CF, Laranjinha J, et al
    A High Fat/Cholesterol Diet Recapitulates Some Alzheimer's Disease-Like Features in Mice: Focus on Hippocampal Mitochondrial Dysfunction.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210122. doi: 10.3233/JAD-210122.
    PubMed     Abstract available


  1387. YAO W, Chen H, Sheng X, Zhao H, et al
    Core-Centered Connection Abnormalities Associated with Pathological Features Mediate the Progress of Cognitive Impairments in Alzheimer's Disease Spectrum Patients.
    J Alzheimers Dis. 2021 Jun 22. pii: JAD210481. doi: 10.3233/JAD-210481.
    PubMed     Abstract available


  1388. CHAUDHARY S, Ashok A, McDonald D, Wise AS, et al
    Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2021 Jun 19. pii: JAD210221. doi: 10.3233/JAD-210221.
    PubMed     Abstract available


  1389. KANG S, Gim J, Lee J, Gunasekaran TI, et al
    Potential Novel Genes for Late-Onset Alzheimer's Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study.
    J Alzheimers Dis. 2021 Jun 18. pii: JAD210145. doi: 10.3233/JAD-210145.
    PubMed     Abstract available


  1390. XU LZ, Li FY, Li BQ, Cao SM, et al
    Decreased Levels of Insulin-Like Growth Factor-1 Are Associated with Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2021 Jun 17. pii: JAD210516. doi: 10.3233/JAD-210516.
    PubMed     Abstract available


  1391. MITOLO M, Stanzani-Maserati M, Manners DN, Capellari S, et al
    The Combination of Metabolic Posterior Cingulate Cortical Abnormalities and Structural Asymmetries Improves the Differential Diagnosis Between Primary Progressive Aphasia and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 17. pii: JAD210211. doi: 10.3233/JAD-210211.
    PubMed     Abstract available


  1392. TARGUM SD, Fosdick L, Drake KE, Rosenberg PB, et al
    Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 16. pii: JAD210530. doi: 10.3233/JAD-210530.
    PubMed     Abstract available


  1393. BAHAR B, Kanagasingam S, Tambuwala MM, Aljabali AAA, et al
    Porphyromonas gingivalis (W83) Infection Induces Alzheimer's Disease-Like Pathophysiology in Obese and Diabetic Mice.
    J Alzheimers Dis. 2021 Jun 16. pii: JAD210465. doi: 10.3233/JAD-210465.
    PubMed     Abstract available


  1394. FRANCOIS M, Karpe A, Liu JW, Beale D, et al
    Salivaomics as a Potential Tool for Predicting Alzheimer's Disease During the Early Stages of Neurodegeneration.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD210283. doi: 10.3233/JAD-210283.
    PubMed     Abstract available


  1395. AKUSHEVICH I, Yashkin AP, Kravchenko J, Yashin AI, et al
    Analysis of Time Trends in Alzheimer's Disease and Related Dementias Using Partitioning Approach.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD210273. doi: 10.3233/JAD-210273.
    PubMed     Abstract available


  1396. PAULO SL, Ribeiro-Rodrigues L, Rodrigues RS, Mateus JM, et al
    Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-beta-Induced Alzheimer's Disease Model.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD201567. doi: 10.3233/JAD-201567.
    PubMed     Abstract available


  1397. FERNANDEZ G, Parra MA
    Oculomotor Behaviors and Integrative Memory Functions in the Alzheimer's Clinical Syndrome.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD201189. doi: 10.3233/JAD-201189.
    PubMed     Abstract available


  1398. ESPAY AJ, Sturchio A, Schneider LS, Ezzat K, et al
    Soluble Amyloid-beta Consumption in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210415. doi: 10.3233/JAD-210415.
    PubMed     Abstract available


  1399. QU M, Shi H, Wang K, Wang X, et al
    The Associations of Plasma/Serum Carotenoids with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210384. doi: 10.3233/JAD-210384.
    PubMed     Abstract available


  1400. LOURENCO MV, Ribeiro FC, Santos LE, Beckman D, et al
    Cerebrospinal Fluid Neurotransmitters, Cytokines, and Chemokines in Alzheimer's and Lewy Body Diseases.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210147. doi: 10.3233/JAD-210147.
    PubMed     Abstract available


  1401. WANG ZT, Li KY, Tan CC, Xu W, et al
    Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210140. doi: 10.3233/JAD-210140.
    PubMed     Abstract available


  1402. BABILONI C, Ferri R, Noce G, Lizio R, et al
    Resting State Alpha Electroencephalographic Rhythms Are Differently Related to Aging in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD201271. doi: 10.3233/JAD-201271.
    PubMed     Abstract available


  1403. CASTILLO-MENDIETA T, Arana-Lechuga Y, Campos-Pena V, Sosa AL, et al
    Plasma Levels of Amyloid-beta Peptides and Tau Protein in Mexican Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 11. pii: JAD200912. doi: 10.3233/JAD-200912.
    PubMed     Abstract available


  1404. SERRA L, D'Amelio M, Esposito S, Domenico CD, et al
    Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer's Disease: Implications for Treatment.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210171. doi: 10.3233/JAD-210171.
    PubMed     Abstract available


  1405. DARMANTHE N, Tabatabaei-Jafari H, Cherbuin N
    Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210092. doi: 10.3233/JAD-210092.
    PubMed     Abstract available


  1406. KVELLO-ALME M, Brathen G, White LR, Sando SB, et al
    Time to Diagnosis in Young Onset Alzheimer's Disease: A Population-Based Study from Central Norway.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210090. doi: 10.3233/JAD-210090.
    PubMed     Abstract available


  1407. SAMARA M, Levine SZ, Yoshida K, Goldberg Y, et al
    Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician's Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: Evidence based on Individual Participant Data from Five Randomized Clinical Trials of D
    J Alzheimers Dis. 2021 Jun 9. pii: JAD201541. doi: 10.3233/JAD-201541.
    PubMed     Abstract available


  1408. RICHARD CHEN X, Shao Y, Sadowski MJ
    Segmented Linear Mixed Model Analysis Reveals Association of the APOEvarepsilon4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210434. doi: 10.3233/JAD-210434.
    PubMed     Abstract available


  1409. COVATTI MALCORRA BL, Mota NB, Weissheimer J, Schilling LP, et al
    Low Speech Connectedness in Alzheimer's Disease is Associated with Poorer Semantic Memory Performance.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210134. doi: 10.3233/JAD-210134.
    PubMed     Abstract available


  1410. VECCHIO F, Miraglia F, Alu F, Orticoni A, et al
    Contribution of Graph Theory Applied to EEG Data Analysis for Alzheimer's Disease versus Vascular Dementia Diagnosis.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210394. doi: 10.3233/JAD-210394.
    PubMed     Abstract available


  1411. SCHOEMAKER D, Velilla L, Zuluaga Y, Baena A, et al
    Global Cardiovascular Risk Profile and Cerebrovascular Abnormalities in Presymptomatic Individuals with CADASIL or Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210313. doi: 10.3233/JAD-210313.
    PubMed     Abstract available


  1412. ZHAO X, Li C, Ding G, Heng Y, et al
    The Burden of Alzheimer's Disease Mortality in the United States, 1999-2018.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210225. doi: 10.3233/JAD-210225.
    PubMed     Abstract available


  1413. SPERA V, Sitnikova T, Ward MJ, Farzam P, et al
    Pilot Study on Dose-Dependent Effects of Transcranial Photobiomodulation on Brain Electrical Oscillations: A Potential Therapeutic Target in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210058. doi: 10.3233/JAD-210058.
    PubMed     Abstract available


  1414. BEN AYED I, Castor-Guyonvarch N, Amimour S, Naija S, et al
    Acute Exercise and Cognitive Function in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 1. pii: JAD201317. doi: 10.3233/JAD-201317.
    PubMed     Abstract available


  1415. GRECO FA, McKee AC, Kowall NW, Hanlon EB, et al
    Near-Infrared Optical Spectroscopy In Vivo Distinguishes Subjects with Alzheimer's Disease from Age-Matched Controls.
    J Alzheimers Dis. 2021 Jun 1. pii: JAD201021. doi: 10.3233/JAD-201021.
    PubMed     Abstract available


    May 2021
  1416. JIN N, Babiloni C, Drinkenburg WH, Hajos M, et al
    Recommendations for Preclinical Testing of Treatments Against Alzheimer's Disease-Related Epileptiform Spikes in Transgenic Rodent Models.
    J Alzheimers Dis. 2021 May 29. pii: JAD210209. doi: 10.3233/JAD-210209.
    PubMed     Abstract available


  1417. DELAZER M, Zamarian L, Djamshidian A
    Handwriting in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 28. pii: JAD210279. doi: 10.3233/JAD-210279.
    PubMed     Abstract available


  1418. JEONG W, Joo JH, Kim H, Kim YK, et al
    Association Between the Use of Hypnotics and the Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 27. pii: JAD201319. doi: 10.3233/JAD-201319.
    PubMed     Abstract available


  1419. BABIC LEKO M, Jurasovic J, Nikolac Perkovic M, Spanic E, et al
    The Association of Essential Metals with APOE Genotype in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 27. pii: JAD210158. doi: 10.3233/JAD-210158.
    PubMed     Abstract available


  1420. WEI W, Liu Y, Dai C, Baazaoui N, et al
    Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
    J Alzheimers Dis. 2021 May 27. pii: JAD201599. doi: 10.3233/JAD-201599.
    PubMed     Abstract available


  1421. THOMSEN BB, Madsen C, Krohn KT, Thygesen C, et al
    Mild Microglial Responses in the Cortex and Perivascular Macrophage Infiltration in Subcortical White Matter in Dogs with Age-Related Dementia Modelling Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 26. pii: JAD210040. doi: 10.3233/JAD-210040.
    PubMed     Abstract available


  1422. KING-ROBSON J, Wilson H, Politis M
    Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 May 22. pii: JAD201457. doi: 10.3233/JAD-201457.
    PubMed     Abstract available


  1423. BARRIO JR, Whitehouse P, Alavi A, Hoilund-Carlsen PF, et al
    New IDEAS Amyloid Imaging 2021 Study: Running in Place with Ineffective Anti-Amyloid Treatments for Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 May 20. pii: JAD210383. doi: 10.3233/JAD-210383.
    PubMed    


  1424. LI X, Tian Y, Yang YX, Ma YH, et al
    Life Course Adiposity and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2021 May 20. pii: JAD210345. doi: 10.3233/JAD-210345.
    PubMed     Abstract available


  1425. LAURIOLA M, D'Onofrio G, Ciccone F, Germano C, et al
    Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer's Disease, Vascular Dementia, Psychobehavioral, and Functional Complications.
    J Alzheimers Dis. 2021 May 20. pii: JAD210166. doi: 10.3233/JAD-210166.
    PubMed     Abstract available


  1426. YANG H, Luo Y, Hu Q, Tian X, et al
    Benefits in Alzheimer's Disease of Sensory and Multisensory Stimulation.
    J Alzheimers Dis. 2021 May 20. pii: JAD201554. doi: 10.3233/JAD-201554.
    PubMed     Abstract available


  1427. BARTHELSON K, Dong Y, Newman M, Lardelli M, et al
    PRESENILIN 1 Mutations Causing Early-Onset Familial Alzheimer's Disease or Familial Acne Inversa Differ in Their Effects on Genes Facilitating Energy Metabolism and Signal Transduction.
    J Alzheimers Dis. 2021 May 19. pii: JAD210128. doi: 10.3233/JAD-210128.
    PubMed     Abstract available


  1428. HAN H, Wang F, Chen J, Li X, et al
    Changes in Biothiol Levels Are Closely Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 19. pii: JAD210021. doi: 10.3233/JAD-210021.
    PubMed     Abstract available



  1429. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2021 May 18. pii: JAD219004. doi: 10.3233/JAD-219004.
    PubMed    


  1430. FERNANDEZ-AGUILAR L, Lora Y, Satorres E, Ros L, et al
    Dimensional and Discrete Emotional Reactivity in Alzheimer's Disease: Film Clips as a Research Tool in Dementia.
    J Alzheimers Dis. 2021 May 18. pii: JAD210233. doi: 10.3233/JAD-210233.
    PubMed     Abstract available


  1431. RODRIGO-HERRERO S, Luque-Tirado A, Mendez-Barrio C, Garcia-Solis D, et al
    TMA-93 Validation by Alzheimer's Disease Biomarkers: A Comparison with the Free and Cued Selective Reminding Test on a Biobank Sample.
    J Alzheimers Dis. 2021 May 18. pii: JAD210115. doi: 10.3233/JAD-210115.
    PubMed     Abstract available


  1432. PISTONO A, Senoussi M, Guerrier L, Rafiq M, et al
    Language Network Connectivity Increases in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 18. pii: JAD201584. doi: 10.3233/JAD-201584.
    PubMed     Abstract available


  1433. BERNSTEIN AS, Rapcsak SZ, Hornberger M, Saranathan M, et al
    Structural Changes in Thalamic Nuclei Across Prodromal and Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 18. pii: JAD201583. doi: 10.3233/JAD-201583.
    PubMed     Abstract available


  1434. MAO C, Sha L, Li J, Huang X, et al
    Relationship Between General Cognition, Visual Assessed Cortical Atrophy, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: A Cross-Sectional Study from a Chinese PUMCH Cohort.
    J Alzheimers Dis. 2021 May 16. pii: JAD210344. doi: 10.3233/JAD-210344.
    PubMed     Abstract available


  1435. DUAN W, Zhou GD, Balachandrasekaran A, Bhumkar AB, et al
    Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
    J Alzheimers Dis. 2021 May 16. pii: JAD210199. doi: 10.3233/JAD-210199.
    PubMed     Abstract available


  1436. JIMENEZ EC, Sierra-Marcos A, Romeo A, Hashemi A, et al
    Altered Vergence Eye Movements and Pupil Response of Patients with Alzheimer's Disease and Mild Cognitive Impairment During an Oddball Task.
    J Alzheimers Dis. 2021 May 16. pii: JAD201301. doi: 10.3233/JAD-201301.
    PubMed     Abstract available


  1437. ALVES SS, Silva-Junior RMPD, Servilha-Menezes G, Homolak J, et al
    Insulin Resistance as a Common Link Between Current Alzheimer's Disease Hypotheses.
    J Alzheimers Dis. 2021 May 15. pii: JAD210234. doi: 10.3233/JAD-210234.
    PubMed     Abstract available


  1438. YIN X, Xie Q, Huang L, Liu L, et al
    Assessment of the Psychological Burden Among Family Caregivers of People Living with Alzheimer's Disease Using the Zarit Burden Interview.
    J Alzheimers Dis. 2021 May 15. pii: JAD210025. doi: 10.3233/JAD-210025.
    PubMed     Abstract available


  1439. DU F, Yu Q, Yan SS
    PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2021 May 14. pii: JAD210095. doi: 10.3233/JAD-210095.
    PubMed     Abstract available


  1440. YE F, Wu A
    The Protective Mechanism of SIRT1 in the Regulation of Mitochondrial Biogenesis and Mitochondrial Autophagy in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 11. pii: JAD210132. doi: 10.3233/JAD-210132.
    PubMed     Abstract available


  1441. MASSETT HA, Mitchell AK, Alley L, Simoneau E, et al
    Facilitators, Challenges, and Messaging Strategies for Hispanic/Latino Populations Participating in Alzheimer's Disease and Related Dementias Clinical Research: A Literature Review.
    J Alzheimers Dis. 2021 May 11. pii: JAD201463. doi: 10.3233/JAD-201463.
    PubMed     Abstract available


  1442. OU GY, Lin WW, Zhao WJ
    Construction of Long Noncoding RNA-Associated ceRNA Networks Reveals Potential Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 11. pii: JAD210068. doi: 10.3233/JAD-210068.
    PubMed     Abstract available


  1443. CAMARGO A, Wang Z
    Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
    J Alzheimers Dis. 2021 May 5. pii: JAD210116. doi: 10.3233/JAD-210116.
    PubMed     Abstract available


  1444. DU Y, Dennis B, Liu J, Meyer K, et al
    A Conceptual Model to Improve Care for Individuals with Alzheimer's Disease and Related Dementias and Their Caregivers: Qualitative Findings in an Online Caregiver Forum.
    J Alzheimers Dis. 2021 May 3. pii: JAD210167. doi: 10.3233/JAD-210167.
    PubMed     Abstract available


  1445. HANNESTAD J, Duclos T, Chao W, Koborsi K, et al
    Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial.
    J Alzheimers Dis. 2021 May 3. pii: JAD210011. doi: 10.3233/JAD-210011.
    PubMed     Abstract available


    April 2021
  1446. SERPENTE M, Fenoglio C, Arighi A, Fumagalli GG, et al
    Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210249. doi: 10.3233/JAD-210249.
    PubMed     Abstract available<